var title_f8_33_8720="Pancreatoscopy-directed stone fragmentation";
var content_f8_33_8720=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80055&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80055&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pancreatoscopy-directed stone fragmentation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 327px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFHAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACil61PDZ3M5Aihds9MCgCvRXQWXhDWrwjyrGUg99pratfhnrk+MwlMjPIxSckgucLRXptv8J9RfZ5sqpuzjJqdfhNPtQtdJls9/SpVSL2KcWtzyuivUH+FkqqhN0nzNjr096qyfDO4BAW4UkkjrR7SN7Cszzmiu1l+H2oggROjMTgCsu78Iavbgk25cZxlapNMRz1FW59Ou7ckTW8i49qqkEHBBH1pgJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFORS7BVBJPQCgBtKAScAEn2rsfCnw/wBX1+aPy4THCx++1ex+EvhHp+nmGS+/f3APKn7tS5pAeB6R4b1PVZFS0tZHLdMCu+0P4RX1wiSXz+UCcFCORX0Hpuj2llHHDBboqKCcRJhh+NXRHtVCCuQCQVHP41m5tj5TyvRfhZo9nsaaNriQH5h6iussvDmlWaoILSBMMSpZQSPY1vSgr1DDjI9s1XbAwCw6dQOuexpXuFtLEEdpGo3RIOFyNgAANDRLxjaNwzknv3q1gHPG0kAc9BSSLxINykMcAAfe+lDk3oKyRRaEE4ygyOc/w1E0attOQFbjCDn61dkHBPO3dxn29agc8s3PPccbT61kko7mtzNuYwAR8oLcN8vKVTkgDrhiFyMMSPu/T61oykM6hcj1Gep9agfbswS3Xkdeaqyew72MWaHaSBsVmOAfSsm4jAxz944HPSukvUbEnBzgAjHQ+lYOp/K5DDB6lWou4hZM5u/hRgTtGCcbSvWsi40u1nbEkCFQPvY61v3KB2yA23PQHgVBLESjDgHPCMMfjVe05kNQRw+p+HrVdpi3oxGcY4rBn0iaP7hD/SvRb6DKglXOBjJPWsmVCDlgBnoR2p+0ZEoJbHAywyRHEiFfrUddxPaxyKQ6jHfjofQVj3miqSTESh9D0rWMrkWOfoqxc2c1scSoQPUVXqhBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUtOjRpHCRqWY8ACvVvh78LbvVPKvNSUx2xOR7+1JuwHCeHfDF/rk6JbwvsJ5YDoPWvdfBfwqtNLVJb8CacYOR0/GvQNF0C00i1WOzt0iTGGwOc1txRj5gBh8DG3096w5+bRhYg0+xgt4ljhRUTd90DCiraJltmAyjJAHT86kiAYqQQfmxuI4z9KUpmMAn5QDw39P8KEh81tCDkquzLEDOBwVqMjYco+7I6qMCrEpOxiylvlAVehqOX5g7Eb9uACvAFVyrcL3M+4VeTx1xn0/CqrKSWOCzA8jGBitGUE8BgDnhccmq8qrn+7j16ioRSRFEdytyGOcAAdqfIAAeMD7oB6r70satnnAHUc8GoySCSrhTg4YjPXtRcm2pBMCDgYweBnuO5qnM6scFiAT19MVZlwNxA46EMc/iKrTBgCU+dT8uQKlxuaIpyOSTnC54YBeg9aYXY5CbhvGBx1FMvPkLFPMwBgAnqO9Zsky4YhiqdMgnK1pBWVxWdyS5lVY8LwPu4YnP1rAuZDIWAYAdCepNaM9w7gDLZ6Y29V9azpvncBSSB90AYyPes7qO47FExlyTtz3AziiVDsIPyg4b5hkn3qyYd6jLL83dv4aesBdW2tkEZKgHjFQtdjS9jCvYQC2455z8p4H/16wnX97gjJ5wDXRaijNEz7cn6Y49a56UnJVgcE5yO30NOMlezBrQhwcYxz7UxlJwD0PQetT9c5ByeOO1SRR7uig/wjHarbdyUjPlgSQFSFP1FYl/oQIL242kdV611otiFfCEAEDrSvCQCCME44x1qk2iXFPY8yngkgfbKhU1FXol/YRXKESoCOnTmuQ1TSntGLRgtH/KtVNMzaMqiiirEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVmws5764WG2jLu3YCnaZYT6jdpb2qFnY9u1fTfwp+HEGiW8d3doJLxgGUEZA+tTKVhNmP8AC/4VxWaR3urRiSYgOi4zj617Ra2iRKkcQPHI2jCgVbhhVIgqqFwcjA5PrUqp93LfcOAB0IrO7YFDyszfISxJOSBg/wD6qcsYIGRnCkELwfxq5s+VVPOGPyjqPxqLyi2FBLNg8HjFZqm2zRSK6qBkjdkAAMBgD60PgZI2tjAJA61JId4L53bSFJ6Y/Coj8+f4gzdBwDWq2sQ1cYxG/aDtGQcnkioXxwSMMSTuPQ/hUjE7m2g8du4qLHTkVPMr2GkQ7TsKoWw3r1B9qjcYVQS5A4zjvVhkB3FYzkn+9ULLlmCKeegJ/M1LaKSZXJ2lgAOSBwKjbOQcDIOcE9cdqmOSVDYCj7uP73+FMXK/eGMk7scnNQn0K5SBhhgC23GWzt6e1V5YyBh+A2Tx/nrV5sk7SSJD39veqcx4IQ43HleuAPSm02gvYyL2PeF3LtB6gAkgetYs4cMMAbc4X3Fb10ytvYEqeme4FY1wiMxOAc9x/D9Kzs49TVWasZ8j4bjkdAR2pqxqRkYUk9x0/wDrVakG4kjOTxjHQe1IuSFz19/Smtwt0RGIgUAZdwP31HH0qYWxKsAuCB8xz2qa3jDuhzuTPG44/A1bjgXyxkrhmJ+Ucim7iv0OX1GyUjaq4Y87+yj0rlbu1ZZiNoCHJB9fcV6NqCBlyzFQBuyRw2K4vWUG04UDccgqelZRbUi2rowgm/A6jHUcVahjBODjOOfakSMh+2ewqxGhVDhmUHgMO/t9K6dDJO24oUFchcjHTpn3prx4QgnC9QvUn8e1WQCNxbPTaQe1IF7Akg9gPSpkm2DaKDxEHcecDOPT/wCvVC4g81Tx8p9s1uOgwM45Ocn+VVLiPJORwecDjAqb8pSimcJq+kAEyWwwe65rAIIODwRXpNxEGPrnpiuZ1vSw2ZIRiTuB3rop1OYxnGzObopSCCQeCKStSAooooAKKKKACiiigAooooAKKKKACprS3kup0hhUs7HAxUSgswVRknoK93+C3gTATVNRQD+KMEZDVMpWA6b4QfD6PRbeHUbyIPcsNy59PevYoVCoVwuFORnqfaqlvGscWAi5ByCD0HpVxDktyTnnA6YqU0tQ9SdcgHgrj8acFynQngHimMrAttwA2CrZyRT1yqgO2WXoQOv1ovfYTEK70YKPlLDpwKiYZLbVzzgJnpUz7XUkheCCCOlRPhuw+YklemfxoYFdh/Hu5VuuOn4d6ikX1CjgnB7/AOFWnyQCDgqMBgOntVeRMMV6E9AOd1RKLLRVfJXJLFVwM4ximK2TjPGfw/OpnTGCwUAtyepGKgIIQEEk5/i449qleZQjgMgDrkddp4/KmSLuYE4xwNwHIqZ8cgZIyACeo+nrTSv7zcSc5xu7/lUyjfUpFVxuLYyT7DsO9MA246gbTz1OPepSgJBCknbxg/zqMxkIxRuMAEgdKSiVcicEI2PlBwMf/XqhcfK+xgSEByAf881oTKPJl5LAkcjgH61nTEYBUjqcZHX2qm7EuNzMuS3IIZTt+Ye3+NZ8wbBByeMnb3X2rUulXHy9jnO3r7VnyRqDxhueOMZ9qxcm3c002M6RsyHdH8vbntSRq3zABVwQQeuB/hV4xCNGbjYDyyjNN2sBgHB6g98e9VG7YPQdDhGLEexIFWBNuCjguRjGMbfqarl0YdeAMjcOTQH+Yoq8/eCH+ZNbpKxnJhPg8AqMg71C5xXGa1CUfoSf4RjjH+NdhPIAjEEuNvyjp+FcvrUhaQ8LHjnAGc+9c0ou5pGWhhxx7sHd1/ujvVuOIgcj7o5Ge/rSxpkg5574GB+FWY4lbjBK9eBz7VtYzk7kMacHayk+uOtNZC2dwyRx1xircsRUAsuMckk9aYY8gjaBjn8feiL1FbQpkZbG4DHGAM5FQyx8c5wemTmtBomMeSMKtRPGGU44PAAUdf8A69JxuUnYx7iMYOAM9xj+VZtzGBtx3446YroLhOSRnaT/ABGs25iySAMsevHAFTG6Lkr7HH61pwcGaFcMOo9a50gg4PWvQLiIkHIwpGcZ7VzWuads/fxjAPUV1RempzyjYw6KKKskKKKKACiiigAooooAKKKnsbZ7y7it4hl5GCigDsfhd4Vk8QazG7ACCNsnPevqzR7SOztFiiDIkfEaY4471x3w20CLQ9CihXIkYbnOO/au9jyv8JYkYP8As+5rByuyki2iksqxk8jKk8DPepkUHBHCk4+Y9D/hUURHlEYGwcAE5Kn1qUYxnkt0XA4xRBK4S3J+/O1SGHygZGKcSSzfNuUnPTFRLjOEOR/Du/XNLkMrABSf4c/wVpaxLHnBCg7VwM5qOQ4GDzx0J569RTpSRvAYMjEcY71GTksAuAzZwD90UeYrCFhgktkA43en4d6ZgYjJTIyTjOFPvSOdoQng8ndnP50hOBkgnI7jp7ikyloRFRhCMEYJyo5HtUPlkqR97I4LcH8KslQNxDPnG0MOPwNRyAZXqAOhY9DWUloaIgJ3HO5mIbG4jBHsBSDcTgDLbuv8X5VKzEkgs2dw7f1pgx14PzHv8350Jq1hdSBl4BUk/KenX8aidRgk8nA+Ze1T4LYAOWAOeen+NQuVIORk46Yximhsq3DbSWPXfywHFZdxJtkZuMnPXoavXTEA4bo3XvWLctzjJxk9OtRUuVFXI5JdoTaWXA+b/a9qrTOQ+1SqsRnO7jHpUbuRtPT056n3qtLKMMuTt+8Bt6tUxlFbjasTzTBIyEUoF5CA5H1NVHkXGDtYDGCeM5/pUBff14GfmION30o8xg+XbJIwSw4AptpbDs7FsyFcliVdeuOQoqGSZFO0ZCg/dbqaro6kJtReMgAtjPuarzSkKylyoIwzEZx7ChTQJDdR1Dy0ZVGGHy89vasPf5xw3XHaluyd2B3Hb+vvUVtkkHaM9j/e9quzlsJpR2LsZO8kNuYjpt498VeQKzLjMgK8FvlFQxRybgASoHQZxg1d8sqCABuA+bJ4J9qOWwrXIVRWG1VJ3HnjJA9c+lRtGC28gscdG4FToGLD5m+UYXsB9aV+CMIAT1xz+NStBXWxnzIQAQhIHPHr6Uxl4LsDgcYzzmr8iMx7EgfQYqsUCsuBhsZAxmk77jKEsY5BxuxnjnNULiLcgYcKeCK1pRxyWOTwQKoXOCPmAJB6sKTuUnYxp4wAQBkdfp/9aqFxGrryo3N154ArYuI2bGOAxzkHr7/SqE4IBBY8davma3E43OE1O1NtOcD5GPFU667V7ITwsAB5g5znpXJMpVipGCODXTF3RzvcSiiimAUUUUAFFFFABXpvwY8O/b9TbUJ0zDDwoPc15xawNc3EcMYJZyAMV9S/DzRo9H0G1iAwWAdjt5H1pOSW41udfZARrGCoAGW4POK1EfoQwGeeeazYHGARg/NnO38vwrRRvlZsn5uXwvT0rk5m3obOOhahwMFCRj7vHQ+9WQcEo27A9Wxg1S8w5BbJk9OgA9akMojHIUbf4zyG9q3hZGTRaBDAgKpL/dzwPzpfNDKCecjDccJVTzMZPUKuSrnp9KN3XazFSAPT8KpgkWieVJ24PTceDUat8hbazgDkMcY+lQkglgxX0AAzx6ih2LNkEnjCM3ApJpjsS5/g53MMAr0HsaQEhxtBWUfKvPHvUG7chAY47/WkY7iBtVex5+6fWok76DRITuGDwM4AY9D700EB36g52sMcD6VHuHJRU3H5cf1prMCpKMWAIUMxwwodrDUWPzgFWG3nbgt973pmV2YBB+bBGOPzprPkHOw/NyTyeKRpC5YHIBycdiKnToOwSH5Sp+cg/dx8oHqDVW8bIb5iwUDBYY21NJIMLypyMLg42+5qjdSqVBBGM4Jz3HeqtpcErsoXL/O5HzsG5JGGrEupPMJ+XHPzHv8AQeprSunIyVJyRyfesli28Yydp+Uep9Pb61zzm5bGsY2KO0xAg7WRTnn+Ien1qvIWyAWJ55wc8egq/Ki/LwxJOQMY3N6e31qlIAx3bV5yd2Mc+lRCXRl2IHyXU8FicAMOMetJjGONoJ5we/r9KVvmHV/n5IA7+tRk7nIGOV6kdK1bRDFlc4JYAt/eYdPYVnTzbsbQUH8Kn9c1ZmZlUYO0JyvOdvvWRfTLuY9cdSeualK7H0IpJFDjPIyQO1WLQDeOy/7PUj0rLEhLYPatK2lK7ecNjtWi0M2b8EaEKHRMY3A55I9KtmBdihlO37xU8c9uayre5IXCADK4471pQThomBKtk4XceR+FOTuStBrQGNi7BS+OAxyOaiYDZgncFHOeME1bDq3GRj0PA+tV7gKWRcjeRuU45/GpXmNq5Vba4JCqWXjb/eqGVhtHzMwAwc8AH0qWUnAJ3AE/NkYyahmGM7ty/wAQCnIFU9wT6FWTbjChOR/e6GqU4YAKMqPvKBzz6n2q/Jk4HOAc8pyapzDBwMHJzu6Z9qTTew0zPnjVge4PJ7flVGdfmG0YPVfQVpyYGcEbxyM9BWdOFBJ//VSeqsDM25UEHjj3rktbtvKn8xQArenY12EwxkbgMdB6CsnVbUTQOB0xkfWtqd0jGW5yVFKRgkHqKStiQooooAKKKKAO1+FWk/2l4jjZ1YxRcsQOlfT8C7QMFh/CCOhUV4/8C9MMOnzXrBgZOAQOtewRHoM8Hjk/drGcbu5pEsxrgqdzEH3qykhAU5Yxt1GeoqnuIDrhTk4z/WneYdz52lBjkdfqKmCSKL4cAAEE4Ocjkge9JKomV1b7vXDHr9Kp+YVkGDkkjn1HvUisPmGOh4yeF+lNztsFi2GGNvLMMAF+o9hUxYtKTk8dyOD7VVDHGfm59e9P3DqeSe27qKV29x2HhvlYknb6DgChmKqWJBx685PqKYWJx3xxj+8KTccKQWyPunHbvSb6DtZEjNnoQVAGCRjNMdwA2FOOCR2z700YA4OB/CSc7aYhVyAShboQT39aylJrQpRTHljk4wMHBzw30FJvPBCg8FTn+X1pQuSe2RgM/UewpD0HRR0CscEGkm3uFrCEthdp5AwOKidio7HjIyehFPdgRh2z/e2n7xqjczEgfeG444Hp0q7NKyEPnnyp3EHeMsAvT3rMmm3M2QOnOV6UT3BPJ3cnGenI71VEgbkHvjk9/Wic9LFJajLhi7AEqoIxyPu//rqqRhsgKGztHP3asysctk/L/EOMk1VmByVctv6PjH3ewrBXTLZDIuQR0+p5qlMmc5ORnKrnj61blZ3JJ3b/ALrHHBHYVAysWUbcHptI6j1rRKMUIpSAkHjj72Txn6VBMSqNkjAwfoD1NaBiCg7iSvc9QfpVC8fAXOzceMH+EetRfS7BO7sZV3Msanjp0BGD9TWJKxZjjPXv29qsXsxaU8kleMk5xVYcnOOnf0ojJ2KkhUwjY59Mf0q5FkMMHPpVZVyQRnPvVuFeR6NwcHvWiutTNouQMNu1Q3rtXvVyIn5WOVOM5Awaq26cjJJ3DBwasHBDgMSygA5q1Zksn80hztA5OBk5x71aR1YHJzt7sOaqbCeQCVznpgCpkXa+wMd3VcdAD1p6PQjm1HyKAAw2nB6MeADVKfaASFQqDjrV5D8uQGDqcKNuciq0+1cscE56Fe3pURumaaPUz5WZW5PTgkHPFVZScbcswHIyO1WZiFHAXk4xVSRcD7w45Jz1FWtFZkNFOTA6AHHTP86pyBT3IH8WKvOBsYgnPVsHtVSTbggAg+pHaoSe5S1KEgBxnlenTkVXlhBTooAPerj43Z7dKgYAggZyPXnNdSfu6GTRw+s2/wBnvXHGG5wO1Ua6HxNFmOOUKBjgjvXPVUdjNhRRRTAKdGpd1UdScU2r2ix+dqtsmM5cUnoB9LfDu0Fl4dso2VhuAJz0rrVAJc8k5w2O6+1YOifu7CFFyVCAEDtWqjg8A5PQZrG5skX0J/vMC3y7SO1OYEqpXGR3PFQK5JUknjqGqyWIGM5AOcDBFQnqXYbjByq7VYcFjnmpYQQOBgDoOopqqACwOQP4hzj2Ap68AA8cYI9KmW47FhDnZkkH7uc/09KcOuGXaw4B7moN2SxfaASBgjkU/cDkllI6c9W96qMlLcLEjZBbcTheRyODSYPA5I7g+vrQDyowrAdQQfm96EBJ3Mwz/CRx+JpSkraDGuC/Bzz3HHHrTrcKykqw24x0ztpZAjKw52k45PT3p8ahBgfwnGVGFP8A9eskrvUG7AqHy8AAHO0KeaY5yxU89h3PHb6VMSNqqpBBbOPT2zVOeQABcHHONvX6Zq+S2or3K9y2EOGIJ64HU+lZF1Md2R8pPABPT3qxeXDMSMjIHY4waxp5DycNyM/N3PrUubWiNIwTCaYkDccbuR/jTRKN2QEHGAcfrVV5epAJxzkdh6//AFqngDy8AFQOeR2NZXbZTVidW4GAMdDgc/WlWNzkleAMZPcVZhtwF4OFPC7zytWEi7Kylfu4B6/59au2pm3Ypm3V8btuehAPWmG1HJwTv+U46mtYQ5Yhg2MYbI/SmtFnBPDHhsjGK0cdAUrmDd27lPkzk9hgAGua1a1kdmxu54Leh9a75rcMhBCqTxg/zqjNYgseVyeOD09655p9C4NJnlhtGRyGDDHb0qWO3JJ4AA45/hrubvTUZ9xwpbjbzwfXrVD+zAGK7XCdHI5yaqmmlqOTT0OdjtgnGFAzj8KmiRVbGB6citaXTz3JyOCuO1VjA+7C5HHG4jGPSt07uxk0QADOR16AgdferEMeXwod/oOoFRkBeVbr0BNW7Vd2PnABGdwyMfWrsnsZ6p6khjAU7Bwx+UMf50gVQ3HJA5B6D6VNJjG47ANvQA/nVSSQKQrsDjge1SnrYbV1oTxnavDEtnrnnHpVO5IUk4c44I9RTvOUAH5yentVWa4Af5fvdPoPSiWr0COiImblgd2Mc89vSq0oxjOePu57e9OkI5PG0cjjr+NVJMncfm6ZxnFAyKccHG3P5fjVGbDNkg8DpVyRsqSfTOSOtUZD04I59cke9TzWRJEw7kk+oNVnHJOcZ9KnbJU8H8agPK44x2BrS+gktdTJ1qIyWsik8gZFchXb3qFoyOM7e1cVINrsPQ1tC9tTOW42iiirJCtrwiu7XbfJGAe9YtbXhR1j1RHbkDtmoqu0Gy6ceaSR9GaTeB1RAy4PGegYehrctJASAQQ2SPavPNBvo8KFAYvwAe1dlbXq7fl3N0Ifv78e1cFOq5Ox2zp8uxupgkA8sc8A8/WpVkLjgoSFzx39/rWTHdjftUM2T/F1arBnReMhcHp2A/xrpTSM+U0nmCoCCVAGeeCPp61HBdx3CExdM456/hVMTZyuSNvUHn8qem2M7VXyxnIHXH41lKSKUTRDZJ+Zh2Ge49KkV9yrkkE8DcOMVnqduGIA2nGC3Aq1CWbGDjPftj0rNvl2G4lxeQGJYhuCQetTBG6MGGeW46HtVdXU8qU2njGOT71OCCfm6nsx6+9Ul1JasObIBJDAjBPGcHtUgb59zbx3YKOM/So5X2nO5Cq8cfxe9QSPtyuVZR3B6/StHT5loQ3YkeQ/KpYZGWZTxt9hWZPJwu188HGDjHtVqWQhMDOwdSeTn/D3rKuXbnpjpx0/OolOysXBJlO6LOSCD+I6/jVGWMkcsSexJ7VoBNxAPGeOO9WY4dmPl5Iwdwz+VYpOZd0jAFuchnH7v+92/wD1+1akMCRgE/uyBnLfpiri24IUADbyDnpn1x61NFDtU+hXnI3ZH9K1jCwnO4xYcHG0gsMFW5Jz6fWp0jHmEAjGNo3DlfpTo1AIUfKOuM5wPrUyAo6kMQcHtmq20Mm7kHlggA4YMdoO7HzevtSsg2kkHg7SM/eapjhFOAqqRg7ud2T+lGF8wqDgqOhHb1PvW2jRJXxgHdv39HPH4Ux1zuDDA/jAHIqyV4B3ZI/hYc/U1E2QFI2nb3x973rNRHcpSQZDAkgHrkZ2j1qlPacErHuYdQD0HrWztA4LAkeg61DLGo68jodp5b2FQotMrmVjn5YDkqTkL0Pdv9mqU1sSGzgFuSMfc9q6OQD5lKnjgg/oBVSaAE7SRuxnBPL+1NrTQaZzE8BAYgAE8Ebf1qFD5ShWztP3uOvvW9La715HJOGiJ5Y1kXlmU3FSzYPIP8PtUwk47hKPMyvNcBzgZJ7H1FZ9xcEgAlskZPcUsm4PjjJ54HSs+5O0FSBuPJwensKrnQcrRI03TLdPTtUbybRnggdF7/iaoszBjtBB649qazsScdMdhn8KtdzNlsy9ACAfXrmo5GLDJznOBk1A3rjj2pobB59e3WgAc5zuyceneq8ufTr6dqkaQdxxnv1HvUExAwR+AU9aNtwsQyAgHBJx3HaoMANkdeg56VLM6/NuOeOi8VC5B4OCcce3tTiroTIJckZ+orjL9dl5KP8Aart5BhDxkEdPX2rjNWGL6TNbU29jKS1KdFFFaEhWloThLzJrNq3phxcCoqK8WioO0kz0nSdSaMorYIAxz0Pt9K7LTtRWSNRv4xyT2x/nivKoXZQBncCc81uaRqUkMgG47f7vZv8APavNlHk1PTi+ZHrFtOrAkkkkhs5/n7+1aUL/ALzJyg9PT3+tcho2pRSqm6RXYnBUnqfU+9dLaXAxjcQgOeuf8mqhLmE1bc1IlddoKjGSCewz3HvU6bNoPOPu/Kc/lVSB9o+UqCOcDkAew9aspJsbEZAbqAB0+lXdIncl3lWJUqWUYwBnI/wqeGXcAq8/h94e/tVLzOSwJA/h9/UfSkDkkYzjHAJ4x6H2qLXGzWSU5by9zBzxkcsO5+tS/aSr/JuKkcFuuO5+vtWMHbluQCfl3N0+v9KeJiM/N1OSW6/j71DkyeU1zKWDbRgjlSfT/H2pkk4BzuRlVdq4X+XrWetwCM5wxyTxyPb61H9obIxuUJxgDO0n0rVVHYXsy20uDkDO35QccD2qERh3AyMk7R6D/wCt70yM/MRyWzggHPP+FWo1yoKr8hyVJHUjt9Peph7zuO1hiRHAJUHccE+uKmSMDbtH3jkkHkfX3qQISWC4zwwH901Jj5s/eUnOOhPvW17GbIgo4xyDlsKOfqfejKx9cKuz7y85+tPCnIQBiQDwpwR7n/CnmNXVt3zcDJQdPqKcpEkOGDZyAvAI659ql5C5UkYON4OVUelSBRnLE4DffH+FMTgBiFHzH5jzx9PSpS5txAQqg5woc4Bxw3+H1pMFlII3c5Kn7xH1p2eQS21iDgtyrD2HalVMLtcMcDIBODmrjoSyILgjDYyOMnt6UKAWXDYI+7ntU5BZjtbPTGFxz70rh8kFTz145zVLcm5WKEKSMgHpz0qKRSGOOCRhQev4VaZADl8K+CGJ6D6VEyYQ9VO3jcc5+lNQu7g2U5ECgKcKg6KeTn3qnPESrqw2nIY+/wBD2rSk2hTudFGByBwTVaSMD7oySe54P41m1qWnoUJYwQ2OSTn/AGvrmqc8a7fXK5IHU+5960mUsxxyeTg8D86qypuGWx93gng1NSN0Umc1qNsJFdmVjtGQV4H/AOuubuoDzxwDgkcgV3N9HlHLDcu0e2Kxrm1AclcYz949B+HesHBmidzkmiAOSc9gBxj/AOtULsAMZ9sdMf8A1q2NRtW3ZAVCSeRwp+ntWHKjgnJHHH/1vpXRGWljNxGuwAPOfX0qJpDj1HrTZAwQstV2cjjJwepbrWijfUgcJSScE5+nUVGznHJwew9DSlsjhuOxPQ00Kf4l6HP09xRy3YEcmScHHI49RTcHJzyB1B7VJjI+UgjuBzSEDOACM9B1qrW0QO4xwAh25rjtcA/tGTHSuzkDBGwQCOx61xetHN+/OTVQvcykihRRRWpAVYsG23K8ZqvUkDbZUPvSauhrc6mPkZGfpViIkyLzgjtVKBzsyOeO1XYV3qpJwfX/ABrlqJS0OylJnRabdGJ1MbMOcn6+v1rutKvTIFZ1K+uOufb/AGq4LSIQ0qlvnTOMdMmu60+HYFBBB9D/AD+tcag4s65STR0VtIvlqrdM52gdPp/WrfmEL6ntg8ge1ZlshXBAIGen/wBf1q5b427V+Vc5OB0+n9a12WpCsy0oViu0YU89en/1qmyCGOBtJ546f/Wqv945JKg/ewOB6D6VNHu53A4HUdsf4U72Wg7EnAB5wT97jp6Uu12LF1bH8WePpn3pVUcbuvXLH731qdI9uC2AwG7ry/8AgamMb7kvTYrMuMbwc9Tjk/X60mwJgsenPHJP0/rVsZDYXr2wvU+n1pxBB3btmO4GSD7e3rWcpJaItK5SkZo7d2V1AXoVHQ/3fpV+yYvEX2bMDgBun09qhjt8AmRQSByAeGHt/s1bhHlqoBTA5GBjHt/u1cJcupnKDuWE4A3HgLkFurVJjKjkEccev40wD5OflyfmJ5A/+t6U8jB5G3d0H+Pof8a0U1IycbCADJ3KSuD8ucY98+tRuCj7xl1Kjpxj/GrCEKVBwXUnKn/H1olwI/nwo28A/wBKohibgzOfvPkfN0I+gpyDPlkFVYEhmPX8RQAGiZgAc4wxPP4U9gxyF3bv4c459quJLI1j5IUZbGADzv8Ap6ClALYVF3MT0J5WnFQGJ2fOBxk9DTUIK8lSo7dwfU0J62C1xCgcsRuYE5BLYoIQMxAA3Hgk9D60OwGQSAw4AA60rEleWwh4D47f40+ZITQ3GcjbwTxzkNUeP4gFUjkEDOKeWyxAH5dvcUud2dgLBuFHTIpxbJK7KR1yM/NyMjP+FVplJ5IyQ3PpVsYxjOPxz+FV3wxGEwzNwAemO9J2KRQkRQAWGRzgZwKrMhyB1AH8X+etX5QRtbjHOc/1qtIOm4gccA/xH/GpexZmTxkj5iQSOM9fw96zp4iCW4HPUj+lbEyjcGOcjsTyDVGVBuJJK+ueSazjFhcw7qFcHKgHrkng/T2rBvbLHJUqD0/z6V1lxAwDdPuk8/09qzpo9qncdpKjrzn/AOtWiiJs5C5tSjbSpGeeT1rMniKsQRnv7iuxu4AR8q7D781hXdthjlMc8nPH403NrQFHQxAGGey+h55/xqQLhATz756VKyBWxnqeMf560hGccYB6H1NNMm5ASSD2x+GaWNTnkcHtUirwCQGB6k04KAAOuK2jC4uYrzA7DxgHp7VwmpNuvZT713V+wW2YlsYHGe9efztvmdvUmqUeUzk7kdFFFUQFKOCKSigDprA7ohjvita0jZyAFwOlZXhQrK4jbk9BmvQLDTMgMqgA9veuWbtdHTSRLoOneaUdgcIeBjr/APXrtbODYuACCCCc8j/9dZunQCPClGKsOc/wn/GuktowFAkXr8uAeh/xrCOp1vYSCMsepUHgkD+Qq4seUGWGDxgHHSmog3FjkkcHB/l71Z27HTOMden+fxqlJXsyeURUHJPfquOv/wBapljHzcAgcE56j/CiMZBOOfr1+ntUqwj5cAsUGcdMemfaqcky0mOijHO0g8YAYcfjUiJhQQTyec8lff60qJlfm+pLnGPrU4TP3FJyMrk8n2J9azQPQhZDnkksASGB5Ppj/apEX5uDjjgoO/f/AOvVqOMPjOQGPO0cqfT6+9KYj8xYA8FsZxnt8v8AWsKkLvQtPQgjUH2GM/L6+3+zUirwMgbmOcfwken+7Unl5IGS2APu8Y+n+z61KE3YQ4IbsOAR7f7NEKb6kvcZEMONuCc9cZz9fb0qVQAiHGwFep53fUetC4Kk7iBt7DGD6H2p5G1jhQMgD1FbQp8uplPUbtCAqoKgdj7/ANaGTdG6hgCRgHGc/T3pxXnDLkg55PP/AOunHPGVwc54PGPb3qubUzaKoieMN5LKx245HX3oM6o+GAA24PU5PqKnIKAFgQc5yD/DSODuG3O7qhx29/arvYmwoY7F2/vMcqCOopv3B8jBgBxxwT6GlVgVyrHk4Dn+E9/wphXBYqScdsYH1p3sFhHdQD8vA45PIb1pqjH3eW7Y6N/9ekIAyVddwGQcdf8A69IqMqsOpA7nB/CpauAr/M3Uhf7x6/SkYja21QSO3936UpAz2U4wAOd1McEDnPB4Ofu//Wq1LSxNhshBGRznG0r0qOU/vAGYgg596ew3ZweWOSOgYVGI+SABjrsY8fnUdRkMmFVeMHkHufxqu/yhx7DI6/8A6jU7AndtJwO3Tb9aryHsp+UnHsf/AK9VICs6YXZjgc89f/11VkTts5POQeauyKwJQYAPI7nP1qvJ8xycbj6d/pU3AzJUCggN1H1/CqEqED5BjI5B5/yK1rhAoxwFB3cc4rPnBOec5PB6E/8A1qd+w7GVOGjjyAqIRz3NYt8u9mKgHAz6VtXSnONoz7nn8axrvBByTkf3u3/16hxYzBuo/nyDk46/571Vzhh3zxx6/wCNaN2N5JyTkYzjv/jWbLxxg88cDv8A41vBdzJ7jiwA9OamB9e3FUfMKNgYI96kSXaBkc9M10RaQmVvEMpg0yUgj5jge/0rga6Pxbd+Y8cCsSByQe1c5VPcxCiiikAUUUUAaOiXRtb1GzxnNex+HGe7AmXZtGGIzyBXhqsVYMOor174daklxZhCy+anKjHX2NYVl1OrDaux6HbqF5HfkqT2rUhYbWXczcYAx1HufWsuCQbDyCe+R19q0LcgqAqkkd1PJ/2R71zNpbHZYuICcEcgDGB2+nvVhFOAAMt1z2b2Ht61XQAgAYYEHODjPsPerC4wNgY8cY6H6fTvUtDUSeIDg5wc8ADJ/wD1VOAD7rk/P3x6kenpUAzvwDn+I7eCR6j29qmSRQgPAA+bdzke59vSi11oa8hMijIYgbh0LnPHvU6LhSOTx1Y8qf8AGmIeTkFO3I6E+v1qcgbnBXacgbSMke2fU04uxm4j1XKkfNj7ny8ZPp9acFBB6AbgCAeRjrj+tKo+4wPyN8uCe/pj+970uOeFxnkAcZ7cf1oVmS7oaApyTyMn5geT6cdh60bc7iQG46ZwPqPakYMJAdobgcr39/pUpTDYJIbO75eePX6VOtwGqCTt3EDP3jwMe/8ASgYK4XIBOdnQf/rpQ4GHBXPLEkZz9R/KmSHhQA27HQn1/wA/hTkn0IaQ5WIJbOOCPl5P0+tBG3A6MB8qjkf/AK/WjIyOMkjA4xn2/wB73oQhgVAU4+8QeR7fWnGLZEkUpTLGrFT5vOenX2qwmPLzkAnvzx/9apQNzfL97qoU9BTQy5AJOCTzjOPU/StPJmb8hSoEuEIDY4A+79aYfm+X5mA4GeoP9aRQQoUHcnJG7gfX/wCtTlf5eSxRPb7pokAxlY4BBIY9cYB/+vSAAgEjjODnkinthMqdpwOm7I5/rUbYU9T0wCv8jRshWAjOcj3wO/0qPtk8N6gc07jlSvzHg4OT+BpHYnBPJPP1ppXEQSBt7fKGjUfxHn60khUKOFJAGMc0844IwQOQTzUTZbGzOfvEdMe9P0AZJnBJOcEDJ4/MVXc5ckYC5Iwfu/8A66lYgEtkbl5y3eoJMZb5g2Dk54x7Y703YCFtu0gLhT1/2qgZsAsCQF/u84FSn7+fug8cf4VCwOAdvDAj5epqLLcRSlO5RswQc8dD9T7VQnLEgnacHByelaE+GIBbPHPHcVm3LBhyADjGAO3rSSuyjMumDKxAwd34/XNY1yMM2DwOeeRWtdHZyDgdBn0rIun4wuD35P8AOnYd7GbPzwOvp7f41QkTOVPfgc/55q9OOT0wemT+lVXxtOFUZ7irjGwnqU3RR97G32Heq9xJtXJ6gZ4q6zDJB5GM9ODWD4guhFasqkbm4BHerWrImrI5i/nNxdSSE5yeKr0UVuc4UUUUAFFFFABXQeD9VbTdSTL7UY8mufpQSpBHBFTOPMrFwm4Suj6V065WSFJYydpAK5wev9a1opEUjmT5eQe/Pb615X8OPEAmgFtO4DR9Nx6+1ejW86vtBCn157en/wBevNcXGVj2ISTipI3o5VIBDb0JyMDG72HvVmJgeq7l9UON309Md6xYrn5ggLbsYKgdfYehrQSYNyDksO3G7HcemO/rVcyehaV9i/HjcTwV68HGP9r/AHauRFsBj6Z3EfKo9W/2T2qrAwZSXClcZJT/ANCx/d9q0YEwmZCFxhi3Yf7R/wBk9hWXK2zo5NCVF+Tn5SOob7qg9MnuT2qaJWCqq5z029wT29z6GmhcYLEIq8ru5C59fXPb0qUACMFiwAG3B/hz/Dn+8exrRaEOA4oVKk5ZiNuUHJP93/e96UlnUlsMwwBz1x1x6Y7+tEjKqtkOwyF8sDk/7IP973pAoJJ+9kZBTuey+xHc046GUoIUjbnGCrLk7eN3uPQDuKTYcMFyQB1U9ff/AHfanZB27stlN3Ix+K+wppbILFsdGJPGR/e+ntVO1jBqzEJyCdwzwBgcfjSL2JxuBwOeQacxG4lvlx94MMAe/wDhTSOnCFlO3HTb700k0Q0DE8glsZ5GOren1pjD5xksG7jbxn+79acw4BAAwduQ3U/41FLKVJ272zwDnOW9KUW4vUTRWubmSILhFILcnBBHtVmOTMYbhc85HaoY5GkZllQkt147j0qyDyCOg/AVrKaM2hNueDjaPmAY5/GkJ+TJJ5P3j/X2pGwOpxt+Y46j8fSmg4AJA45OeQfrSSuSwOFwRlec4A4oZt3BBLE8+h9qax+XjOBxgnpTRnBQE47joD/9epbvoFhDjGOcZx6Y9qjZ/mZRjJ/u/wBKGORlhkn0pDjbnc2OvTHNVshWEaQ565B69hiomkBbGAFzzuJyKV8fxjJPUf1FRliCCu7ABAyM1Kb2ZLGSlcHJyQMc8gVXmdcnJOc5DEcr7U6U4A7Y7nvULn7y9MEe/wCtG7G9EN3gyZUnGfvHgmmHLKNo+YAnIODihyc/dzhvu/8A16rtINgJdwAfTv6U+VCuV5wTggLyNww3esuckNmUrluRg9D/AIVfuHQ59T8x+X7pH9KzbtmG/EYJYZJx0HqKm76FGbdOnsCeCOuKxbkjoPX5uOlaFw7bsnpjoRj8azp2BJwo4681UPd3EylM33geM9fXH+NV5GyD8xyRyMdR7e9TSgZ6Hr+ftVSZhtxnj+Z9KNZFLQq3Em1ckn169RXF6zdG5uiN2UU8elbXiC9EcOxCCX6GuWrelC2phVnd2EooorYxCiiigAooooAKKKKALemXr2F4k0ZPB5HqK9r8Nawl/Zh0bLEYZV/z1rwmui8Ja2+m3axuf3DnDD19q5sTTco80dzrwtblfJLZnvVrvmI+bdkeuN49B7itm3XzMDeSWHDKcbsenpjv61yei3sdyiNGUYP055PtXU6Y8byYkLvu5bAI3Y7jjjH615calj38NR5mdDaRogG8BjtD9Mf8Dx/d9q04sKuV+XYQ+5uQM/x47g+lVLWXfgDb83z52nB/2x9PStC3Ub1wxzy4b0/2z6g+lNpy95M7HBRVrArhWGMxHJIZhnaD6jvnt6U/mMqApXaNgRucZ/gz3Y9j2qw6q8OwDy3Xn1259fXP6VEIysbrsOxRs25+7n+HPqfXtVqSS3MnFMYIw4GVlyBsQE8j/Y/3vekAACjqsny8fKHPsexHc1IVZXw3zEjYQP4h/wA88+vvSxqWI5DblIQMcKw9PYr60Qn0ZjOnpoIeRkMJMkE8Y3Y/iX2Hf1pnVt4IJLbg5HP+9j09qVwSgZRu3DcG6bsfxD0x6d6DjGeuTu3dyf72PT2rqurWOScLDCVKh8jON+48456n2NDDsNwK/K3fHf8AWkYsV+XAON2RyT7n1HtUTYAI+VSeMZ+7/wDro22OeURWwwywHI24x+n196YM4BOOm0c9Mf1pxYkEYwey98en/wBeonOezZYY+uO3/wBehvm0IaHDPHKlieMnuKccbOR8rnK+h96hzuBUkgNxyMZI7f560Nn5mOzDDPHH4/8A1qbgQ0OLDhcd8/7v+Ipu5h97APX5vukU0uwJAOCAPpTHyH29+gQ8jPrVLQhoexyoOfYj0qP+HuQeOe/t9aGY+uMfKCT09jUTMcEYYnvxx+FLRakakhOSQpY7uBnjHtTG53FQrHoQW61Bvy3JBOOueTUTSHgEg+oxgmgGTs4wQpwD93npUBdUwRwF4O096Y0m3O4Hj27etQSTdeFyCOD1x60m1cIxHSyDcedvGCGGeagY4HcZAHByKjkkIkONw2njPI5/nTd/znDYyccfy/8Ar1VkxPsPkYhGXJzkcLyKrzMpDD+HPJHApJHyeDsI+UgHBNVbhi2N5B4wRU8z2BaEM7uHYEDb1PPWs65cAMqck853dqkuZMRnJHJ6D2rJun288Y69OlEUlqy9yCd+uOWPHXtWdKQBgDAH6fWp5pS2SRt9cdhVKaTnac4Pf3q3ytaAlYqTvtIBJGeP/rVm6hcCOJmY9Byat30yIjNIcADDe1cPrGom6kKIf3Y7+tOlFszqVLFS9uGubhpHP0qvRRXVscrdwooooAKKKKACiiigAooooAKKKKAOs8IeI2sJ1huWzC3BJPb0z2r2vwtfrezRup80MQQSww+Pw7enevmiu48B+LH0y6S3u23W7EZz/F6Z+lefisLdc0D38px6jJUqvXZn1Hp5MwOwbVJ35OBu/wBsew9K2oI8RpkbQvzltvOT/F+PpXK+HtUgvLUNFMJI5AHDk5ye7exHpXURMmzO8F0AYsAD/wAC6dT6VxRaitWe5iItMtpGVBxlAvI+XlM9c/X9KaYyACDhVO0gHOM/w+5Pr2qaPB3SDcqR/eYDOzI6DjnP6U+7BUAsAqgDI25GD/D+PrV4dKbucLlrYojEjjcBt5TB7/8ATP8A+vUUgU7l2Fy/Ax/Fjt7Y9e9XGVclfL3AfJwfXpH9PeoJ1O0ANuL/AC+hbHYntj1710zpynuVvoQ+Zv3ZeMq67uOr47+2PTvURYsScKzcOB3P+1/9aplGVJypJUk5GA5H8X1H61CzfLjHyMPM6dR/ex6+1PnUlbsYTgIzKqgseg3YHLf734+lRYA43DIGAV5Iz2zUjcoCwYbTksBwM/xfj6VBJkYRwU2cEddv+JNV7RJWOeVPqI5zg44Axz6+g/xqMfM2BjJ9+h9PrQ+5SNpAPTAPfuv/ANemBlZSGy2eFA7kfw/ShWMGh68gjqx6fN3H8v600sG4+Ylvm+p9f/rU2RtxJJU5XnjB47fhVJpxu4YcfMPc9yP8KzcmnZktKxaZwpyTu7/N3pjMFzgbe4x1U1C0i44zhfmAP8//AK1K3UfMvHzZxzWiV0ZMkLctyhOOvUH/AOvUEj569Pu+470pbCgMODyR2H0qBj0JYYPC/wCB/wAaOZWsQ0Dkt6fMMEnjpUTuTzgnuPSkdh0HzY7HvVaRwByx57Af5xQQx0sg+Y8bB15wfrVIu0ZLFs9jnmlaVSDll+bkkiqzy5XdkZ9aSi9wb0Jmk2AcAYGOKY03yg89gSf5VWdgNxBIXqAetRPKQy4Dd+DyBV200AtvMQpAHGe/+NVbmUEFssRnnFV3nIXgnaxwQD+VVZZyWOCu7HT1xUhcLmQhwQy8jrmsa7c5OGJ3c4PT6/8A1quXD7sDqDyeORWVdN13hsev9anl7lXKks2DgYz/AEqjPcbQTnaAMEHsKW8mVEJJ2465rjNb1Vp2aGE4j7kVpToq90ZyqWQmvaqbqQxQkiMcHnrWLRRXWlY5m76sKKKKYgooooAKKKKACiiigAooooAKKKKACiiigDufAfjm40CYRzszwMwOeuD2PPpX0d4V8R2Wr6dFNZzB3++yJy6nu3Tr7V8cVveGfE19oFwr2srBQcgA4IPqK4q2EhJ88Vqe9gM2cUqWI1j0fY+1rO4SCIgMCgJztXcUz6cc57+lTlgH3E4jVdo54T/Z9wf0rx7wJ8SrPV1jjnkS3uR06YU9+PevTbS6jmwyvGD9xtoBCZ7D2Pc1EFClZtansOnGS54O6Zpy3DbHVYxtYBdrjGP9kf7J9arSuzZ2jcrEDngyY/hz2x2NMUrK8hfBQ/Jtfvj+D/d96JJopIgpUNu+UKzYD4/hPoB29ayr4ibejsiVGw5GGMM0b7uRu4Lgdz6EfrUUgDMXZiP49xHX/bx6+1R+YTuBIZW+bcfvNju3oR2HemM4wpBIY/vN56kf38f3h/dqZVG0rkyiNbMSqSxiwN5OckZ/jHufSoWcrwuVZewOduew9c96dPIVbccoOpKDdtz/ABD1Y9xVOWUjqArJxxyE9h657+lVdNXRyzVmTOV3NgABflC44/3R6j3puT0DqD2PQ/7v/wBeolcjGMgjhRnIA/u/SjftX72SePmHX2+ldEXdHFUWtxkr9+cdcevr+VVi22Qt1xzkjr7mpHbKnG1jnr0J9voKhZeTyWAzyONwqLdzCUrEkbZ6nBHOB/OpNxVccgdTj+lQx9M/MW7nPal3qGG3ICnI5zindIlajpDlQFDHPAGelVcjzCOnYgn9KkdtoGc4B5IPNUnf05BODxzTjG5nJ2JWYEZyGHUAHFVbh92QD8x7dN1IX43HHPXj9Kq3EhYYAYk8sOn/AOqpkrArEbOQGOCvs1RFz3Pvz0qPzemWVR1yev4+9Vy5Izz6kf3vpWlON46mTdmTu5H3/kyPrVRmO5cthR6dKc7cKAvOPXkD0qtLIoUfNk9ME8ijYe4ksg3EkjJOBgYJHpVaabHDdAeh6/iajuZsZVmyD1J/oazZ7wqGx0B70kUWp5/lyCcnqT0NYeo6hHFGzkkAddx6+9Z+sa+lsGGdzHsPWuJ1HUJr2TMjHHpWkYORnKdti5rGsSXZKRErH0OO9Y1FFdCVtEYN3CiiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCSGV4ZA8TlWHQg16L4I+Jl3ozxQ3v723XIAPOFPVfYV5tRWVSjGqrSOvC42rhXem9O3Q+svDfjfT9Xt1FvcJuYY8qRx/wB8ey+9dKLtZEAyvzYU7+kn+y3oB2PevjC0u57R98EjITwQOhHoa7bRPiRqVonl3bechwpz/EPQ/TtXBUwcou8NT3qGcUaqtUXK/wAD6XkvFGB8zFiWJk43Ed2PZh2HeoJLpSpf5lOd2/v/AL/s/tXmOl+P7DUSSZdjkDIY/fI6Mfcdq1W8QJNIGE4Yk7t4/wDQ8f3vauacXf3kdbqQkrxZ2JvhgHds2ndlTwM/xL/tHuO1RidRgqNhB/hOQoPYex71yy6tHKDwAMFhs6g/3h/tHuKtW98NyncqdhtOVH09Qe9a02rbHLUZ0YffuYBQQdpxwD/sj/Z96C/AwSc8HnH4fQdjWZDcISSTnHyLzgY/u/7vvVh51K8Hjpk+o7f7voa2UuxxVCcykBcAE5I5HUf56Uzf/eJyoynq3196rS3Cgbd2cjOemPY+9QPOASxDYC7l+bkf/X9qfNY55WNDcQNw64yKhd1BBHTqCvY1WMpBGDt43Z3Zx/ifaozcYxyAB264NVZNXM9Se4uOc5GAeT/hVZp1yVzwexPX8fSqtzOE+8SARyMdOe3tVKW6JbDgY6YA4/8A1UKViWrl1pix+Yjd0OTgEVUmuNwIY4ycljVOW4JJwBhuu70qvNch+hz26cEe/vUvXcLWJ5J23EkjnHBHUev1oaYAMM4B5wOfyNZU1wpY5YKD3JqvNqEcfUrxnvx9a0btsRZGrJcjDAg+XnOD94VQmu0AOHVff+lc5qHiS3gDb3BPbB5BrlNS8UXFyGSEBEPHIpqDmRzpHX6prMMCne4UngAnNcfqniKSbKW2VXGCT3rBllklbdIxY+9R1vGkkZSqNjndnYs7Fie5ptFFamYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQA5WKnKkg+orQtNZvbYYWZiOvXnPrWbRUyipbouM5Q+FnY2fjSdFCyg9c5HY+tbuneM7dtokOw9OD0Hp9D3rzGisvq8E7o6Fjai3Pd9O8WWkgx56HI2jd6en0rat9ctpNu2RWVvl+9gHHY+3pXzikrofldh9DVmPUbuMYWZselZPDO90y/rnN8SPooarE4IMhYEk89z6n+lRNqCZJ3cn5j7n19jXgUeuX6dJ2/Opl8SaivSY9c/j61P1efVieIi9ke8G/QR/e4PJwOVPqPemS6ngncy5A+bAA49v614WfE2onOJiM+9MbxFqLAfvzwMVp7Bk+3R7XcX+SQzDJ6fNwR6VlXGpxL/ABrsP95q8ifWb5wAZ2AHAxVaS8uJPvTOfxo+rkuv2PVZ/EFvGPmnX8/51jXniy3UcMzn0Brz1nZjlmJPuabV+wjazIdZnU3XiuRwRCmCe571i3Wq3dxnfKQPQVQorRQijNybFYljkkk+9JRRVkhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pancreatoscopy showing fragmentation of a pancreatic duct stone using a holmium laser.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8720=[""].join("\n");
var outline_f8_33_8720=null;
var title_f8_33_8721="Befunolol: International drug information";
var content_f8_33_8721=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Befunolol: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4323560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bentos (FR, JP);",
"     </li>",
"     <li>",
"      Betaclar (IT);",
"     </li>",
"     <li>",
"      Glauconex (AT, BE, DE, LU, NL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1977884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Befunolol Hydrochloride",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1977886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Beta Blocker, Intrinsic Sympathomimetic Activity (ISA)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1977889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of ocular hypertension and open-angle glaucoma",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1977885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Ophthalmic: One drop in affected eye(s) twice daily",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1977888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution, ophthalmic, as hydrochloride: 0.25%, 0.5%, 1%",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10534 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-6BDFF69EB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8721=[""].join("\n");
var outline_f8_33_8721=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4323560\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977884\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977886\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977889\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977885\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821217\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1977888\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10534\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10534|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_33_8722="Patient information: Low-potassium diet (The Basics)";
var content_f8_33_8722=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16441\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"         Anatomy of the urinary tract",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/5/25687\">",
"          Potassium on food labels",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?25/30/26092\">",
"           Some foods that are low in potassium",
"          </a>",
"          <li>",
"           <a class=\"graphic graphic_table\" href=\"UTD.htm?28/3/28732\">",
"            Some foods that are high in potassium",
"           </a>",
"          </li>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/35/28212\">",
"         Patient information: Chronic kidney disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/2/18467\">",
"         Patient information: Dialysis and diet (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/34/15906\">",
"         Patient information: Hyperkalemia (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?13/5/13398\">",
"         Patient information: Chronic kidney disease (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/41/42640\">",
"         Patient information: Low potassium diet (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Low-potassium diet (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H4130437\">",
"      <span class=\"h1\">",
"       What is potassium?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Potassium is a mineral found in most foods. The body needs potassium to work normally. It keeps the heart beating and helps the nerves and muscles work. But people need only a certain amount of potassium. Too much or too little potassium in the body can cause problems.",
"     </p>",
"     <p>",
"      Having too much potassium in the blood is called &ldquo;hyperkalemia.&rdquo; This can cause heart rhythm problems and muscle weakness.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130452\">",
"      <span class=\"h1\">",
"       Who might need to be on a low-potassium diet?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People usually need to be on a low-potassium diet to treat or prevent hyperkalemia.",
"     </p>",
"     <p>",
"      The most common causes of hyperkalemia are:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Certain medicines &ndash; Some medicines, including certain ones for high blood pressure and heart problems, might raise the level of potassium in the body.",
"       </li>",
"       <li>",
"        Kidney disease &ndash; Normally, the kidneys filter the blood and remove excess salt and water through urination (",
"        <a class=\"graphic graphic_figure graphicRef79864 \" href=\"UTD.htm?26/28/27072\">",
"         figure 1",
"        </a>",
"        ). They keep the level of potassium in the blood normal. When the kidneys don&rsquo;t work well or stop working, they can&rsquo;t get rid of the potassium in the urine. Then, too much potassium builds up in the blood.",
"        <br/>",
"        <br/>",
"        Many people who get a treatment called &ldquo;dialysis&rdquo; for kidney disease need to be on a low-potassium diet. Dialysis is a treatment that takes over the job of the kidneys.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130490\">",
"      <span class=\"h1\">",
"       What does eating a low-potassium diet involve?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Almost all foods have potassium. So the key is to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Choose foods with low levels of potassium (",
"        <a class=\"graphic graphic_table graphicRef81516 \" href=\"UTD.htm?25/30/26092\">",
"         table 1",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Avoid or eat only small amounts of foods with high levels of potassium (",
"        <a class=\"graphic graphic_table graphicRef58250 \" href=\"UTD.htm?28/3/28732\">",
"         table 2",
"        </a>",
"        )",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your doctor will probably recommend that you work with a dietitian (food expert) to help plan your meals. He or she will tell you how much potassium you should eat each day.",
"     </p>",
"     <p>",
"      To figure out how much potassium you are eating, you will need to look at the food&rsquo;s nutrition label (",
"      <a class=\"graphic graphic_figure graphicRef85761 \" href=\"UTD.htm?25/5/25687\">",
"       figure 2",
"      </a>",
"      ). You will need to look at the:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        &ldquo;Potassium&rdquo; number &ndash; This tells you how much potassium is in 1 serving of the food. If you eat 1 serving, then you are eating this amount of potassium.",
"       </li>",
"       <li>",
"        &ldquo;Serving size&rdquo; &ndash; This tells you how big a serving is. If you eat 2 servings, then you are eating 2 times the amount of potassium listed.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130568\">",
"      <span class=\"h1\">",
"       What are other ways to cut down on potassium?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Here are some other ways to cut down on potassium:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Drain the liquid from canned fruits, vegetables, or meats before eating.",
"       </li>",
"       <li>",
"        If you eat foods that have a lot of potassium, eat only small portions.",
"       </li>",
"       <li>",
"        Reduce the amount of potassium in the vegetables you eat. You can do this for both frozen and raw vegetables. (If the vegetables are raw, peel and cut them up first.) To reduce the amount of potassium, soak the vegetables in warm unsalted water for at least 2 hours. Then drain the water and rinse the vegetables in warm water. If you cook the vegetables, cook them in unsalted water.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4130583\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/2/18467?source=see_link\">",
"       Patient information: Dialysis and diet (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/35/28212?source=see_link\">",
"       Patient information: Chronic kidney disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/34/15906?source=see_link\">",
"       Patient information: Hyperkalemia (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42640?source=see_link\">",
"       Patient information: Low potassium diet (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/5/13398?source=see_link\">",
"       Patient information: Chronic kidney disease (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?8/33/8722?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16441 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-B6FAD70B64-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8722=[""].join("\n");
var outline_f8_33_8722=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130437\">",
"      What is potassium?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130452\">",
"      Who might need to be on a low-potassium diet?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130490\">",
"      What does eating a low-potassium diet involve?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130568\">",
"      What are other ways to cut down on potassium?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4130583\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16441\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"      Anatomy of the urinary tract",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/5/25687\">",
"       Potassium on food labels",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_table\" href=\"UTD.htm?25/30/26092\">",
"        Some foods that are low in potassium",
"       </a>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?28/3/28732\">",
"         Some foods that are high in potassium",
"        </a>",
"       </li>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/5/13398?source=related_link\">",
"      Patient information: Chronic kidney disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/35/28212?source=related_link\">",
"      Patient information: Chronic kidney disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/2/18467?source=related_link\">",
"      Patient information: Dialysis and diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/34/15906?source=related_link\">",
"      Patient information: Hyperkalemia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42640?source=related_link\">",
"      Patient information: Low potassium diet (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_33_8723="Fludeoxyglucose F-18: Patient drug information";
var content_f8_33_8723=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Fludeoxyglucose F-18: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/43/4786?source=see_link\">",
"     see \"Fludeoxyglucose F-18: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F13316569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3546407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used with a PET scan to see parts of the brain better.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F13316532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3546405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to fludeoxyglucose F 18 or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F13316534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F13316572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698137",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of high blood sugar like confusion, feeling sleepy, more thirst, more hungry, passing urine more often, flushing, fast breathing, or breath that smells like fruit.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood sugar may occur. Signs may be dizziness, headache, feeling sleepy, feeling weak, shaking, a fast heartbeat, confusion, hunger, or sweating. Keep hard candies, glucose tablets, liquid glucose, or juice on hand for low blood sugar.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F13316536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very low blood sugar or very high blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F13316571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3546410",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not eat the day before getting this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F13316537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17075 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.96.59.103-C3E2CEE167-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8723=[""].join("\n");
var outline_f8_33_8723=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13316569\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13316532\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13316534\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13316572\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13316536\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13316571\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13316537\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/43/4786?source=related_link\">",
"      Fludeoxyglucose F-18: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_33_8724="Gram stain sputum 9C answer";
var content_f8_33_8724=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary tuberculosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 356px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power light micrograph of a lung biopsy from a patient with tuberculosis shows multiple granulomas (hematoxylin and eosin stain).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8724=[""].join("\n");
var outline_f8_33_8724=null;
var title_f8_33_8725="Cost-effective mammography screening strategies";
var content_f8_33_8725=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F67061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F67061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 644px\">",
"   <div class=\"ttl\">",
"    Cost-effective mammography screening strategies for women aged 40 to 79 years, by age and breast density",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 624px; height: 819px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cost-effective mammography screening strategies for women aged 40 to 79 years, by age and breast density. Strategies assume a willingness-to-pay threshold of $100,000 (top) or $50,000 (bottom) per QALY gained.",
"    <div class=\"footnotes\">",
"     BI-RADS: Breast Imaging Reporting and Data System; QALY: Quality-Adjusted Life-Year.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Schousboe JT, Kerlikowske K, Loh A, Cummings R. Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness. Ann Intern Med 2011; 155:10. Copyright &copy; 2011 American College of Physicians.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8725=[""].join("\n");
var outline_f8_33_8725=null;
var title_f8_33_8726="Causes of chronic knee pain in the young athlete";
var content_f8_33_8726=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of chronic knee pain in the young athlete",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8726/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8726/contributors\">",
"     Albert C Hergenroeder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8726/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8726/contributors\">",
"     Joseph Chorley, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8726/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8726/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8726/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/33/8726/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H8889317\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knee pain in the young athlete may be acute or chronic. Acute pain usually is caused by injury to the bones, ligaments, cartilage, muscles, or tendons; these injuries may occur in isolation or simultaneously. Chronic pain, which may involve the same structures, usually results from overuse or inadequate rehabilitation of acute injury. Although acute and chronic injury are the most common causes of knee pain in young athletes, it is important to consider causes of knee pain that are unrelated to sports activity. These include malignancy, infection, arthritis, bone cysts, and referred pain from the hip (eg, slipped capital femoral epiphysis, Legg-Calv&eacute;-Perthes disease).",
"   </p>",
"   <p>",
"    The common causes of chronic knee pain in the young athlete will be reviewed here. The common causes of acute knee pain and the evaluation and management of chronic knee pain are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5273?source=see_link\">",
"     \"Approach to the young athlete with acute knee pain or injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29223?source=see_link\">",
"     \"Approach to the young athlete with chronic knee pain or injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/61/4056?source=see_link\">",
"     \"Treatment of knee injuries in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889684\">",
"    <span class=\"h1\">",
"     ETIOLOGY OF CHRONIC KNEE PAIN AND INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of chronic knee pain, swelling, or instability can encompass a period of weeks to years. The patient may delay medical evaluation because of gradual onset of pain or the absence of an acute event, or in the hope that the pain will resolve spontaneously. Medical care commonly is sought when the pain interferes with sports performance or activities of daily living. Conditions that cause acute knee pain or injury can become a chronic problem if medical care is delayed or rehabilitation is insufficient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28455?source=see_link&amp;anchor=H2#H2\">",
"     \"Traumatic causes of acute knee pain and injury in the young athlete\", section on 'Causes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The athlete may have primary or secondary chronic injury to an isolated structure or to a combination of structures (eg, bones, ligaments, menisci). The subjective complaints include swelling, pain, mechanical symptoms,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    giving way.",
"   </p>",
"   <p>",
"    The complaint of \"giving way\" requires clarification. Patients who have immediate swelling and exacerbation of pain and are unable to bear weight usually have mechanical instability (eg, ligamentous injury, dislocation or subluxation of the patella, a loose body, or meniscal lesion). In contrast, patients with patellofemoral dysfunction (PFD) or the patellofemoral pain syndrome complain of giving way that is a result of muscle insufficiency, and are unlikely to fall to the ground or have an acute exacerbation of pain or swelling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889691\">",
"    <span class=\"h2\">",
"     Patellofemoral pain syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patellofemoral pain syndrome (PFPS) can be defined as anterior knee pain involving the patella and retinaculum that excludes other intraarticular and peripatellar pathology. PFPS describes a symptom complex and is a diagnosis of exclusion. The patellofemoral pain syndrome (PFD) is the most common cause of chronic anterior knee pain seen in sports medicine clinics. Patients with PFPS may also complain of giving way that is a result of muscle insufficiency",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sudden pain. However, they are unlikely to fall to the ground or have an acute exacerbation of pain or swelling, in contrast to patients with chronic ligamentous instability, patellar dislocation or subluxation, a loose intraarticular foreign body, or a meniscal lesion. Pain is often exacerbated when patients ascend or descend stairs or rise from a seated position (the \"theater sign\"). The onset of PFPS symptoms often follows a change in training, including increased running mileage or pace, adding steps to the workout, squats, longer workouts, or new training techniques. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43993?source=see_link&amp;anchor=H11#H11\">",
"     \"Patellofemoral pain syndrome\", section on 'Clinical presentation and examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889698\">",
"    <span class=\"h2\">",
"     Cruciate ligaments",
"    </span>",
"    &nbsp;&mdash;&nbsp;As is the case in acute ACL or PCL injury, the signs of chronic ACL or PCL insufficiency include shifting, giving way, swelling, and pain. As much as 90 percent of patients with chronic ACL insufficiency also has meniscal injuries. It is important to remember that there is a referral bias in this statistic since these are the patients who present with symptoms; the denominator of patients with ACL injuries who are asymptomatic is not known. The physical examination techniques used to diagnose chronic ligamentous injuries of the knee are the same as those for acute injuries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29223?source=see_link&amp;anchor=H3#H3\">",
"     \"Approach to the young athlete with chronic knee pain or injury\", section on 'Examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889705\">",
"    <span class=\"h2\">",
"     Meniscal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of chronic meniscal injuries include intermittent swelling and pain; mechanical symptoms are often absent. The pain and swelling can mimic degenerative joint disease, and the two conditions may occur together. The signs of chronic meniscal injury include chronic lateral and medial joint line pain (",
"    <a class=\"graphic graphic_picture graphicRef70461 \" href=\"UTD.htm?12/54/13152\">",
"     picture 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16632?source=see_link&amp;anchor=H19#H19\">",
"     \"Meniscal injury of the knee\", section on 'Chronic degenerative meniscal injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889712\">",
"    <span class=\"h2\">",
"     Osteochondritis dissecans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteochondritis dissecans (OCD) is a condition in which a segment of articular cartilage, with its underlying subchondral bone, gradually separates from the surrounding osteocartilaginous tissue (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69442 \" href=\"UTD.htm?25/56/26510\">",
"     image 1",
"    </a>",
"    ). OCD is an infrequent cause of joint pain in children with the knee being most frequently affected. Overuse or repeated trauma is frequently reported. Approximately three-quarters of cases of OCD of the knee involve the nonarticular surface of the lateral side of the medial femoral condyle. OCD usually affects boys between 9 and 18 years of age, and is often an incidental finding.",
"   </p>",
"   <p>",
"    Early in the course, the athlete with OCD may complain of vague pain with activity. As the process progresses, he or she may have activity-related pain with intermittent swelling and, depending upon the size of the fragment of articular cartilage, locking of the knee. Examination findings include tenderness to palpation of the involved condyle with the knee in flexion and alteration of gait with the foot of the affected side rotated laterally to reduce the pain of weight-bearing. Clinical findings and plain radiographs frequently establish the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13913?source=see_link&amp;anchor=H2510199#H2510199\">",
"     \"Clinical manifestations and diagnosis of osteochondritis dissecans (OCD)\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889719\">",
"    <span class=\"h2\">",
"     Osgood-Schlatter",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osgood-Schlatter disease is an overuse injury that occurs in active adolescents who recently have undergone a rapid growth spurt. Patients complain of anterior knee pain that increases gradually over time. Pain may be exacerbated by direct trauma, running, jumping, or kneeling, and is relieved by rest. The characteristic physical examination finding is localized tenderness, and often, prominence of the tibial tuberosity; the range of motion and stability of the knee are normal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12392?source=see_link&amp;anchor=H7#H7\">",
"     \"Osgood-Schlatter disease (tibial tuberosity avulsion)\", section on 'Diagnostic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889726\">",
"    <span class=\"h2\">",
"     Iliotibial band syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The iliotibial band consists of connective tissue that runs from the ilium to the fibula. Iliotibial band syndrome, which occurs almost exclusively in runners, is characterized by an aching or burning pain at the site where the band courses over the lateral femoral condyle (",
"    <a class=\"graphic graphic_picture graphicRef76147 \" href=\"UTD.htm?24/61/25552\">",
"     picture 2",
"    </a>",
"    ); occasionally, the pain radiates up the thigh toward the hip. There may also be an abnormal shortened iliotibial tract. Risk factors for developing this syndrome include a varus alignment of the knee, excessive running mileage, worn shoes, or continuous running on uneven terrain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8726/abstract/1\">",
"     1",
"    </a>",
"    ]. The diagnosis of iliotibial band syndrome should be considered in the active patient with focal tenderness with or without palpable clicking over the lateral femoral condyle, and a knee examination that is otherwise normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889733\">",
"    <span class=\"h2\">",
"     Tendonitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tendinitis of the knee extensors (patellar and quadriceps tendons) or semimembranosus can cause chronic knee pain in the young athlete.",
"   </p>",
"   <p>",
"    Knee extensor tendinitis, also called jumper's knee, includes patellar tendinitis, Sinding-Larsen-Johannson (SLJ) syndrome, and quadriceps tendinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8726/abstract/2\">",
"     2",
"    </a>",
"    ]. Athletes, particularly those involved in running and jumping sports, complain of chronic anterior knee pain that may be worse after going up or down stairs, or after prolonged sitting. The location of tenderness distinguishes among these disorders: the patellar ligament (patellar tendinitis), inferior pole of the patella (SLJ syndrome), and superior pole of the patella (quadriceps tendinitis) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8726/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SLJ syndrome affects the attachment of the patellar tendon to the inferior pole of the patella [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8726/abstract/3\">",
"     3",
"    </a>",
"    ]. It probably is caused by repetitive microtrauma leading to traction apophysitis. SLJ syndrome typically affects children between 10 and 13 years of age. Radiographs may demonstrate calcification at the tendon attachment to the distal pole of the patella [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8726/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Semimembranosus tendinitis causes posteromedial knee pain after strenuous activity (eg, prolonged walking, climbing, or running). It is exacerbated by excess pronation of the foot and internal torsion of the hip or femur [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8726/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of knee tendinitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/61/4056?source=see_link\">",
"     \"Treatment of knee injuries in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889740\">",
"    <span class=\"h2\">",
"     Prepatellar bursitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repetitive flexion and extension (eg, as in distance running) or direct repetitive trauma (as in wrestling) may cause inflammation of the prepatellar bursa, located between the patella and overlying skin. With chronic inflammation, the walls of the prepatellar bursa may thicken and become fibrotic. Patients may have swelling and pain of the anterior knee (",
"    <a class=\"graphic graphic_picture graphicRef56055 \" href=\"UTD.htm?19/3/19504\">",
"     picture 3",
"    </a>",
"    ). The diagnosis can usually be made by simple inspection and palpation of the anterior patella. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28422?source=see_link&amp;anchor=H2#H2\">",
"     \"Knee bursitis\", section on 'Prepatellar bursitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889747\">",
"    <span class=\"h2\">",
"     Baker's cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;A Baker's cyst (ie, cystic enlargement of synovial tissue into the popliteal space) is a manifestation of chronic joint effusion and possible internal derangement. Both degenerative arthropathy and meniscal tears are associated with Baker's cysts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27016?source=see_link\">",
"     \"Popliteal (Baker's) cyst\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889754\">",
"    <span class=\"h2\">",
"     Plica syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plicae are normal synovial folds in the knee that are thought to be remnants of embryologic development [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8726/abstract/6\">",
"     6",
"    </a>",
"    ]. Plica syndrome is caused by a redundant synovial thickening, usually in the medial superior portion of the medial retinaculum coursing toward the medial quadriceps tendon. Patients may complain of pain and popping or snapping when rising from the seated (knee flexed) position. Patients also may complain of catching, locking, or pseudolocking. Examination reveals tenderness medial to the patella, usually slightly proximal to the inferior pole [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8726/abstract/7\">",
"     7",
"    </a>",
"    ]. Atrophy of the quadriceps may develop if plical syndrome is present chronically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889761\">",
"    <span class=\"h2\">",
"     Discoid meniscus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lack of development of the normal crescent shape of either meniscus results in a discoid meniscus, which inhibits femoral excursion on the tibia and may cause mechanical symptoms and swelling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889768\">",
"    <span class=\"h2\">",
"     Referred hip pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic knee pain can represent referred pain from primary pathology in the hip, such as arthritis, osteomyelitis, slipped capital femoral epiphysis, and Legg-Calv&eacute;-Perthes disease.",
"   </p>",
"   <p>",
"    Adolescents with SCFE can present with knee or thigh pain. Examination of the knee is normal, but range of motion of the hips, particularly internal rotation, is often limited. Urgent referral is necessary since a delay in diagnosis can be catastrophic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23209?source=see_link\">",
"     \"Slipped capital femoral epiphysis (SCFE)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Legg-Calv&eacute;-Perthes disease is the name for idiopathic avascular necrosis of the femoral head, which generally presents between 3 and 12 years of age. Patients complain of acute or chronic knee pain with activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16729?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of hip pain in childhood\", section on 'Legg-Calv&eacute;-Perthes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889775\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may have chronic knee pain with subjective complaints that are not characteristic of any of the conditions described above and occur in the absence of joint findings. The diagnosis of juvenile fibromyalgia should be considered in patients with tender points about the knee in association with diffuse pain, fatigue, headaches, sleep disturbance, and subjective joint swelling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7896?source=see_link\">",
"     \"Clinical manifestations and diagnosis of fibromyalgia in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pain out of proportion to the history and physical examination and associated with at least one sign of autonomic dysfunction suggests complex regional pain syndrome (CRPS). In children, CRPS typically occurs in one lower extremity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37768?source=see_link\">",
"     \"Complex regional pain syndrome in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/43/43697?source=see_link\">",
"       \"Patient information: Osgood-Schlatter disease (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/27/5554?source=see_link\">",
"       \"Patient information: Iliotibial band syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8889782\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Knee pain in the young athlete may be acute or chronic. Assuming that no other systemic cause has been identified, acute pain usually is caused by injury to the bones, ligaments, muscles, or tendons. Chronic pain, which may involve the same structures, usually results from overuse or inadequate rehabilitation of an acute or chronic injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28455?source=see_link&amp;anchor=H1#H1\">",
"       \"Traumatic causes of acute knee pain and injury in the young athlete\", section on 'Introduction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The onset of chronic knee pain, swelling, or instability can encompass a period of weeks to years. The patient may delay medical evaluation because of gradual onset of pain or the absence of an acute event, or in the hope that the pain will resolve spontaneously. Subjective complaints of chronic knee pain include swelling, pain, mechanical symptoms, inability to adequately perform a certain action,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      giving way. (See",
"      <a class=\"local\" href=\"#H8889684\">",
"       'Etiology of chronic knee pain and injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with patellofemoral dysfunction or the patellofemoral pain syndrome complain of giving way that is most often a result of quadriceps muscle insufficiency, and are unlikely to actually fall to the ground or have an acute exacerbation of pain or swelling. In contrast, a patient with an ACL or meniscal tear is likely to fall to the ground and have swelling and pain. (See",
"      <a class=\"local\" href=\"#H8889691\">",
"       'Patellofemoral pain syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Osteochondritis dissecans (OCD) is a condition in which a segment of articular cartilage, with its underlying subchondral bone, gradually separates from the surrounding osteocartilaginous tissue (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef69442 \" href=\"UTD.htm?25/56/26510\">",
"       image 1",
"      </a>",
"      ). Examination findings include tenderness to palpation of the involved condyle with the knee in flexion. Other findings may be similar to those in patients who have meniscal tears. (See",
"      <a class=\"local\" href=\"#H8889712\">",
"       'Osteochondritis dissecans'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who have immediate swelling and exacerbation of chronic knee pain and are unable to bear weight usually have mechanical instability (eg, ligamentous injury, dislocation or subluxation of the patella, a loose body, or meniscal lesion). (See",
"      <a class=\"local\" href=\"#H8889698\">",
"       'Cruciate ligaments'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8889705\">",
"       'Meniscal injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with Osgood-Schlatter disease, iliotibial band syndrome, tendonitis, prepatellar bursitis, or Baker&rsquo;s cyst are usually readily identified based upon characteristic physical findings. (See",
"      <a class=\"local\" href=\"#H8889719\">",
"       'Osgood-Schlatter'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8889726\">",
"       'Iliotibial band syndrome'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8889733\">",
"       'Tendonitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8889740\">",
"       'Prepatellar bursitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8889747\">",
"       'Baker's cyst'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic knee pain can be referred pain from primary pathology in the hip, such as arthritis, osteomyelitis, slipped capital femoral epiphysis (SCFE), and Legg-Calv&eacute;-Perthes disease. Adolescents with SCFE can present with knee or thigh pain. Examination of the knee is normal, but range of motion of the hips, particularly internal rotation, is often limited. Immediate nonweightbearing and urgent referral is necessary in a child with SCFE since a delay in diagnosis significantly worsens the prognosis. (See",
"      <a class=\"local\" href=\"#H8889768\">",
"       'Referred hip pain'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8726/abstract/1\">",
"      Messier SP, Edwards DG, Martin DF, et al. Etiology of iliotibial band friction syndrome in distance runners. Med Sci Sports Exerc 1995; 27:951.",
"     </a>",
"    </li>",
"    <li>",
"     Tachdjian MO. The knee and leg. In: Clinical Pediatric Orthopedics: The Art of Diagnosis and Principles of Management, Appleton and Lange, Stamford 1997. p.87.",
"    </li>",
"    <li>",
"     Staheli, LT. The lower limb. In: Pediatric Orthopaedics, Volume 2, 3rd edition, Morrissy, RT (Eds), Lippincott, Philadelphia 1990. p.41.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8726/abstract/4\">",
"      Medlar RC, Lyne ED. Sinding-Larsen-Johansson disease. Its etiology and natural history. J Bone Joint Surg Am 1978; 60:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8726/abstract/5\">",
"      Safran MR, Fu FH. Uncommon causes of knee pain in the athlete. Orthop Clin North Am 1995; 26:547.",
"     </a>",
"    </li>",
"    <li>",
"     Anterior cruciate ligament tear. In: Essentials of Musculoskeletal Care, 2nd edition, Greene, WB (Eds), American Academy of Orthopedic Surgeons, Rosemont, IL 2001. p.360.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8726/abstract/7\">",
"      Wito��ski D, Wagrowska-Danielewicz M. Distribution of substance-P nerve fibers in the knee joint in patients with anterior knee pain syndrome. A preliminary report. Knee Surg Sports Traumatol Arthrosc 1999; 7:177.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16562 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-961E418322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8726=[""].join("\n");
var outline_f8_33_8726=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8889782\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8889317\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8889684\">",
"      ETIOLOGY OF CHRONIC KNEE PAIN AND INJURY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889691\">",
"      Patellofemoral pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889698\">",
"      Cruciate ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889705\">",
"      Meniscal injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889712\">",
"      Osteochondritis dissecans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889719\">",
"      Osgood-Schlatter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889726\">",
"      Iliotibial band syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889733\">",
"      Tendonitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889740\">",
"      Prepatellar bursitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889747\">",
"      Baker's cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889754\">",
"      Plica syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889761\">",
"      Discoid meniscus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889768\">",
"      Referred hip pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8889775\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8889782\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/16562\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/16562|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/56/26510\" title=\"diagnostic image 1\">",
"      Osteochondritis dissecans knee",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/16562|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/54/13152\" title=\"picture 1\">",
"      Joint line palpation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/61/25552\" title=\"picture 2\">",
"      Palpation lateral femoral condyle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/3/19504\" title=\"picture 3\">",
"      Palpation of prepatellar bursa",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5273?source=related_link\">",
"      Approach to the young athlete with acute knee pain or injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29223?source=related_link\">",
"      Approach to the young athlete with chronic knee pain or injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7896?source=related_link\">",
"      Clinical manifestations and diagnosis of fibromyalgia in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13913?source=related_link\">",
"      Clinical manifestations and diagnosis of osteochondritis dissecans (OCD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37768?source=related_link\">",
"      Complex regional pain syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28422?source=related_link\">",
"      Knee bursitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16632?source=related_link\">",
"      Meniscal injury of the knee",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12392?source=related_link\">",
"      Osgood-Schlatter disease (tibial tuberosity avulsion)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16729?source=related_link\">",
"      Overview of hip pain in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43993?source=related_link\">",
"      Patellofemoral pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/27/5554?source=related_link\">",
"      Patient information: Iliotibial band syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/43/43697?source=related_link\">",
"      Patient information: Osgood-Schlatter disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27016?source=related_link\">",
"      Popliteal (Baker's) cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23209?source=related_link\">",
"      Slipped capital femoral epiphysis (SCFE)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28455?source=related_link\">",
"      Traumatic causes of acute knee pain and injury in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/61/4056?source=related_link\">",
"      Treatment of knee injuries in the young athlete",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_33_8727="Laparoscopic surgery in pregnancy";
var content_f8_33_8727=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Laparoscopic surgery in pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8727/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8727/contributors\">",
"     Michael P Stany, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8727/contributors\">",
"     John C Elkas, MD, JD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8727/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8727/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8727/contributors\">",
"     David L Hepner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8727/contributors\">",
"     Tommaso Falcone, MD, FRCSC, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8727/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8727/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/33/8727/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advantages of laparoscopic surgery are similar for pregnant and nonpregnant women; nevertheless, this procedure had been avoided during pregnancy because of concerns that it may be harmful to the fetus. Potential concerns include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rise in intraabdominal pressure during pneumoperitoneum could decrease utero-placental blood flow and result in fetal hypoxia",
"     </li>",
"     <li>",
"      Fetal acidosis could develop from absorption of carbon dioxide (CO2)",
"     </li>",
"     <li>",
"      The fetus could be injured directly or indirectly if the uterus is perforated by a trocar or Veress needle.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Within the last decade, however, multiple case reports and case series describing the safe performance of laparoscopic procedures in pregnant patients have been published, resulting in a paradigm shift [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Appendicitis, gallbladder disease, mesenteric cysts, and adnexal",
"    <span class=\"nowrap\">",
"     masses/torsion",
"    </span>",
"    have been successfully managed laparoscopically during pregnancy. More advanced laparoscopic procedures, such as radical nephrectomy, splenectomy, adrenalectomy, retroperitoneal lymphadenectomy, and ventral hernia repair, have also been reported in gravid patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/4-7\">",
"     4-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss issues specific to laparoscopic surgery during pregnancy. Discussions of laparoscopic surgery in the general population and specific laparoscopic procedures can be found separately. (See individual topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumoperitoneum can alter maternal hemodynamics, arterial oxygenation, and acid-base balance as a result of CO2 absorption, pressure on uteroplacental vessels, and upward displacement of the diaphragm (which further reduces maternal residual lung volume and functional residual capacity). Hemodynamic changes include a decrease in cardiac index and increases in mean arterial pressure and systemic vascular resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Animal models have been used to evaluate the maternal and fetal effects of increased intraabdominal pressures associated with CO2 pneumoperitoneum. The following studies illustrate some of the findings from this work:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a gravid baboon model, one group found that there were no adverse maternal or fetal effects during laparoscopy with an intraabdominal pressure (IAP) of 10 mmHg; however, at a pressure of 20 mmHg, maternal respiratory acidosis was noted despite an increase in the ventilatory rate [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/9\">",
"       9",
"      </a>",
"      ]. The maternal hypercarbia resulted from absorption of CO2 from the abdominal cavity. Fetal Doppler flow studies after the procedure were similar to baseline measurements.",
"     </li>",
"     <li>",
"      In a gravid ewe model, another group found that laparoscopy with an IAP of 20 mmHg decreased maternal placental blood flow by 61 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/10\">",
"       10",
"      </a>",
"      ]. However, after one hour at this IAP, fetoplacental perfusion, pH, and blood gas tension did not deteriorate further.",
"     </li>",
"     <li>",
"      In another gravid ewe model, CO2 pneumoperitoneum caused fetal tachycardia, hypertension, and hypercarbia, most likely as a result of fetal CO2 absorption [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/11\">",
"       11",
"      </a>",
"      ]. These changes were reversed by inducing mild maternal respiratory alkalosis, which promoted fetal to maternal diffusion of CO2; the changes did not occur when",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"       nitrous oxide",
"      </a>",
"      was used to create the pneumoperitoneum.",
"     </li>",
"     <li>",
"      A fourth study showed that gravid ewes who were insufflated with carbon dioxide for 60 minutes at a pressure of 15 mmHg developed progressive fetal hypotension and bradycardia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/12\">",
"       12",
"      </a>",
"      ]. After deflation of the pneumoperitoneum, uterine blood flow returned to normal, and the fetal partial pressure of carbon dioxide and pH changes resolved within one hour. However, fetal oxygen saturation and content remained depressed, and fetal cardiovascular status continued to decline during the two-hour postinsufflation period.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prospective studies evaluating the safety of laparoscopy in human pregnancy are lacking, but multiple case series have reported laparoscopic procedures in all trimesters of pregnancy with minimal morbidity to the fetus and mother. The best available outcome data were derived retrospectively from a study from Swedish health registries [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/2\">",
"     2",
"    </a>",
"    ]. This study compared the outcome of 2181 laparoscopies performed on pregnant patients prior to 20 weeks of gestation with the outcome of 1522 laparotomies performed in a similar population. There were no significant differences between groups in any measured outcome: birthweight, gestational duration, intrauterine growth restriction, congenital malformations, stillbirths, or neonatal deaths. No adverse long-term effects have been reported, but data are sparse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1966250\">",
"    <span class=\"h2\">",
"     Anesthetic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potential effects of anesthetic drugs in pregnancy are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15482?source=see_link&amp;anchor=H22#H22\">",
"     \"Management of pregnant women undergoing nonobstetric surgery\", section on 'Anesthetic drug issues'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the need for surgery has been determined, the surgical approach (laparotomy or laparoscopy) is based on the skills of the surgeon and the availability of the appropriate staff and equipment.",
"   </p>",
"   <p>",
"    The indications for laparoscopic treatment of acute abdominal processes are the same in pregnant and non-pregnant patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/3\">",
"     3",
"    </a>",
"    ]. Hemodynamic instability is a contraindication to using a laparoscopic approach. Laparotomy is often preferred to laparoscopy in the presence of a large solid ovarian mass on preoperative ultrasonography, and when the patient has had multiple prior surgeries",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a history of adhesive disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     BENEFITS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of laparoscopy during pregnancy are similar to those in nonpregnant patients: less postoperative pain, less postoperative ileus, reduction in adhesion formation, shorter hospital stay, and faster return to usual activities [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There may also be specific benefits during pregnancy. As an example, there is often less uterine manipulation intraoperatively during laparoscopic procedures than during laparotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, avoidance of a large abdominal scar while the uterus is enlarging results in a better cosmetic outcome and less postoperative discomfort (lower narcotic requirements, better respiratory effort) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The laparoscopic approach may provide better exposure than laparotomy because of optical magnification, lighting, and other technical factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TIMING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laparoscopy can be performed in any trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/3\">",
"     3",
"    </a>",
"    ]; however, as with other types of surgery performed during pregnancy, the optimal time to operate is the early second trimester. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15482?source=see_link\">",
"     \"Management of pregnant women undergoing nonobstetric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When surgery is required during the third trimester, the enlarged uterus can interfere with adequate visualization. However, successful laparoscopic management of appendicitis, cholecystitis, intussusception, and an adnexal mass has been described in the third trimester, as late as 34 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/16-22\">",
"     16-22",
"    </a>",
"    ]. Whether a laparoscopic procedure is feasible in the third trimester depends upon individual clinical factors (eg, the disorder being treated, body habitus, size of the uterus, comorbid medical and obstetrical conditions). There is no absolute maximum gestational age for performing laparoscopy; we will perform these procedures in the early third trimester if we feel that it is technically possible and clinically appropriate.",
"   </p>",
"   <p>",
"    Although procedures performed in the first trimester should be easier technically, introducing a potential teratogen during organogenesis is a concern. In addition, it is preferable to perform surgery after the period when spontaneous miscarriages are likely to occur. However, in some cases, surgery cannot be delayed from the first to the second trimester. In cases of suspected ovarian torsion, for example, prompt surgical intervention is indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to initiating the procedure, an oro- or naso-gastric tube is inserted into the stomach to prevent perforation of a distended stomach, and to reduce the risk of aspiration of gastric contents. A Foley catheter is placed in the bladder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Thromboprophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no data from randomized trials on the use of unfractionated or low molecular weight",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or intermittent pneumatic compression for venous thromboembolism prophylaxis in pregnant patients undergoing laparoscopy.",
"   </p>",
"   <p>",
"    In 2008, the Society of American Gastrointestinal and Endoscopic Surgeons recommended placing pneumatic compression devices on the lower limbs of pregnant women undergoing laparoscopic procedures for surgical problems [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For women at low risk of thrombosis, the 2008 American College of Chest Physicians' clinical practice guideline on prevention and treatment of thrombosis did not recommend mechanical or pharmacologic thromboprophylaxis for laparoscopic procedures (gynecologic or general surgical), but did recommend thromboprophylaxis for women undergoing major gynecologic surgical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/23\">",
"     23",
"    </a>",
"    ]. They did not specifically address laparoscopic procedures during pregnancy, and did not define criteria for a major procedure. Interestingly, they considered cesarean delivery, a major obstetrical surgical procedure, to be a low thrombotic risk procedure and advised against mechanical or pharmacologic thromboprophylaxis in low risk women undergoing cesarean delivery.",
"   </p>",
"   <p>",
"    There are several reasons why pneumatic compression devices or pharmacologic thromboprophylaxis should be considered. Although abdominal wall tissue trauma is decreased with a laparoscopic approach, activation of the coagulation system is similar for laparoscopy and laparotomy, and the coagulation system is activated in pregnant women. Immobilzation can be lengthy, as laparoscopic procedures may be as long or longer than open surgeries; many \"major\" surgical procedures (ie, a body cavity is entered and organs are removed or normal anatomy is significantly altered) are performed through a laparoscope. Lastly, the use of pneumoperitoneum and reverse Trendelenburg contribute to venous stasis and, possibly, thrombosis.",
"   </p>",
"   <p>",
"    For these reasons, we place pneumatic compression devices on all pregnant women undergoing laparoscopic surgery. The need for pharmacologic thromboprophylaxis should be determined on a case-by-case basis, taking into account the expected scope and length of the procedure and whether the woman has risk factors for venous thrombosis in addition to the pregnancy (eg, thrombophilia, past history of venous thrombosis, malignancy, diabetes mellitus, varicose veins, paralysis, obesity). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14055?source=see_link\">",
"     \"Deep vein thrombosis and pulmonary embolism in pregnancy: Prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Prophylactic tocolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence to support the use of prophylactic tocolytics or glucocorticoids. However, these drugs may be indicated in management of threatened preterm delivery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35674?source=see_link\">",
"     \"Inhibition of acute preterm labor\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31610?source=see_link\">",
"     \"Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Patient position",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending on the planned procedure, the patient is placed in the supine or low lithotomy position with a leftward tilt (after 16 weeks of gestation) to avoid significant compression of the aorta and inferior vena cava. Left lateral rotation of the operating table may also help to displace the uterus adequately [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/16\">",
"     16",
"    </a>",
"    ]. After a pneumoperitoneum has been created, the patient's position can be adjusted further to allow gravity to aid with visualization. As an example, varying degrees of Trendelenburg position can move the intestines cephalad and thus improve visualization for procedures in the pelvis. Left-sided rotation of 30 degrees with chest and thigh restraining straps improves visualization of the appendix and gall bladder during laparoscopic appendectomy and cholecystectomy in the third trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. These positions displace the gravid uterus off of the inferior vena cava, in addition to exposing the right paracolic gutter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Trocar placement/insertion",
"    </span>",
"    &nbsp;&mdash;&nbsp;While all patients undergoing laparoscopy are at risk of trocar injury, the gravid uterus makes trocar insertion and creation of a pneumoperitoneum more difficult and potentially more hazardous. Inadvertent placement of a Veress needle through the umbilicus into the pregnant uterus has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Supraumbilical primary trocar placement is a common practice; we suggest positioning the port at least 6 cm above the uterine fundus and elevating the abdominal wall (",
"    <a class=\"graphic graphic_figure graphicRef70365 \" href=\"UTD.htm?6/34/6688\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/27\">",
"     27",
"    </a>",
"    ]. This placement provides an adequate distance between the tip of the laparoscope and the uterus to allow optimal visualization and instrumentation. With increasing gestational age, use of the subxyphoid, left upper quadrant, or right upper quadrant insertion points also helps to avoid the enlarged uterus. Lateral displacement of the uterus during trocar insertion may also decrease the risk of uterine and fetal injury.",
"   </p>",
"   <p>",
"    Both the Hasson (open) technique and the Veress needle technique have been used for establishing a pneumoperitoneum in pregnant patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/3\">",
"     3",
"    </a>",
"    ]. The Veress needle technique requires a blind entry with its attendant risk of",
"    <span class=\"nowrap\">",
"     uterine/fetal",
"    </span>",
"    injury, especially when inserted through the umbilicus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/26\">",
"     26",
"    </a>",
"    ]. A blind approach, however, was successfully used in a series of 10 third trimester procedures in which the Veress needle was inserted in the mid-clavicular line, 1 to 2 cm below the costal margin in either the left or right upper quadrants [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/16\">",
"     16",
"    </a>",
"    ]. Some surgeons recommend an open technique for trocar insertion because of greater assurance of safety [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/20,27-29\">",
"     20,27-29",
"    </a>",
"    ]. Given the feasibility of both methods, each surgeon should use the technique with which he or she has the most experience and comfort.",
"   </p>",
"   <p>",
"    Our preferred entry technique is use of a Veress needle inserted in the left-upper quadrant. As discussed above, gastric decompression with an orogastric tube prior to placement of the needle decreases the risk of gastric injury. The needle should be angled approximately 15 degrees caudad to minimize risk of liver, gastric, and splenic injury [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/30\">",
"     30",
"    </a>",
"    ]. The uterus is gently manually displaced toward the right during placement in order to avoid uterine injury.",
"   </p>",
"   <p>",
"    A sponge stick may be placed in the vagina and used to exert gentle cephalad pressure on the uterus, if necessary. Transcervical instruments should NOT be used to manipulate the uterus.",
"   </p>",
"   <p>",
"    Laparoendoscopic single-site surgery (LESS), also referred to as single port laparoscopy, utilizes a single skin incision, through which a port with multiple operating channels is introduced. There are a few reports of use of LESS in pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]. Further study is needed before LESS techniques can be recommended for use in the pregnant population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pneumoperitoneum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even though intraabdominal pressure needs to be sufficient to allow for adequate visualization, maintenance of a low pressure is mandatory, given the possible adverse effects of increased intraabdominal CO2 pressures on the hemodynamic and respiratory physiology of the gravid patient. Intraabdominal pressure between 8 to 12 mm Hg and not exceeding 15 mmHg should be maintained [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/15,26\">",
"     15,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gasless laparoscopy may be a safer alternative to the traditional CO2 pneumoperitoneum, but specialized abdominal wall lifting devices are often necessary for a completely gasless procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Other techniques have been described that can decrease intraabdominal pressures using a combination of pneumoperitoneum and abdominal wall retraction [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/37\">",
"     37",
"    </a>",
"    ]. We perform laparoscopy with a CO2 pneumoperitoneum, but we try to operate as efficiently as possible to minimize operative time and any potential",
"    <span class=\"nowrap\">",
"     maternal/fetal",
"    </span>",
"    morbidity.",
"   </p>",
"   <p>",
"    Several large studies found measurement of end-tidal carbon dioxide pressure (capnography) was adequate for intraoperative CO2 monitoring in pregnant women; routine blood gas monitoring was unnecessary [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/17,18,38\">",
"     17,18,38",
"    </a>",
"    ]. We recommend keeping the end-tidal CO2 at 32 to 34 mmHg, as respiratory acidosis has not been reported at this level [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study of eight pregnant women from 17 to 30 weeks of gestation undergoing laparoscopic cholecystectomy under general anesthesia measured changes in arterial to end-tidal carbon dioxide pressure difference (PaCO2-PetCO2) before, during, and after CO2 pneumoperitoneum [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/41\">",
"     41",
"    </a>",
"    ]. There were no significant differences in either mean PaCO2-PetCO2 or PaCO2 and pH during the various phases of laparoscopy, demonstrating that capnography is adequate to guide ventilation. Respiratory acidosis did not occur when end tidal CO2 was maintained at 32 mmHg.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Fetal assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal heart rate should be confirmed and documented before and after the procedure, and is usually done with a hand-held Doppler device (eg, Doptone). Due to the pneumoperitoneum, transabdominal fetal monitoring is usually not possible during laparoscopy in the second trimester. If fetal monitoring is necessary during the procedure, transabdominal fetal monitoring may be possible through the left abdominal wall with the patient in a steep leftward tilt [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/24\">",
"     24",
"    </a>",
"    ]. Another option is transvaginal ultrasound assessment of the fetal heart rate.",
"   </p>",
"   <p>",
"    If maternal acidosis is suspected and confirmed, it can be reversed by immediately hyperventilating the mother and decreasing intraabdominal pressure. These measures can help to resuscitate the fetus by improving placental blood flow and fetal oxygenation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8727/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15482?source=see_link\">",
"     \"Management of pregnant women undergoing nonobstetric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal heart rate and uterine activity should be monitored in the recovery room, as appropriate for gestational age. Opioids and antiemetics can be used, as needed, to control postoperative pain and nausea. Nonsteroidal antiinflammatory drugs should be avoided, especially after 32 weeks of gestation, because they may cause premature closure of the fetal ductus arteriosus. Cesarean delivery is performed for standard obstetric indications; the presence of a recent abdominal incision does not preclude pushing in the second stage of labor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Laparoscopic surgery can be performed safely and effectively in pregnant women. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Safety'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The procedure has been performed as late as 34 weeks of gestation, but the optimal time is the early second trimester. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Timing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnant women are placed in the left lateral recumbent position to minimize uterine compression of the vena cava and the aorta. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Patient position'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest use of pneumatic compression devices rather than no thromboembolism prophylaxis for low risk pregnant women undergoing laparoscopic procedures for surgical problems (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Thromboprophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no evidence that open procedures are safer than blind procedures. Modification of port sides is necessary when the uterus is significantly enlarged. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Trocar placement/insertion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest intraabdominal pressure be maintained between 8 to 12 mm Hg and not exceed 15 mmHg (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Maintaining intraabdominal pressure at this level helps to avoid a decrease in placental blood flow. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Pneumoperitoneum'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Safety'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest keeping the end-tidal carbon dioxide at 32 to 34 mmHg, as respiratory acidosis is unlikely at this level (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If maternal acidosis is suspected or confirmed, then immediate hyperventilation of the mother and decreasing the intraabdominal pressure may improve placental perfusion. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Fetal assessment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20264204\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The opinion or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/1\">",
"      Soriano D, Yefet Y, Seidman DS, et al. Laparoscopy versus laparotomy in the management of adnexal masses during pregnancy. Fertil Steril 1999; 71:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/2\">",
"      Reedy MB, K&auml;ll&eacute;n B, Kuehl TJ. Laparoscopy during pregnancy: a study of five fetal outcome parameters with use of the Swedish Health Registry. Am J Obstet Gynecol 1997; 177:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/3\">",
"      Pearl J, Price R, Richardson W, et al. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. Surg Endosc 2011; 25:3479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/4\">",
"      Lee D, Abraham N. Laparoscopic radical nephrectomy during pregnancy: case report and review of the literature. J Endourol 2008; 22:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/5\">",
"      Felbinger TW, Posner M, Eltzschig HK, Kodali BS. Laparoscopic splenectomy in a pregnant patient with immune thrombocytopenic purpura. Int J Obstet Anesth 2007; 16:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/6\">",
"      Alouini S, Rida K, Mathevet P. Cervical cancer complicating pregnancy: implications of laparoscopic lymphadenectomy. Gynecol Oncol 2008; 108:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/7\">",
"      Wai PY, Ruby JA, Davis KA, et al. Laparoscopic ventral hernia repair during pregnancy. Hernia 2009; 13:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/8\">",
"      Steinbrook RA, Bhavani-Shankar K. Hemodynamics during laparoscopic surgery in pregnancy. Anesth Analg 2001; 93:1570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/9\">",
"      Reedy MB, Galan HL, Bean-Lijewski JD, et al. Maternal and fetal effects of laparoscopic insufflation in the gravid baboon. J Am Assoc Gynecol Laparosc 1995; 2:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/10\">",
"      Barnard JM, Chaffin D, Droste S, et al. Fetal response to carbon dioxide pneumoperitoneum in the pregnant ewe. Obstet Gynecol 1995; 85:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/11\">",
"      Hunter JG, Swanstrom L, Thornburg K. Carbon dioxide pneumoperitoneum induces fetal acidosis in a pregnant ewe model. Surg Endosc 1995; 9:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/12\">",
"      Uemura K, McClaine RJ, de la Fuente SG, et al. Maternal insufflation during the second trimester equivalent produces hypercapnia, acidosis, and prolonged hypoxia in fetal sheep. Anesthesiology 2004; 101:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/13\">",
"      Andreoli M, Servakov M, Meyers P, Mann WJ Jr. Laparoscopic surgery during pregnancy. J Am Assoc Gynecol Laparosc 1999; 6:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/14\">",
"      Stepp K, Falcone T. Laparoscopy in the second trimester of pregnancy. Obstet Gynecol Clin North Am 2004; 31:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/15\">",
"      Levy T, Dicker D, Shalev J, et al. Laparoscopic unwinding of hyperstimulated ischaemic ovaries during the second trimester of pregnancy. Hum Reprod 1995; 10:1478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/16\">",
"      Upadhyay A, Stanten S, Kazantsev G, et al. Laparoscopic management of a nonobstetric emergency in the third trimester of pregnancy. Surg Endosc 2007; 21:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/17\">",
"      Affleck DG, Handrahan DL, Egger MJ, Price RR. The laparoscopic management of appendicitis and cholelithiasis during pregnancy. Am J Surg 1999; 178:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/18\">",
"      Rollins MD, Chan KJ, Price RR. Laparoscopy for appendicitis and cholelithiasis during pregnancy: a new standard of care. Surg Endosc 2004; 18:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/19\">",
"      Geisler JP, Rose SL, Mernitz CS, et al. Non-gynecologic laparoscopy in second and third trimester pregnancy: obstetric implications. JSLS 1998; 2:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/20\">",
"      Roman H, Accoceberry M, Bolandard F, et al. Laparoscopic management of a ruptured benign dermoid cyst during advanced pregnancy. J Minim Invasive Gynecol 2005; 12:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/21\">",
"      Casey FE, Lau KN, Mesbah MC, Khalife ME. Use of laparoscopy for resolution of intussusception in the third trimester of pregnancy: a case report. J Reprod Med 2009; 54:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/22\">",
"      Lenglet Y, Roman H, Rabishong B, et al. [Laparoscopic management of ovarian cysts during pregnancy]. Gynecol Obstet Fertil 2006; 34:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/23\">",
"      Hirsh J, Guyatt G, Albers GW, et al. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:71S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/24\">",
"      Barnes SL, Shane MD, Schoemann MB, et al. Laparoscopic appendectomy after 30 weeks pregnancy: report of two cases and description of technique. Am Surg 2004; 70:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/25\">",
"      Sen G, Nagabhushan JS, Joypaul V. Laparoscopic cholecystectomy in third trimester of pregnancy. J Obstet Gynaecol 2002; 22:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/26\">",
"      Reedy MB, Galan HL, Richards WE, et al. Laparoscopy during pregnancy. A survey of laparoendoscopic surgeons. J Reprod Med 1997; 42:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/27\">",
"      Yuen PM, Ng PS, Leung PL, Rogers MS. Outcome in laparoscopic management of persistent adnexal mass during the second trimester of pregnancy. Surg Endosc 2004; 18:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/28\">",
"      Lin YH, Hwang JL, Huang LW, Seow KM. Successful laparoscopic management of a huge ovarian tumor in the 27th week of pregnancy. A case report. J Reprod Med 2003; 48:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/29\">",
"      Mathevet P, Nessah K, Dargent D, Mellier G. Laparoscopic management of adnexal masses in pregnancy: a case series. Eur J Obstet Gynecol Reprod Biol 2003; 108:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/30\">",
"      Tulikangas PK, Nicklas A, Falcone T, Price LL. Anatomy of the left upper quadrant for cannula insertion. J Am Assoc Gynecol Laparosc 2000; 7:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/31\">",
"      Lee YY, Kim TJ, Kim CJ, et al. Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of peri-operative outcomes. Eur J Obstet Gynecol Reprod Biol 2010; 151:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/32\">",
"      Song T, Kim TJ, Kim MK, et al. Single port access laparoscopic-assisted vaginal hysterectomy for large uterus weighing exceeding 500 grams: technique and initial report. J Minim Invasive Gynecol 2010; 17:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/33\">",
"      Kim WC, Kwon YS. Laparoendoscopic single-site surgery for exteriorization and cystectomy of an ovarian tumor during pregnancy. J Minim Invasive Gynecol 2010; 17:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/34\">",
"      Garzarelli S, Mazzuca N. One laparoscopic puncture for treatment of ovarian cysts with adnexal torsion in early pregnancy. A report of two cases. J Reprod Med 1994; 39:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/35\">",
"      Melgrati L, Damiani A, Franzoni G, et al. Isobaric (gasless) laparoscopic myomectomy during pregnancy. J Minim Invasive Gynecol 2005; 12:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/36\">",
"      Oguri H, Taniguchi K, Fukaya T. Gasless laparoscopic management of ovarian cysts during pregnancy. Int J Gynaecol Obstet 2005; 91:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/37\">",
"      Stany MP, Winter WE 3rd, Dainty L, et al. Laparoscopic exposure in obese high-risk patients with mechanical displacement of the abdominal wall. Obstet Gynecol 2004; 103:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/38\">",
"      Fatum M, Rojansky N. Laparoscopic surgery during pregnancy. Obstet Gynecol Surv 2001; 56:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/39\">",
"      O'Rourke N, Kodali BS. Laparoscopic surgery during pregnancy. Curr Opin Anaesthesiol 2006; 19:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/40\">",
"      Kodali BS, Chandrasekhar S, Bulich LN, et al. Airway changes during labor and delivery. Anesthesiology 2008; 108:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8727/abstract/41\">",
"      Bhavani-Shankar K, Steinbrook RA, Brooks DC, Datta S. Arterial to end-tidal carbon dioxide pressure difference during laparoscopic surgery in pregnancy. Anesthesiology 2000; 93:370.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6812 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-C9EBEEE8B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8727=[""].join("\n");
var outline_f8_33_8727=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SAFETY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1966250\">",
"      Anesthetic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      BENEFITS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TIMING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Thromboprophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Prophylactic tocolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Patient position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Trocar placement/insertion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pneumoperitoneum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Fetal assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20264204\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6812\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6812|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/34/6688\" title=\"figure 1\">",
"      Port placement in pregnant women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31610?source=related_link\">",
"      Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14055?source=related_link\">",
"      Deep vein thrombosis and pulmonary embolism in pregnancy: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35674?source=related_link\">",
"      Inhibition of acute preterm labor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15482?source=related_link\">",
"      Management of pregnant women undergoing nonobstetric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_33_8728="Breast pain";
var content_f8_33_8728=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Breast pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8728/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8728/contributors\">",
"     Mehra Golshan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8728/contributors\">",
"     Dirk Iglehart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8728/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8728/contributors\">",
"     Anees B Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8728/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8728/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/33/8728/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast pain is common in women, and occasionally occurs in men. Evaluation of breast pain is important to determine whether the pain is due to normal physiological changes related to hormonal fluctuation or to a pathological process such as breast cancer. Breast pain is usually mild, although approximately 11 percent of affected women will describe their pain as moderate to severe [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the etiology, evaluation, and treatment of breast pain in women. Evaluation of a breast mass is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24825?source=see_link\">",
"     \"Breast masses and other common breast problems\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of breast pain depends upon the population studied and definition used. A survey of working women found that 45 percent had mild and 21 percent had severe breast pain, although most had not reported their symptoms to a clinician [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/2\">",
"     2",
"    </a>",
"    ]. In a large cohort of women 40 to 69 years of age enrolled in a health maintenance organization, breast pain was the most common breast related symptom prompting evaluation and accounted for almost one-half of breast related office visits [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/3\">",
"     3",
"    </a>",
"    ]. By comparison, a series of 10,000 consecutive surgical consultations for new female patients (mean age 46 years) referred for breast evaluation reported only 5 percent had a chief complaint of breast pain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FOR BREAST CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of breast cancer reported for women presenting with breast pain ranges from 1.2 to 6.7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/5\">",
"     5",
"    </a>",
"    ]. Conversely, localized breast pain was the only presenting symptom in up to 15 percent of women with newly diagnosed breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/3,5-7\">",
"     3,5-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While both breast pain and breast cancer may occur in the same patient, data conflict on whether the presence of breast pain increases a patient's risk for breast cancer:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two older case control studies found an increased risk of breast cancer for women with mastalgia. In one study, 192 women with premenopausal node-negative cancer were matched with control subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/8\">",
"       8",
"      </a>",
"      ]. The odds ratio of cancer for mastalgia was 1.35, and increased to 3.32 for severe pain. In the second study, the adjusted relative risk for breast cancer in premenopausal patients with cyclical mastalgia was 2.12 [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/9\">",
"       9",
"      </a>",
"      ]. However, recall of breast pain might be significantly increased in a retrospective survey of women with breast cancer.",
"     </li>",
"     <li>",
"      On the other hand, when both imaging studies and breast examination are normal, it is unusual to detect an underlying occult breast cancer in women presenting with breast pain. In an observational study in a large integrated health plan, breast symptoms were reported for 32 percent of 13,000 patients undergoing diagnostic mammograms and 5 percent of 110,000 patients having screening mammograms [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/10\">",
"       10",
"      </a>",
"      ]. The odds of having breast cancer were increased only for patients with complaints of a breast mass, but not for patients with breast pain alone. Another observational study included two year follow-up for breast imaging in 987 women with breast pain and 987 asymptomatic women [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/11\">",
"       11",
"      </a>",
"      ]. The prevalence of breast cancer was the same in symptomatic and asymptomatic women; malignancy was only diagnosed in women who had suspicious radiologic studies [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Taken together, these findings suggest that women who present with mastalgia can be reasonably reassured that their risk of breast cancer is low, in the absence of an abnormal examination. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Physical examination'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H10\">",
"     'Evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast pain may be cyclical (two-thirds) or noncyclical (one-third) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/12\">",
"     12",
"    </a>",
"    ]. Cyclical pain is usually associated with hormonal changes of the menstrual cycle, usually presenting in the week prior to onset of menses. It is frequently bilateral, and most severe in the upper outer quadrant of the breasts. Noncyclical pain is more likely to be related to a breast or chest wall lesion and may be constant or intermittent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cyclical breast pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minor cyclical breast discomfort is normal; it begins during the late luteal phase and dissipates with onset of menses. This is usually bilateral and diffuse pain. Cyclical breast discomfort is caused by normal hormonal changes associated with ovulation that stimulate the proliferation of normal glandular breast tissue and result in pain. The stimulation of ductal elements by estrogen, stimulation of the stroma by progesterone,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stimulation of ductal secretion by prolactin all contribute to cyclical pain during the menstrual cycle. Cyclical breast pain can also be associated with pharmacologic hormonal agents (eg, postmenopausal hormone therapy or oral contraceptive pills).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cyclical mastalgia &ndash; Cyclical mastalgia is more severe and persistent than normal cyclical breast pain [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/13\">",
"       13",
"      </a>",
"      ]. &nbsp;In a study of 1171 healthy premenopausal women, 11 percent had moderate to severe cyclical breast pain, which interfered with sexual activity in 48 percent, physical activity in 37 percent, social activity in 12 percent, and school activity in 8 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/13,14\">",
"       13,14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fibrocystic breast changes &ndash; Breast pain has traditionally been attributed to fibrocystic changes, fibrocystic breast disease, chronic cystic mastitis, and mammary dysplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/15-17\">",
"       15-17",
"      </a>",
"      ]. However, breast pain and nodularity are so common that the term fibrocystic \"disease\" is inaccurate as these symptoms are usually a normal response to hormonal changes during the menstrual cycle. From a clinical standpoint, terminology that describes the breast examination accurately such as \"nodular, sensitive breast\" is more accurate and avoids labeling the patient with normal physiologic changes as having a \"disease.\"",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Noncyclical breast pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noncyclical breast pain does not follow the usual menstrual pattern and is more likely to be unilateral and variable in its location in the breast. Multiple etiologies can cause noncyclical breast pain, as detailed below.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Large pendulous breasts &ndash; Large pendulous breasts may cause pain due to stretching of Cooper's ligaments. Neck and shoulder pain and headache may be present, as well as a rash under the pendulous breast.",
"     </li>",
"     <li>",
"      Diet, lifestyle &ndash; The role of diet and lifestyle in causing breast pain is uncertain, although some women have reported benefit from modifying aspects of their usual diet. Controlled studies have not demonstrated an effect of caffeine on fibrocystic breast changes [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/18,19\">",
"       18,19",
"      </a>",
"      ], though patients report pain relief with caffeine avoidance, possibly through a placebo effect. Nicotine may increase breast pain by increasing epinephrine levels and through epinephrine's stimulatory effect on cyclic AMP (3'-5'-cyclic adenosine monophosphate). Thus, smoking cessation may be associated with a reduction of mastalgia, although this effect may also be related to a placebo effect [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/20-22\">",
"       20-22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hormone replacement therapy &ndash; Up to one-third of menopausal women receiving postmenopausal hormone therapy experience some degree of noncyclical breast pain, which may spontaneously resolve over time [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/23-25\">",
"       23-25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ductal ectasia &ndash; Ductal ectasia is characterized by distention of subareolar ducts due to inflammation unrelated to infection. Ductal ectasia may be associated with fever and acute local pain and tenderness caused by penetration of the duct wall by lipid material, which may resolve to leave a subareolar nodule. In one study, the site and degree of duct dilatation correlated with the intensity of noncyclical breast pain [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mastitis &ndash; Mastitis or breast abscess is most common in lactating women in the first month after giving birth. It is usually caused by an obstructive lactopathy. When initiating lactation, the nipple and areolar skin often undergo local inflammation and swelling until the nipple is conditioned to frequent suckling. This swelling results in relative obstruction to milk flow that can then be seeded by skin bacteria (eg, Staphylococcus aureus or Streptococcal species) leading to bacterial mastitis. The breast becomes diffusely painful, swollen, and red; with an area of fluctuance and eventually pointing if an abscess develops. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/28/454?source=see_link\">",
"       \"Lactational mastitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"       \"Common problems of breastfeeding and weaning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammatory breast cancer &ndash; Women with de novo inflammatory breast cancer (primary disease) may present with pain and a rapidly progressing tender, firm, enlarged breast. The skin over the breast is warm and thickened, with a \"peau d'orange\" (orange skin) appearance, but there is often no fever or leukocytosis (",
"      <a class=\"graphic graphic_picture graphicRef70894 \" href=\"UTD.htm?13/8/13442\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef82220 \" href=\"UTD.htm?2/34/2592\">",
"       picture 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=see_link\">",
"       \"Inflammatory breast cancer: Clinical features and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hidradenitis suppurativa &ndash; Hidradenitis suppurativa can involve the breast and present as breast nodules and pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6265?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of hidradenitis suppurativa\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other &ndash; Other etiologies of breast pain include pregnancy, thrombophlebitis, macrocysts, prior breast surgery, and a variety of medications (hormones as well as some antidepressants, cardiovascular agents, and antibiotics) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Extramammary pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients who present with self-diagnosed breast pain actually have referred pain from sources outside of the breast. Extramammary pain may be from musculoskeletal sources such as chest wall pain, spinal or paraspinal problem, trauma or scarring from prior biopsy. It may also be related to medical problems such as biliary, pulmonary, esophageal or cardiac disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chest wall pain &ndash; Chest wall pain is often lateral and may be burning or knife-like, localized or diffuse. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=see_link\">",
"       \"Major causes of musculoskeletal chest pain\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Chest wall pain is frequently due to the pectoralis major muscle, related to activities such as water-skiing, raking, rowing, shoveling, or other actions that strain or use the pectoral muscle repetitively. The pain can be reproduced by asking the woman to place her hand flat on the iliac wing and push inward.",
"   </p>",
"   <p>",
"    Chest wall pain, usually presenting as bilateral, parasternal discomfort, can also arise from costochondritis (typically the second through fifth costochondral junctions) or Tietze's syndrome (typically second and third costochondral junctions), which usually cause bilateral, parasternal discomfort.",
"   </p>",
"   <p>",
"    Other etiologies include slipping and clicking ribs and arthritis. Radicular chest wall pain may be due to cervical arthritis.",
"   </p>",
"   <p>",
"    Local heat and analgesics may relieve pain, but most women don't require therapy beyond reassurance that the source of pain is muscle strain or articular. In severe cases, injection of the affected area with local anesthetic and corticosteroid can be diagnostic and therapeutic.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spinal and paraspinal disorders &ndash; This is pain that typically occurs in older women in whom vertebral, spinal, and paraspinal problems in the neck and upper thorax accumulate with age. Paraspinal muscle spasm and other impingements on the free course of the sensory nerves from the neck and upper thorax can cause a radiculopathy leading to pain or hyperesthesia. Burning pain, which is typical of nerve root pressure, is a common feature. Imaging studies of the neck may reveal the etiology of the pain.",
"     </li>",
"     <li>",
"      Other &ndash; Chest wall pain induced by trauma or trauma-induced fat necrosis, intercostal neuralgia often due to a respiratory infection, and underlying pleuritic lesions can mimic benign breast disease. Similarly, gallbladder disease or ischemic heart disease may present as intermittent chest pain attributed to the breast.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Postthoracotomy syndrome is an unusual disorder in which a healing chest wound simulates the effect of a suckling infant. It can be associated with an elevated prolactin concentration, breast pain, and milk production. A similar effect can be seen with other forms of chest wall irritation, including burns and chafing from clothing overlying the nipple [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;It may be helpful to ask women with cyclical pain to record the occurrence and severity of breast pain in a diary and note potential aggravating and ameliorating factors. Questions the patient should be asked about her pain include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Where in the breast does the pain occur?",
"     </li>",
"     <li>",
"      Is the pain bilateral?",
"     </li>",
"     <li>",
"      What does the pain feel like?",
"     </li>",
"     <li>",
"      How severe is the pain?",
"     </li>",
"     <li>",
"      Is it phasic, with peaks at midcycle and premenstrually?",
"     </li>",
"     <li>",
"      Is it associated with use of oral contraceptive pills or hormone replacement therapy?",
"     </li>",
"     <li>",
"      Did it begin after a recent birth or pregnancy loss or termination?",
"     </li>",
"     <li>",
"      Is it related to vigorous or repetitive use of the pectoral muscle group?",
"     </li>",
"     <li>",
"      Is there concurrent neck problem?",
"     </li>",
"     <li>",
"      Are there systemic or other local symptoms, such as fever or erythema?",
"     </li>",
"     <li>",
"      Is there a history of recent trauma to the chest?",
"     </li>",
"     <li>",
"      Does the pain affect her ability to perform daily activities?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, a complete medical and surgical history and systematic review of systems should be obtained. Breast cancer risk should be assessed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=see_link\">",
"     \"Screening for breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The key point in examining a woman with breast pain is to look for additional signs suggestive of breast malignancy, such as a mass, skin changes, or bloody nipple discharge. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24825?source=see_link\">",
"     \"Breast masses and other common breast problems\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/23/3449?source=see_link\">",
"     \"Nipple discharge\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The four breast quadrants, subareolar areas, axillae, supraclavicular and infraclavicular areas should be systematically examined with the woman both lying and sitting with her hands on her hips and then above her head.",
"   </p>",
"   <p>",
"    The specific goals of the examination are to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Check for skin changes noting the symmetry and contour of the breasts, position of the nipples, scars, skin retraction, dimpling, edema or erythema, ulceration or crusting of the nipple, and changes in skin color",
"     </li>",
"     <li>",
"      Check for enlarged axillary, supraclavicular, or infraclavicular lymph nodes",
"     </li>",
"     <li>",
"      Delineate and document breast masses",
"     </li>",
"     <li>",
"      Check for nipple discharge",
"     </li>",
"     <li>",
"      Identify localized areas of tenderness and relate them to areas of pain noted by the woman and to other physical findings",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the physical examination is normal, an updated mammogram and targeted ultrasound will help rule out any underlying problem. Mammography is not routinely ordered in women under age 35 years. However, it is not inappropriate to order a mammogram as part of a diagnostic evaluation of a clinically suspicious mass in younger women.",
"   </p>",
"   <p>",
"    If the pain is cyclical and no abnormality is found on physical examination or imaging studies, a cancer diagnosis is unlikely. Those with negative findings can be treated supportively, as described below. Positive imaging studies require appropriate follow-up. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39482?source=see_link\">",
"     \"Breast imaging: Mammography and ultrasonography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the value of both mammography and ultrasound for evaluation of breast pain has not been proven and the yield is low if physical examination is normal. One case-control study showed that in women referred for mammography, the incidence of breast cancer was similar in the painful breast (0.5 percent), the nonpainful breast (0.5 percent), and in women without breast pain undergoing routine screening (0.7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood tests are not useful, except in the evaluation of galactorrhea. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19254?source=see_link\">",
"     \"Clinical manifestations and diagnosis of hyperprolactinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;After obtaining normal findings on clinical and imaging studies, simple reassurance that she does not have breast cancer provides adequate relief for most women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/5\">",
"     5",
"    </a>",
"    ]. For those who seek treatment, several therapies have been shown to relieve breast pain. However, most recommendations for treatment of mastalgia are based upon data from observational or case-controlled studies, with minimal or no data from randomized controlled trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Role of diet and lifestyle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of diet and lifestyle in relieving cyclical breast pain is unclear, with a strong likelihood of a placebo response for many interventions. A low fat (15 percent of calories), high complex carbohydrate diet has been effective in some observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/5,28,29\">",
"     5,28,29",
"    </a>",
"    ]. Elimination of caffeine has not been effective in controlled trials, although it seems to be helpful in some women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. Inconclusive evidence exists for the role of vitamin E&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/30\">",
"     30",
"    </a>",
"    ] and evening primrose oil&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/31\">",
"     31",
"    </a>",
"    ] in reducing pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Symptomatic relief",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Support garments &ndash; A well-fitting brassiere to better support the breast is widely advocated [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/32\">",
"       32",
"      </a>",
"      ]. The use of support bra with steel underwire tends to reduce mastalgia in women with pendulous breasts. In addition, use of a \"sports bra\" during exercise has been shown to reduce pain related to breast movement [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/33,34\">",
"       33,34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Compresses &ndash; Some women obtain relief from application of warm compresses or ice packs or gentle massage. Ice packs are recommended during the obstructive (prebacterial) phase of puerperal mastitis to decrease milk production regionally and thereby relieve ductal intraluminal pressure and subsequent pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"       \"Common problems of breastfeeding and weaning\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/28/454?source=see_link\">",
"       \"Lactational mastitis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    or a nonsteroidal antiinflammatory drug (NSAID), or both can be used to relieve breast pain [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/5\">",
"     5",
"    </a>",
"    ]. Topical NSAIDs may also be useful [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/35\">",
"     35",
"    </a>",
"    ]. At least one topical NSAID has been available in the United States (US) for many years: salicylate, the active ingredient in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , is found in Aspercreme and Nuprin. Another topical NSAID was recently approved by the US Food and Drug Administration (FDA): the Flector Patch contains the NSAID",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/29/38352?source=see_link\">",
"     diclofenac",
"    </a>",
"    , the same active ingredient contained in the oral NSAID Voltaren [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postmenopausal hormone therapy can cause breast pain and this should be decreased or discontinued if at all possible [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/38\">",
"     38",
"    </a>",
"    ]. Similarly, decreasing the dose of estrogen in an oral contraceptive regimen can be effective in controlling breast pain. Oral contraceptives can reduce breast pain severity and duration in some women with cyclical symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Progestogens also improve breast pain symptoms in some women. [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     Danazol",
"    </a>",
"    is the only medication approved by the US FDA for the treatment of mastalgia. Danazol is effective at relieving breast pain and tenderness but it causes significant androgenic effects which generally limit its use and result in discontinuation of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. (See",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     \"Danazol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_patient\" href=\"UTD.htm?31/54/32613?source=see_link\">",
"     \"Danazol: Patient drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with more severe mastalgia,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    10 mg can provide breast pain relief [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/46\">",
"     46",
"    </a>",
"    ], although this medication is associated with side effects including include menopause-like symptoms such as hot flashes, vaginal dryness, joint pain, and leg cramps. Tamoxifen also increases the risk of blood clots, strokes, uterine cancer, and cataracts. Tamoxifen is infrequently used for this indication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41576?source=see_link\">",
"     \"Managing the side effects of tamoxifen\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several other drugs that affect estrogen or prolactin secretion (including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/40/8840?source=see_link\">",
"     bromocriptine",
"    </a>",
"    and GNRH agonists) have been studied [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/47,48\">",
"     47,48",
"    </a>",
"    ], but are not advocated for use in patients with severe mastalgia because of significant side effect profiles.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis is variable and influenced by the age of onset of pain and whether pain is cyclical or noncyclical [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/49\">",
"     49",
"    </a>",
"    ]. In one series, cyclical breast pain spontaneously resolved within three months of onset in 20 to 30 percent of women, but transient relapses were common [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/50\">",
"     50",
"    </a>",
"    ]. In another series, noncyclical breast pain spontaneously resolved in 50 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/51\">",
"     51",
"    </a>",
"    ]. Relief may be spontaneous or related to a hormonally mediated event, such as pregnancy or menopause [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8728/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281281168\">",
"    <span class=\"h1\">",
"     MALE BREAST PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast pain in men is usually due to gynecomastia. The causes and management of gynecomastia are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27384?source=see_link\">",
"     \"Causes and evaluation of gynecomastia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/47/760?source=see_link\">",
"     \"Management of gynecomastia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/9/6294?source=see_link\">",
"     \"Epidemiology and pathogenesis of gynecomastia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?40/47/41713?source=see_link\">",
"     \"Patient information: Gynecomastia (breast enlargement in men) (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/62/6115?source=see_link\">",
"       \"Patient information: Common breast problems (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/56/6018?source=see_link\">",
"       \"Patient information: Common breast problems (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Breast pain is common in premenstrual women. Elements from the history can help distinguish pain that is cyclical versus noncyclical, and that which is breast related versus extramammary. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Breast cancer is diagnosed in 1.2 to 6.7 percent of patients presenting with breast pain. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk for breast cancer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest evaluation with history and physical examination. Targeted ultrasonography should be ordered if the breast pain is focal. Mammography should be ordered for women over 35 years of age; it is not routinely ordered in women under age 35 years. However, it is not inappropriate to order a mammogram as part of a diagnostic evaluation of a clinically suspicious mass in younger women. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment with analgesics and a supportive brassiere can be helpful for many women with mastalgia. Other medications, including",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"       tamoxifen",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"       danazol",
"      </a>",
"      , may be used in women with severe mastalgia but these drugs have significant adverse effects. Patients should be informed of potential risks and included in the decision as to whether the risks outweigh the potential benefits of symptom relief. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/1\">",
"      Ader DN, Shriver CD. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg 1997; 185:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/2\">",
"      Maddox PR, Mansel RE. Management of breast pain and nodularity. World J Surg 1989; 13:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/3\">",
"      Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med 1999; 130:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/4\">",
"      Seltzer MH. Breast complaints, biopsies, and cancer correlated with age in 10,000 consecutive new surgical referrals. Breast J 2004; 10:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/5\">",
"      Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc 2004; 79:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/6\">",
"      Preece PE, Baum M, Mansel RE, et al. Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) 1982; 284:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/7\">",
"      BeLieu RM. Mastodynia. Obstet Gynecol Clin North Am 1994; 21:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/8\">",
"      Goodwin PJ, DeBoer G, Clark RM, et al. Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study. Breast Cancer Res Treat 1995; 33:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/9\">",
"      Plu-Bureau G, Thalabard JC, Sitruk-Ware R, et al. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women. Br J Cancer 1992; 65:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/10\">",
"      Aiello EJ, Buist DS, White E, et al. Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms. J Am Board Fam Pract 2004; 17:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/11\">",
"      Duijm LE, Guit GL, Hendriks JH, et al. Value of breast imaging in women with painful breasts: observational follow up study. BMJ 1998; 317:1492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/12\">",
"      Davies EL, Gateley CA, Miers M, Mansel RE. The long-term course of mastalgia. J R Soc Med 1998; 91:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/13\">",
"      Ader DN, Browne MW. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample. Am J Obstet Gynecol 1997; 177:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/14\">",
"      Ader DN, South-Paul J, Adera T, Deuster PA. Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 2001; 22:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/15\">",
"      Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic \"disease\" of the breast--a nondisease? N Engl J Med 1982; 307:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/16\">",
"      Devitt JE. Abandoning fibrocystic disease of the breast: timely end of an era. CMAJ 1986; 134:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/17\">",
"      Hutter RV. Goodbye to \"fibrocystic disease\". N Engl J Med 1985; 312:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/18\">",
"      Levinson W, Dunn PM. Nonassociation of caffeine and fibrocystic breast disease. Arch Intern Med 1986; 146:1773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/19\">",
"      Jacobson MF, Liebman BF. Caffeine and benign breast disease. JAMA 1986; 255:1438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/20\">",
"      Heyden S, Muhlbaier LH. Prospective study of \"fibrocystic breast disease\" and caffeine consumption. Surgery 1984; 96:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/21\">",
"      Minton JP, Foecking MK, Webster DJ, Matthews RH. Caffeine, cyclic nucleotides, and breast disease. Surgery 1979; 86:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/22\">",
"      Abraham GE. Nutritional factors in the etiology of the premenstrual tension syndromes. J Reprod Med 1983; 28:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/23\">",
"      Archer, DR, Fischer, LA, Rich, D, et al. Estrace vs Premarin for treatment of menopausal symptoms: dosage comparison study. Advances in Therapy 1992; 9:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/24\">",
"      Bech P, Munk-Jensen N, Obel EB, et al. Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures. Psychother Psychosom 1998; 67:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/25\">",
"      Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998; 92:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/26\">",
"      Peters F, Diemer P, Mecks O, Behnken L LJ. Severity of mastalgia in relation to milk duct dilatation. Obstet Gynecol 2003; 101:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/27\">",
"      Morley JE, Dawson M, Hodgkinson H, Kalk WJ. Galactorrhea and hyperprolactinemia associated with chest wall injury. J Clin Endocrinol Metab 1977; 45:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/28\">",
"      Boyd NF, McGuire V, Shannon P, et al. Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet 1988; 2:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/29\">",
"      Goodwin PJ, Miller A, Del Giudice ME, et al. Elevated high-density lipoprotein cholesterol and dietary fat intake in women with cyclic mastopathy. Am J Obstet Gynecol 1998; 179:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/30\">",
"      Ernster, FL, Goodson, WH 3d, Hunt, TK, et al. Vitamin E and benign breast \"disease\": a double-blind, randomized clinical trial. Surgery 1985; 97:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/31\">",
"      Blommers J, de Lange-De Klerk ES, Kuik DJ, et al. Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial. Am J Obstet Gynecol 2002; 187:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/32\">",
"      Wilson MC, Sellwood RA. Therapeutic value of a supporting brassi&egrave;re in mastodynia. Br Med J 1976; 2:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/33\">",
"      Hadi MS. Sports Brassiere: Is It a Solution for Mastalgia? Breast J 2000; 6:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/34\">",
"      Mason BR, Page KA, Fallon K. An analysis of movement and discomfort of the female breast during exercise and the effects of breast support in three cases. J Sci Med Sport 1999; 2:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/35\">",
"      Colak T, Ipek T, Kanik A, et al. Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 2003; 196:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/36\">",
"      Diclofenac gel for osteoarthritis. Med Lett Drugs Ther 2008; 50:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/37\">",
"      A diclofenac patch (Flector) for pain. Med Lett Drugs Ther 2008; 50:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/38\">",
"      Dixon JM. Hormone replacement therapy and the breast. BMJ 2001; 323:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/39\">",
"      Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992; 36:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/40\">",
"      Bancroft J, Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 1993; 37:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/41\">",
"      Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study. J Am Coll Surg 1997; 184:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/42\">",
"      Uzan S, Denis C, Pomi V, Varin C. Double-blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease. Eur J Obstet Gynecol Reprod Biol 1992; 43:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/43\">",
"      O'Brien PM, Abukhalil IE. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 1999; 180:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/44\">",
"      Gateley CA, Miers M, Mansel RE, Hughes LE. Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic. J R Soc Med 1992; 85:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/45\">",
"      Srivastava A, Mansel RE, Arvind N, et al. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast 2007; 16:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/46\">",
"      Fentiman IS, Caleffi M, Hamed H, Chaudary MA. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg 1988; 75:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/47\">",
"      Parlati E, Polinari U, Salvi G, et al. Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo. Acta Obstet Gynecol Scand 1987; 66:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/48\">",
"      Sismondi P, Biglia N, Giai M, Defabiani E. GnRH analogs in benign breast disease and breast cancer chemoprevention. A challenge for the year 2000. Eur J Gynaecol Oncol 1994; 15:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/49\">",
"      Wisbey JR, Kumar S, Mansel RE, et al. Natural history of breast pain. Lancet 1983; 2:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/50\">",
"      Kumar S, Mansel RE, Scanlon MF, et al. Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia. Br J Surg 1984; 71:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8728/abstract/51\">",
"      Gateley CA, Mansel RE. Management of the painful and nodular breast. Br Med Bull 1991; 47:284.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 803 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-4838B967EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8728=[""].join("\n");
var outline_f8_33_8728=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FOR BREAST CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cyclical breast pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Noncyclical breast pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Extramammary pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Role of diet and lifestyle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Symptomatic relief",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H281281168\">",
"      MALE BREAST PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/803\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/803|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/8/13442\" title=\"picture 1\">",
"      Inflammatory breast cancer with peau d orange appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/34/2592\" title=\"picture 2\">",
"      Inflammatory breast cancer appearance",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39482?source=related_link\">",
"      Breast imaging: Mammography and ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24825?source=related_link\">",
"      Breast masses and other common breast problems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27384?source=related_link\">",
"      Causes and evaluation of gynecomastia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19254?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=related_link\">",
"      Common problems of breastfeeding and weaning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=related_link\">",
"      Danazol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?31/54/32613?source=related_link\">",
"      Danazol: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/9/6294?source=related_link\">",
"      Epidemiology and pathogenesis of gynecomastia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=related_link\">",
"      Inflammatory breast cancer: Clinical features and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/28/454?source=related_link\">",
"      Lactational mastitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=related_link\">",
"      Major causes of musculoskeletal chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/47/760?source=related_link\">",
"      Management of gynecomastia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41576?source=related_link\">",
"      Managing the side effects of tamoxifen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/23/3449?source=related_link\">",
"      Nipple discharge",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6265?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of hidradenitis suppurativa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/56/6018?source=related_link\">",
"      Patient information: Common breast problems (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/62/6115?source=related_link\">",
"      Patient information: Common breast problems (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/47/41713?source=related_link\">",
"      Patient information: Gynecomastia (breast enlargement in men) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=related_link\">",
"      Screening for breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_33_8729="Clinical features, diagnosis, and treatment of methemoglobinemia";
var content_f8_33_8729=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features, diagnosis, and treatment of methemoglobinemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8729/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8729/contributors\">",
"     Josef T Prchal, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8729/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8729/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8729/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8729/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8729/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8729/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/33/8729/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two types of methemoglobinemia &mdash; congenital and acquired:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital methemoglobinemia is characterized by diminished enzymatic reduction of methemoglobin (ie, hemoglobin with its iron in the ferric state) back to functional hemoglobin (ie, hemoglobin with its iron in the ferrous state). Affected patients appear cyanotic but are generally asymptomatic.",
"     </li>",
"     <li>",
"      Acquired methemoglobinemia typically results from ingestion of specific drugs or agents that cause an increase in the production of methemoglobin. It can be a fatal disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The pathophysiology, clinical features, diagnosis, and treatment of methemoglobinemia will be reviewed here. The genetics and pathogenesis of methemoglobinemia are discussed elsewhere, but will be briefly summarized below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link\">",
"     \"Genetics and pathogenesis of methemoglobinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methemoglobin is an altered state of hemoglobin in which the ferrous (Fe2+) irons of heme are oxidized to the ferric (Fe3+) state. The ferric hemes of methemoglobin are UNABLE to bind oxygen. In addition, the oxygen affinity of any remaining ferrous hemes in the hemoglobin tetramer is increased [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/1\">",
"     1",
"    </a>",
"    ]. As a result, the oxygen dissociation curve is \"left-shifted\" (",
"    <a class=\"graphic graphic_figure graphicRef81216 \" href=\"UTD.htm?2/26/2479\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/4/42055?source=see_link\">",
"     \"Genetic disorders of hemoglobin oxygen affinity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The net effect is that the patient with increased concentrations of methemoglobin has a greater functional anemia than suggested by the laboratory data. The circulating methemoglobin-containing hemoglobin molecules are unable to carry oxygen and the remaining oxyhemoglobin has increased oxygen affinity, resulting in impaired oxygen delivery to the tissues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Formation and reduction of methemoglobin",
"    </span>",
"    &nbsp;&mdash;&nbsp;In normal individuals, autooxidation of hemoglobin to methemoglobin occurs spontaneously at a slow rate, each day converting 0.5 to 3 percent of the available hemoglobin to methemoglobin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. This autooxidation is paralleled with reduction of methemoglobin by the mechanisms described below, and acts to maintain a steady-state level of methemoglobin of about 1 percent of total hemoglobin in normal individuals.",
"   </p>",
"   <p>",
"    There are two pathways for reduction of methemoglobin back to hemoglobin:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The only physiologically important pathway is the NADH-dependent reaction catalyzed by cytochrome b5 reductase (b5R). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link&amp;anchor=H2#H2\">",
"       \"Genetics and pathogenesis of methemoglobinemia\", section on 'Methemoglobin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An alternative pathway, that is not physiologically active, utilizes NADPH generated by glucose-6-phosphate dehydrogenase (G6PD) in the hexose monophosphate shunt. However, there is normally no electron carrier present in red blood cells to interact with NADPH methemoglobin reductase. Extrinsically administered electron acceptors, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      (MB) and riboflavin&nbsp;(",
"      <a class=\"graphic graphic_figure graphicRef53599 \" href=\"UTD.htm?24/8/24718\">",
"       figure 2",
"      </a>",
"      ) are required for this pathway to be activated [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/4\">",
"       4",
"      </a>",
"      ]. This pathway becomes clinically important for the treatment of methemoglobinemia. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Treatment'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Congenital causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of the less common hereditary methemoglobinemias are due to homozygous or compound heterozygous deficiency (ie, autosomal recessive) of cytochrome b5 reductase 3 (cyb5r3, EC 1.6.2.2), one of the four cyb5r genes, which is a member of a flavoenzyme family of dehydrogenases-electron transferases that participates in the transfer of electrons to cytochrome b5 from the NADH generated by glyceraldehyde 3-phosphate dehydrogenase. This disorder is typically seen in three settings: endemic methemoglobinemia; in individuals of consanguineous unions; or in compound heterozygous cytochrome b5 reductase deficiency, which is primarily seen in sporadic cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link&amp;anchor=H19#H19\">",
"     \"Genetics and pathogenesis of methemoglobinemia\", section on 'Cytochrome b5 reductase 3 deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another congenital cause of methemoglobinemia is hemoglobin M disease, which is due to mutations in a single globin gene (ie, autosomal dominant) of either the alpha, beta, or rarely gamma globin gene [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/5\">",
"     5",
"    </a>",
"    ]. In most of the mutations, tyrosine is substituted for either the proximal or distal histidine in the heme pocket, and forms an Fe3+-phenolate complex that resists reduction of Fe3+ heme iron to the divalent state. The net effect is life-long methemoglobinemia. Administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    does not correct this type of congenital methemoglobinemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link&amp;anchor=H22#H22\">",
"     \"Genetics and pathogenesis of methemoglobinemia\", section on 'Hemoglobin M disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Deficiency of cytochrome b5 is the rarest form of congenital methemoglobinemia, and has been described in only one or two families [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Acquired causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of methemoglobinemia are acquired, resulting from increased methemoglobin formation by various exogenous agents (",
"    <a class=\"graphic graphic_table graphicRef51406 \" href=\"UTD.htm?38/28/39372\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/5,8\">",
"     5,8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Acquired methemoglobinemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16555891\">",
"    <span class=\"h3\">",
"     Drugs and anesthetic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"     Dapsone",
"    </a>",
"    and local anesthetic agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/7/6264?source=see_link\">",
"     benzocaine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    ) appear to be the most common precipitating agents of acquired methemoglobinemia (",
"    <a class=\"graphic graphic_table graphicRef51406 \" href=\"UTD.htm?38/28/39372\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of 138 patients with acquired methemoglobinemia, use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"       dapsone",
"      </a>",
"      accounted for 42 percent of cases, with a mean methemoglobin level of 7.6 percent (range 2 to 34 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second study, methemoglobinemia was seen in approximately 20 percent of pediatric oncology patients who received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"       dapsone",
"      </a>",
"      for",
"      <span class=\"nowrap\">",
"       treatment/prevention",
"      </span>",
"      of Pneumocystis jiroveci (PCP) infection [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Dapsone-induced methemoglobinemia'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1176884\">",
"    <span class=\"h4\">",
"     Benzocaine spray for topical anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most severe cases were seen after the use of 20 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/7/6264?source=see_link\">",
"     benzocaine",
"    </a>",
"    spray for topical anesthesia (mean peak methemoglobin level 44 percent, range: 19 to 60 percent). High mean peak methemoglobin levels (mean 32 percent) following benzocaine administration were also noted in a series of 19 patients who underwent transesophageal echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/10\">",
"     10",
"    </a>",
"    ]. The incidence of methemoglobinemia in this setting was 0.7 percent. The molecular mechanism underlying this association has not been elucidated, as previous or subsequent exposure to benzocaine may not be associated with methemoglobinemia. Among the patients who underwent transesophageal echocardiography, those who developed methemoglobinemia were significantly more likely, compared with random controls, to have active infection (68 versus 7 percent) and anemia (84 versus 45 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43817?source=see_link&amp;anchor=H44#H44\">",
"     \"Topical anesthetics in children\", section on 'Benzocaine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1176891\">",
"    <span class=\"h3\">",
"     Inhaled nitric oxide (NO)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhaled nitric oxide (NO) is approved for treatment of infants with pulmonary hypertension because of its vasodilatory effect on pulmonary vessels. During the binding and release of NO from hemoglobin, methemoglobin is formed at a higher rate. In one study of 81 premature and 82 term infants, methemoglobin was above 5 percent in one term infant, and between 2.5 and 5 percent in 16 infants [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16555898\">",
"    <span class=\"h3\">",
"     Aniline and its derivatives",
"    </span>",
"    &nbsp;&mdash;&nbsp;A young woman working in a paint and dye-casting factory employing aniline dyes presented to the emergency department with cyanosis, fever, and altered sensorium, and died of severe methemoglobinemia. While the methemoglobinemia was initially ascribed to a medication she was taking (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25447?source=see_link\">",
"     chloroquine",
"    </a>",
"    ), the casual relation to aniline dye could not be excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two young men experimenting with recreational drugs developed severe methemoglobinemia and the offending agent was identified by Drug Enforcement Administration and Food and Drug Administration (FDA) to be aniline [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/14\">",
"     14",
"    </a>",
"    ]. Aniline and its derivatives (eg, aniline dyes, aminophenol, phenylhydroxylamine) are highly toxic oxidant compounds used in industry. In addition to accidental or deliberate ingestion, they can be absorbed systemically through the skin or lungs. Such absorption can lead to extremely high concentrations of methemoglobin, which may continue for up to 20 hours after exposure and be relatively resistant to treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    or ascorbic acid [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/14\">",
"     14",
"    </a>",
"    ]. In severe, resistant cases, treatment with hyperbaric oxygen or exchange transfusion has been suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Congenital methemoglobinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most individuals with congenital, chronically elevated methemoglobin concentrations are asymptomatic (although some complain of headache and easy fatigability) even with methemoglobin levels as high as 40 percent of total hemoglobin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Disease subtypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type I and type II congenital methemoglobinemia are described in depth elsewhere, but will be briefly described here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link&amp;anchor=H19#H19\">",
"     \"Genetics and pathogenesis of methemoglobinemia\", section on 'Cytochrome b5 reductase 3 deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I disease &mdash; The majority of cases of enzymopenic congenital methemoglobinemia are type I, in which the functional deficiency of cytochrome b5 reductase is limited to erythrocytes and cyanosis is the only symptom and sign.",
"     </li>",
"     <li>",
"      Type II disease &mdash; In type II cytochrome b5 reductase 3 (cyb5r3) deficiency, which represents 10 to 15 percent of cases of enzymopenic congenital methemoglobinemia, cytochrome b5R is deficient in all cells. In addition to cyanosis there are severe developmental abnormalities; most affected infants die in the first year of life.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Cyanosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main complaint of subjects with congenital methemoglobinemia is \"cyanosis\" or a slate-blue color of the skin and mucous membranes, a finding that is due to the different absorbance spectrum of methemoglobin compared with oxyhemoglobin.",
"   </p>",
"   <p>",
"    Cyanosis is clinically detected when the absolute concentration of methemoglobin exceeds 1.5",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    equivalent to 8 to 12 percent methemoglobin at normal hemoglobin concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/5,16\">",
"     5,16",
"    </a>",
"    ]. In contrast, the most common cause of cyanosis is decreased hemoglobin oxygen saturation, which is observed when the absolute level of deoxygenated hemoglobin (reduced hemoglobin) exceeds 4 to 5",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    as in severe respiratory failure or cardiac abnormalities due to right-to-left shunts. This form of cyanosis cannot be clinically differentiated from that due to methemoglobinemia; thus, testing for methemoglobinemia is required. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Laboratory diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Symptoms in type I disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant polycythemia (ie, compensatory erythrocytosis) is only rarely observed in congenital methemoglobinemia. Life expectancy is not shortened and pregnancies occur normally. The general lack of symptoms (other than cyanosis) and normal life expectancy in patients with cytochrome b5 reductase3 deficiency applies only to the more common type I disease in which the enzymatic defect is limited to red cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Symptoms in type II disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to type I congenital methemoglobinemia, all cells are affected in patients with type II methemoglobinemia, who exhibit, in addition to cyanosis, mental retardation and developmental delay with failure to thrive [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Other neurologic manifestations may be present, including microcephaly, opisthotonus, athetoid movements, strabismus, seizures, and spastic quadriparesis. Life expectancy is significantly shortened, and most die in infancy. Neurologic problems may result from abnormal lipid elongation and desaturation affecting the central nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because the enzymatic defect is also found in fibroblasts, prenatal diagnosis is possible by analysis of cytochrome b5R activity in cultured amniotic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Acquired methemoglobinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquired methemoglobinemia typically results from ingestion of specific drugs or agents (",
"    <a class=\"graphic graphic_table graphicRef51406 \" href=\"UTD.htm?38/28/39372\">",
"     table 1",
"    </a>",
"    ) that cause an increase in the production of methemoglobin, which can be fatal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Signs and symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms in patients with acquired methemoglobinemia result from an acute impairment in oxygen delivery to tissues that does not allow sufficient time for compensatory mechanisms to take place. Early symptoms include headache, fatigue, dyspnea, and lethargy. At higher methemoglobin levels, respiratory depression, altered consciousness, shock, seizures, and death may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/8\">",
"     8",
"    </a>",
"    ]. Acquired methemoglobinemia is life threatening when methemoglobin comprises more than 30 percent of total hemoglobin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Cyanosis during endoscopic procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The occurrence of acute cyanosis during endoscopic procedures, such as bronchoscopy, may be due to airway obstruction, but another possibility is the induction of acute methemoglobinemia as a result of the topical anesthetic agent used prior to the procedure (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/7/6264?source=see_link\">",
"     benzocaine",
"    </a>",
"    spray)",
"    <a class=\"external\" href=\"file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm250264.htm\">",
"     FDA benzocaine warning",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Clues that methemoglobinemia is present in such settings include the development of cyanosis in the presence of a normal arterial PO2",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the presence of \"chocolate brown blood\" in the videoscopic field [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/23\">",
"     23",
"    </a>",
"    ]. Several deaths have been attributed to this complication. Rapid recognition, coupled with immediate infusion of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    , can be life saving. &nbsp;(See",
"    <a class=\"local\" href=\"#H25\">",
"     'Acute use of methylene blue'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=see_link&amp;anchor=H12562876#H12562876\">",
"     \"Flexible bronchoscopy: Equipment, procedure, and complications\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Underlying genetic risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A risk factor for acute acquired methemoglobinemia is the asymptomatic heterozygous state for cytochrome b5R deficiency. The classic description of acute toxic methemoglobinemia in United States military personnel receiving malarial prophylaxis in Vietnam demonstrated for the first time that heterozygotes for this autosomal recessive disease can, under certain conditions, develop a disease state that is more clinically significant than their asymptomatic homozygous peers. The latter, because of the chronicity of their methemoglobinemia, are fully accommodated to their disease state, in part by an increase of their erythrocyte mass [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, most individuals presenting with acute acquired methemoglobinemia are not heterozygous for cytochrome b5 reductase deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Clinical suspicion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methemoglobinemia may be clinically suspected by the presence of clinical \"cyanosis\" in the presence of a normal arterial pO2 (PaO2) as obtained by arterial blood gases. The blood in methemoglobinemia has been variously described as dark-red, chocolate, or brownish to blue in color, and, unlike deoxyhemoglobin, the color does not change with the addition of oxygen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4295809\">",
"    <span class=\"h2\">",
"     Pulse oximetry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine pulse oximetry may be",
"    <strong>",
"     inaccurate",
"    </strong>",
"    for monitoring oxygen saturation in the presence of methemoglobinemia, and should not be used to make the diagnosis of this disorder. The presence of methemoglobin can be suspected when the oxygen saturation as measured by pulse oximetry is significantly different from the oxygen saturation calculated from arterial blood gas analysis (\"saturation gap\") [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/9,26,27\">",
"     9,26,27",
"    </a>",
"    ]. The accuracy of a pulse oximeter that uses eight wavelengths of light and can measure both methemoglobin and carboxyhemoglobin is under evaluation, and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link&amp;anchor=H8#H8\">",
"     \"Pulse oximetry\", section on 'Abnormal hemoglobins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Laboratory diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory diagnosis of methemoglobinemia is based upon analysis of its absorption spectrum, which has peak absorbance at 631 nm. A fresh specimen should always be obtained as methemoglobin levels tend to increase with storage. The standard method of assaying methemoglobin utilizes a microprocessor-controlled, fixed wavelength co-oximeter. This instrument interprets all readings in the 630 nm range as methemoglobin; thus, false positives may occur in the presence of other pigments including sulfhemoglobin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a result, methemoglobin detected by the co-oximeter should be confirmed by the specific Evelyn-Malloy method [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/30\">",
"     30",
"    </a>",
"    ]. This assay involves the addition of cyanide which binds to the positively charged methemoglobin, eliminating the peak at 630 to 635 nm in direct proportion to the methemoglobin concentration. The subsequent addition of ferricyanide converts the entire specimen to cyanomethemoglobin for measurement of the total hemoglobin concentration. Methemoglobin is then expressed as a percentage of the total concentration of hemoglobin.",
"   </p>",
"   <p>",
"    Use of the Evelyn-Malloy method for determining the concentration of methemoglobin is especially important after the therapeutic use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    , since the co-oximeter \"reads\" methylene blue as if it were methemoglobin.",
"   </p>",
"   <p>",
"    Sulfhemoglobin, in concentrations greater than 0.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    also causes \"cyanosis\" with a normal PaO2 and may be erroneously measured as methemoglobin. Sulfhemoglobin can be distinguished from methemoglobin by virtue of its peak absorption at 620 nm which, unlike methemoglobin, is not abolished by the addition of cyanide.",
"   </p>",
"   <p>",
"    Distinguishing among the hereditary forms of congenital methemoglobinemia is aided by interpretation of family pedigrees as well as biochemical analyses. Cyanosis in successive generations suggests the presence of the autosomal dominant Hb M disease, whereas normal parents but possibly affected siblings imply the presence of autosomal recessive deficiency of cytochrome b5R or, rarely, cytochrome b5.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Incubation of blood with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      distinguishes cytochrome b5R deficiency from Hb M disease; this treatment will result in the rapid reduction of methemoglobin through the NADPH-flavin reductase pathway in cytochrome b5R deficiency but not in Hb M disease [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/31-33\">",
"       31-33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Measurement of the level of cytochrome b5R activity or cytochrome b5 is required to distinguish cytochrome b5R deficiency from cytochrome b5 deficiency; however, these assays are not commercially available.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Assays of enzyme activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Types I and II cyb5r3 deficiency are distinguished by clinical phenotype as described above and analysis of enzymatic activity in erythroid and nonerythroid cells. Reports of decreased cytochrome b5R activity are difficult to compare since several different assays of cytochrome b5R activity, varying in their substrate and in their normal values, have been used [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/5,34-40\">",
"     5,34-40",
"    </a>",
"    ]. These assays also vary in their technical difficulty.",
"   </p>",
"   <p>",
"    The first widely accepted cytochrome b5R activity assay used a difficult to produce and standardize methemoglobin-ferrocyanide complex and its reduction by an enzyme containing hemolysate or other tissue homogenate [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/36\">",
"     36",
"    </a>",
"    ]. The most rigorous cytochrome b5R enzyme activity is based on partial purification of the enzyme by ultracentrifugation and uses the physiological enzyme substrate (cytochrome b5 prepared by a recombinant DNA technology) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/41\">",
"     41",
"    </a>",
"    ]. This assay is not readily available and is too complex for nonspecialized research laboratories.",
"   </p>",
"   <p>",
"    A subsequently developed assay uses readily available ferricyanide [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/42\">",
"     42",
"    </a>",
"    ] and easily differentiates type I and type II cytochrome b5R deficiency. As mentioned above, patients with type I deficiency have normal enzyme activity in platelets, fibroblasts, Epstein-Barr virus-transformed lymphocytes and granulocytes while, in type II deficiency, the activity in nonerythroid tissues is markedly to moderately decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/37,42,43\">",
"     37,42,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of methemoglobinemia depends upon the clinical setting (ie, acute onset of methemoglobinemia due to drugs or other toxic agents versus congenital life-long methemoglobinemia).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     General precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with hereditary methemoglobinemia should avoid exposure to aniline derivatives, nitrates, and other agents that may, even in normal individuals, induce methemoglobinemia (",
"    <a class=\"graphic graphic_table graphicRef51406 \" href=\"UTD.htm?38/28/39372\">",
"     table 1",
"    </a>",
"    ). Known heterozygotes for cytochrome b5R deficiency should be similarly counseled [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Cytochrome b5 reductase 3 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of cyanosis in individuals with type I and II cytochrome b5 reductase 3 deficiency (cyb5r3 deficiency) is indicated only for cosmetic reasons, if so desired. Treatment options include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    (100 to 300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    orally) or ascorbic acid (300 to 1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    orally in divided doses). Concerns about kidney stone formation with ascorbic acid therapy remain unproven, although high dose therapy may be associated with some risk. Riboflavin (20 to 30",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    has also been used with some success [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/45\">",
"     45",
"    </a>",
"    ], although clinical experience with its use is very limited. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=see_link&amp;anchor=H7#H7\">",
"     \"Risk factors for calcium stones in adults\", section on 'Hyperoxaluria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although effective for reducing the cyanosis, neither",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    nor ascorbic acid has any effect on the neurologic abnormalities in type II disease. Theoretically, a bone marrow or liver transplant would alleviate these neurologic problems if they were due to a problem with circulating fatty acids; however, these approaches have not yet been tested.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Acquired methemoglobinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Offending agents in acquired methemoglobinemia should be discontinued (",
"    <a class=\"graphic graphic_table graphicRef51406 \" href=\"UTD.htm?38/28/39372\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In lesser degrees of methemoglobinemia (ie, an asymptomatic patient with a methemoglobin level &lt;20 percent), no therapy other than discontinuation of the offending agent(s) may be required.",
"     </li>",
"     <li>",
"      If the patient is symptomatic, or if the methemoglobin level is &gt;20 percent, which is often the case in deliberate or accidental overdoses or toxin ingestion, specific therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      is indicated.",
"     </li>",
"     <li>",
"      Blood transfusion or exchange transfusion may be helpful in patients who are in shock. Hyperbaric oxygen has been used with anecdotal success in severe cases [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Acute use of methylene blue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquired methemoglobinemia is life-threatening when methemoglobin comprises &gt;30 percent of total hemoglobin. Although we are unaware of any systematic studies comparing the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    to other available agents or placebo in this situation, the use of methylene blue can be life-saving, and is considered the treatment of choice.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     Methylene blue",
"    </a>",
"    (MB), given intravenously in a dose of 1 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    over five minutes provides an artificial electron transporter for the ultimate reduction of methemoglobin via the NADPH-dependent pathway (",
"    <a class=\"graphic graphic_figure graphicRef53599 \" href=\"UTD.htm?24/8/24718\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/5,10\">",
"     5,10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=see_link&amp;anchor=H6#H6\">",
"     \"Genetics and pathogenesis of methemoglobinemia\", section on 'NADPH-methemoglobin reductase pathway'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The response is usually rapid; the dose may be repeated in one hour if the level of methemoglobin is still high one hour after the initial infusion, but retreatment is frequently not necessary. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Laboratory diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    However, rebound methemoglobinemia as high as 60 percent may occur up to 18 hours after",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    administration, due to prolonged absorption of the implicated agent from topical or enteric sites [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/27\">",
"     27",
"    </a>",
"    ]. Accordingly, it is reasonable to perform serial measurements of methemoglobin levels following treatment with MB in order to evaluate the patient for subsequent worsening.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88122597\">",
"    <span class=\"h4\">",
"     Toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Caution should be exercised to avoid overdosage, as large (&gt;7",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    cumulative doses of MB can cause dyspnea and chest pain, as well as hemolysis in some susceptible subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Since co-oximetry detects MB as methemoglobin, this technique cannot be used to follow the response of methemoglobin levels to treatment with MB. If needed, the specific Evelyn-Malloy method will discriminate between methemoglobin and MB. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Patients with G6PD deficiency'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    MB is a potent, reversible inhibitor of monoamine oxidase A, an enzyme responsible for breaking down serotonin in the brain. Its use in patients taking serotonergic psychiatric medications may result in high levels of serotonin the brain (ie, Serotonin Syndrome), and should be avoided if at all possible",
"    <a class=\"external\" href=\"file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm265476.htm\">",
"     MedWatch Safety Alert",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Dapsone-induced methemoglobinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Marked methemoglobinemia may occur after treatment of dermatitis herpetiformis or Pneumocystis (PCP) infection with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"     dapsone",
"    </a>",
"    . As an example, methemoglobinemia (median level: 9 percent, range 3.5 to 22 percent) was detected in 32 of 167 pediatric patients (19 percent) with a hematologic malignancy or aplastic anemia who received dapsone for PCP prophylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/11\">",
"     11",
"    </a>",
"    ]. The risk of methemoglobinemia appeared to be dose-related but was unrelated to levels of cytochrome b5 reductase. Of interest, the child who achieved the highest level of methemoglobin (22 percent) was also found to be G6PD deficient.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     Cimetidine",
"    </a>",
"    , used as a selective inhibitor of N-hydroxylation, may be effective in increasing patient tolerance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"     dapsone",
"    </a>",
"    , chronically lowering the methemoglobin level by more than 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Since it works slowly, cimetidine is not helpful for the management of acute symptomatic methemoglobinemia arising from the use of dapsone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Patients with G6PD deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     Methylene blue",
"    </a>",
"    should not be administered to patients with known glucose 6-phosphate dehydrogenase (G6PD) deficiency, since the reduction of methemoglobin by MB is dependent upon NADPH generated by G6PD (",
"    <a class=\"graphic graphic_figure graphicRef53599 \" href=\"UTD.htm?24/8/24718\">",
"     figure 2",
"    </a>",
"    ). As a result, MB may not only be ineffective but it is also potentially dangerous, since MB has an oxidant potential that may induce hemolysis in G6PD deficient subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39719?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnosis and treatment of glucose-6-phosphate dehydrogenase deficiency\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In order to avoid these problems, pretreatment screening of populations with a high incidence of G6PD deficiency (eg, African- Americans, subjects of Mediterranean descent, and Southeast Asians) is reasonable, although not usually practical. If",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    is contraindicated, only moderate doses of ascorbic acid (300 to 1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    orally in divided doses) should be given, as this drug may also cause oxidant hemolysis in G6PD deficient patients when given in very high doses (",
"    <a class=\"graphic graphic_table graphicRef74254 \" href=\"UTD.htm?19/22/19821\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Hemoglobin M disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with hemoglobin M disease are generally without symptoms and should be counseled about the benign nature of their condition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8729/abstract/52\">",
"     52",
"    </a>",
"    ]. However, there is no effective treatment for the methemoglobinemia seen in this condition, should it be required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with congenital forms of methemoglobinemia have life-long cyanosis and are usually asymptomatic.",
"     </li>",
"     <li>",
"      Patients with acute acquired methemoglobinemia may be asymptomatic at lower levels of methemoglobin (ie, &lt;20 percent). Symptoms, when present, include headache, fatigue, dyspnea, and lethargy. At methemoglobin levels &gt;40 percent, respiratory depression, altered consciousness, shock, seizures, and death may occur. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Suspecting the diagnosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of methemoglobin (ie, hemoglobin with its iron in the oxidized (Fe3+) state) is suspected when there is clinical \"cyanosis\" in the presence of normal arterial pO2.",
"     </li>",
"     <li>",
"      The blood in methemoglobinemia has been variously described as dark-red, chocolate, or brownish to blue in color, which, if noted during a procedure associated with the use of a topical anesthetic agent, is a valuable clue for making this diagnosis in a timely manner.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Confirming the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory diagnosis of methemoglobinemia is based upon analysis of its absorption spectrum, which has peak absorbance at 631 nm. Methemoglobin detected by the co-oximeter should be confirmed by the specific Evelyn-Malloy method. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Laboratory diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     General treatment principles",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In children and adults with acute acquired methemoglobinemia, levels of methemoglobin &gt;20 percent are associated with clinical symptoms. Mortality rates are high when methemoglobin levels exceed 40 percent. Accordingly, acute acquired methemoglobinemia should be considered a",
"      <strong>",
"       medical emergency",
"      </strong>",
"      .",
"     </li>",
"     <li>",
"      All patients with hereditary methemoglobinemia should avoid exposure to aniline derivatives, nitrates, and other agents that may, even in normal individuals, induce methemoglobinemia (",
"      <a class=\"graphic graphic_table graphicRef51406 \" href=\"UTD.htm?38/28/39372\">",
"       table 1",
"      </a>",
"      ). Known heterozygotes for cytochrome b5R deficiency should be similarly counseled.",
"     </li>",
"     <li>",
"      Treatment of cyanosis in individuals with cytochrome b5R deficiency is indicated for cosmetic reasons only. Treatment options include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      (100 to 300",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      orally) or ascorbic acid (300 to 1000",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      orally in divided doses).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Treatment of acute acquired methemoglobinemia",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A thorough search for an offending agent should be made and, if found, removed",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      discontinued. The most commonly implicated agents include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"       dapsone",
"      </a>",
"      , local (topical) anesthetic agents, aniline dyes, and high nitrate levels in water supplies (",
"      <a class=\"graphic graphic_table graphicRef51406 \" href=\"UTD.htm?38/28/39372\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      If the patient is symptomatic, we recommend the immediate use of intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). The usual dose in this setting is 1 to 2",
"      <span class=\"nowrap\">",
"       mg/kg,",
"      </span>",
"      given over five minutes. The response is usually rapid; the dose may be repeated in one hour if high levels of methemoglobin persist. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Acute use of methylene blue'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with acute methemoglobinemia and glucose 6-phosphate dehydrogenase deficiency may worsen after treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      . An alternative treatment for such patients, which is less effective than methylene blue, is ascorbic acid. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Patients with G6PD deficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Severely affected patients may benefit from adjunctive treatment with exchange transfusion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hyperbaric oxygen, although evidence of their efficacy is only anecdotal. (See",
"      <a class=\"local\" href=\"#H16555898\">",
"       'Aniline and its derivatives'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In asymptomatic patients, usually those with methemoglobin levels &lt;20 percent, no therapy other than discontinuation of the offending agent(s) may be required.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/1\">",
"      Darling R, Roughton F. The effect of methemoglobin on the equilibrium between oxygen and hemoglobin. Am J Physiol 1942; 137:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/2\">",
"      EDER HA, FINCH C, McKEE RW. Congenital methemoglobinemia; a clinical and biochemical study of a case. J Clin Invest 1949; 28:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/3\">",
"      JAFFE ER, NEURMANN G. A COMPARISION OF THE EFFECT OF MENADIONE, METHYLENE BLUE AND ASCORBIC ACID ON THE REDUCTION OF METHEMOGLOBIN IN VIVO. Nature 1964; 202:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/4\">",
"      Yubisui T, Takeshita M, Yoneyama Y. Reduction of methemoglobin through flavin at the physiological concentration by NADPH-flavin reductase of human erythrocytes. J Biochem 1980; 87:1715.",
"     </a>",
"    </li>",
"    <li>",
"     Agarwal N, Nagel RL, Prchal JT. Dyshemoglobinemias. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, 2nd ed, Steinberg M (Ed), 2009. p.607.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/6\">",
"      Hegesh E, Hegesh J, Kaftory A. Congenital methemoglobinemia with a deficiency of cytochrome b5. N Engl J Med 1986; 314:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/7\">",
"      Congenital methemoglobinemia with cytochrome b5 deficiency. N Engl J Med 1986; 315:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/8\">",
"      Coleman MD, Coleman NA. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf 1996; 14:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/9\">",
"      Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore) 2004; 83:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/10\">",
"      Kane GC, Hoehn SM, Behrenbeck TR, Mulvagh SL. Benzocaine-induced methemoglobinemia based on the Mayo Clinic experience from 28 478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors. Arch Intern Med 2007; 167:1977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/11\">",
"      Esbenshade AJ, Ho RH, Shintani A, et al. Dapsone-induced methemoglobinemia: a dose-related occurrence? Cancer 2011; 117:3485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/12\">",
"      Hamon I, Gauthier-Moulinier H, Grelet-Dessioux E, et al. Methaemoglobinaemia risk factors with inhaled nitric oxide therapy in newborn infants. Acta Paediatr 2010; 99:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/13\">",
"      Sankar J, Gupta A, Pathak S, Dubey NK. Death in an adolescent girl with methemoglobinemia and malaria. J Trop Pediatr 2012; 58:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/14\">",
"      Kusin S, Tesar J, Hatten B, et al. Severe methemoglobinemia and hemolytic anemia from aniline purchased as 2C-E (4-ethyl-2,5-dimethoxyphenethylamine), a recreational drug, on the Internet - Oregon, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:85.",
"     </a>",
"    </li>",
"    <li>",
"     Management guidelines for aniline exposure. file://www.atsdr.cdc.gov/mmg/mmg.asp?id=448&amp;tid=79 (Accessed on February 23, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/16\">",
"      Jaffe E. Hereditary methemoglobinemias associated with abnormalities in the metabolism of erythrocytes. Am J Med 1962; 32:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/17\">",
"      Leroux A, Junien C, Kaplan J, Bamberger J. Generalised deficiency of cytochrome b5 reductase in congenital methaemoglobinaemia with mental retardation. Nature 1975; 258:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/18\">",
"      Ewenczyk C, Leroux A, Roubergue A, et al. Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum. Brain 2008; 131:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/19\">",
"      Takeshita M, Tamura M, Kugi M, et al. Decrease of palmitoyl-CoA elongation in platelets and leukocytes in the patient of hereditary methemoglobinemia associated with mental retardation. Biochem Biophys Res Commun 1987; 148:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/20\">",
"      Takeshita M, Tamura M, Yoshida S, Yubisui T. Palmitoyl-CoA elongation in brain microsomes: dependence on cytochrome b5 and NADH-cytochrome b5 reductase. J Neurochem 1985; 45:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/21\">",
"      Junien C, Leroux A, Lostanlen D, et al. Prenatal diagnosis of congenital enzymopenic methaemoglobinaemia with mental retardation due to generalized cytochrome b5 reductase deficiency: first report of two cases. Prenat Diagn 1981; 1:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/22\">",
"      Kaftory A, Freundlich E, Manaster J, et al. Prenatal diagnosis of congenital methemoglobinemia with mental retardation. Isr J Med Sci 1986; 22:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/23\">",
"      Henry LR, Pizzini M, Delarso B, Ridge JA. Methemoglobinemia: early intraoperative detection by clinical observation. Laryngoscope 2004; 114:2025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/24\">",
"      Cohen RJ, Sachs JR, Wicker DJ, Conrad ME. Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam. N Engl J Med 1968; 279:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/25\">",
"      Maran J, Guan Y, Ou CN, Prchal JT. Heterogeneity of the molecular biology of methemoglobinemia: a study of eight consecutive patients. Haematologica 2005; 90:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/26\">",
"      Barker SJ, Tremper KK, Hyatt J. Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry. Anesthesiology 1989; 70:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/27\">",
"      Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg 2009; 108:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/28\">",
"      Kelner MJ, Bailey DN. Mismeasurement of methemoglobin (\"methemoglobin revisited\"). Clin Chem 1985; 31:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/29\">",
"      Molthrop DC Jr, Wheeler RH, Hall KM, Prchal JT. Evaluation of the methemoglobinemia associated with sulofenur. Invest New Drugs 1994; 12:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/30\">",
"      Evelyn K, Malloy H. Microdetermination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in a single sample of blood. J Biol Chem 1938; 126:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/31\">",
"      Jaff&eacute; ER. Hereditary methemoglobinemias associated with abnormalities in the metabolism of erythrocytes. Am J Med 1966; 41:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/32\">",
"      Jaffe ER, Hsieh HS. DPNH-methemoglobin reductase deficiency and hereditary methemoglobinemia. Semin Hematol 1971; 8:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/33\">",
"      BEUTLER E, BALUDA MC. METHEMOGLOBIN REDUCTION. STUDIES OF THE INTERACTION BETWEEN CELL POPULATIONS AND OF THE ROLE OF METHYLENE BLUE. Blood 1963; 22:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/34\">",
"      Board PG, Pidcock ME. Methaemoglobinaemia resulting from heterozygosity for two NADH-methaemoglobin reductase variants: characterization as NADH-ferricyanide reductase. Br J Haematol 1981; 47:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/35\">",
"      Gonz&aacute;lez R, Estrada M, Wade M, et al. Heterogeneity of hereditary methaemoglobinaemia: a study of 4 Cuban families with NADH-Methaemoglobin reductase deficiency including a new variant (Santiago de Cuba variant). Scand J Haematol 1978; 20:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/36\">",
"      Hegesh E, Calmanovici N, Avron M. New method for determining ferrihemoglobin reductase (NADH-methemoglobin reductase) in erythrocytes. J Lab Clin Med 1968; 72:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/37\">",
"      Prchal JT, Borgese N, Moore MR, et al. Congenital methemoglobinemia due to methemoglobin reductase deficiency in two unrelated American black families. Am J Med 1990; 89:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/38\">",
"      Vieira LM, Kaplan JC, Kahn A, Leroux A. Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II. Blood 1995; 85:2254.",
"     </a>",
"    </li>",
"    <li>",
"     Jaffe ER, Hultquist DE. Cytochrome b5 reductase deficiency and enzymopenic hereditary methemoglobinemia. In: The Metabolic and Molecular Bases of Inherited Disease, 7th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, New York 1995. p.3399.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/40\">",
"      Shirabe K, Landi MT, Takeshita M, et al. A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia. Am J Hum Genet 1995; 57:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/41\">",
"      Yubisui T, Naitoh Y, Zenno S, et al. Molecular cloning of cDNAs of human liver and placenta NADH-cytochrome b5 reductase. Proc Natl Acad Sci U S A 1987; 84:3609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/42\">",
"      Board PG. NADH-ferricyanide reductase, a convenient approach to the evaluation of NADH-methaemoglobin reductase in human erythrocytes. Clin Chim Acta 1981; 109:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/43\">",
"      Jenkins MM, Prchal JT. A novel mutation found in the 3' domain of NADH-cytochrome B5 reductase in an African-American family with type I congenital methemoglobinemia. Blood 1996; 87:2993.",
"     </a>",
"    </li>",
"    <li>",
"     Beutler E. Methemoglobinemia and other causes of cyanosis. In: Williams' Hematology, 5th ed, Beutler E, Lichtman MA, Coller B, Kipps TJ (Eds), McGraw-Hill, New York 1995. p.654.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/45\">",
"      Kaplan JC, Chirouze M. Therapy of recessive congenital methaemoglobinaemia by oral riboflavine. Lancet 1978; 2:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/46\">",
"      Goldstein GM, Doull J. Treatment of nitrite-induced methemoglobinemia with hyperbaric oxygen. Proc Soc Exp Biol Med 1971; 138:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/47\">",
"      GOLUBOFF N, WHEATON R. Methylene blue induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia. J Pediatr 1961; 58:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/48\">",
"      Harvey JW, Keitt AS. Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia. Br J Haematol 1983; 54:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/49\">",
"      Coleman MD, Rhodes LE, Scott AK, et al. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br J Clin Pharmacol 1992; 34:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/50\">",
"      Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 1993; 129:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/51\">",
"      Rosen PJ, Johnson C, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 1971; 75:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8729/abstract/52\">",
"      Vichinsky EP, Lubin BH. Unstable hemoglobins, hemoglobins with altered oxygen affinity, and m-hemoglobins. Pediatr Clin North Am 1980; 27:421.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7094 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-6BEDC4A8C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8729=[""].join("\n");
var outline_f8_33_8729=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Formation and reduction of methemoglobin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Congenital causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Acquired causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16555891\">",
"      - Drugs and anesthetic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1176884\">",
"      Benzocaine spray for topical anesthesia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1176891\">",
"      - Inhaled nitric oxide (NO)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16555898\">",
"      - Aniline and its derivatives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Congenital methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Disease subtypes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Cyanosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Symptoms in type I disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Symptoms in type II disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Acquired methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Signs and symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Cyanosis during endoscopic procedures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Underlying genetic risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Clinical suspicion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4295809\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Laboratory diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Assays of enzyme activity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      General precautions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Cytochrome b5 reductase 3 deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Acquired methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Acute use of methylene blue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H88122597\">",
"      Toxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Dapsone-induced methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Patients with G6PD deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Hemoglobin M disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Suspecting the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Confirming the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      General treatment principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Treatment of acute acquired methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7094\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7094|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/26/2479\" title=\"figure 1\">",
"      Hemoglobin oxygen dissociation curve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/8/24718\" title=\"figure 2\">",
"      Methemoglobin reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7094|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/28/39372\" title=\"table 1\">",
"      Agents causing methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/22/19821\" title=\"table 2\">",
"      Drugs and G6PD deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39719?source=related_link\">",
"      Diagnosis and treatment of glucose-6-phosphate dehydrogenase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=related_link\">",
"      Flexible bronchoscopy: Equipment, procedure, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/4/42055?source=related_link\">",
"      Genetic disorders of hemoglobin oxygen affinity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/46/4841?source=related_link\">",
"      Genetics and pathogenesis of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=related_link\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=related_link\">",
"      Risk factors for calcium stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43817?source=related_link\">",
"      Topical anesthetics in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_33_8730="Arsenic exposure and poisoning";
var content_f8_33_8730=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Arsenic exposure and poisoning",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8730/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8730/contributors\">",
"     Rose H Goldman, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8730/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8730/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/33/8730/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/33/8730/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/33/8730/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arsenic is a metalloid element. Acute high-dose exposure to arsenic can cause severe systemic toxicity and death. Lower dose chronic arsenic exposure can result in subacute toxicity that can include skin changes, peripheral sensorimotor neuropathy, diabetes mellitus, peripheral vascular disease, and hepatotoxicity. Long-term effects of arsenic exposure include an increased risk of cancers, even after exposure has ceased.",
"   </p>",
"   <p>",
"    Clinicians may need to consider arsenic exposure in the emergency care setting when treating those suspected of acute poisoning or those who present with prolonged or intermittent gastrointestinal symptoms that are atypical for most viral and bacterial enteric illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. In the office setting, clinicians also need to consider chronic arsenic exposure when determining causes of peripheral neuropathy or addressing patient concerns about arsenic found in drinking water and other environmental settings. Exposure to weaponized arsine gas is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/20/8521?source=see_link&amp;anchor=H25#H25\">",
"     \"Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons\", section on 'Toxic asphyxiants'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1229512021\">",
"    <span class=\"h1\">",
"     SOURCES OF EXPOSURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arsenic is a naturally occurring element found in the earth's crust and within numerous ores. It is classed as a metalloid because it complexes with metals; it also reacts with other elements such as oxygen, hydrogen, chlorine, carbon, and sulfur. Elemental arsenic is rare, and the element exists more commonly as organic or inorganic compounds.",
"   </p>",
"   <p>",
"    Arsenical compounds can be grouped as inorganic, organic, and arsine gas (AsH3), and they are further classified according to their valence states: elemental (0), arsenite (trivalent, +3), and arsenate (pentavalent, +5). Trivalent Arsenic or arsenite compounds, both inorganic and organic, are considered the most toxic. Some fish and crustaceans contain large amounts of organic arsenic called \"fish arsenic,\" consisting mostly of arsenobetaine (a trimethylated arsenic compound) and arsenocholine, which are thought to be of negligible toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Human exposures can occur from natural sources, such as volcanic eruptions, and arsenic leaching from soil and rocks into drinking water.",
"   </p>",
"   <p>",
"    Inorganic arsenic levels in food are generally low, and when present, usually occur from contaminated soil-derived foods such as rice [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. Certain foods may contain potentially toxic levels of arsenic. Some analyses have found high levels of inorganic arsenic in hijiki (hiziki) seaweed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Of note, arsenic is no longer produced in the United States (US); all of the arsenic used in the US is imported [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/3\">",
"     3",
"    </a>",
"    ]. Human-made exposures derive from various sources including [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Use and manufacture of arsenic-containing pesticides (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/47/16119?source=see_link\">",
"       arsenic trioxide",
"      </a>",
"      , sodium arsenite, calcium arsenite, arsenic acid), ant poisons, and herbicides (cacodylic acid) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Semiconductors (gallium arsenide)",
"     </li>",
"     <li>",
"      Fossil fuel combustion",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Smelting/refining",
"      </span>",
"     </li>",
"     <li>",
"      Mining [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Metallurgy",
"     </li>",
"     <li>",
"      Decorative glass-making",
"     </li>",
"     <li>",
"      Use of",
"      <span class=\"nowrap\">",
"       medicines/contaminated",
"      </span>",
"      drugs, as found in some Asian folk remedies, homeopathic remedies, and herbals [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Some \"moonshine\" (illegally distilled alcohol) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/10\">",
"       10",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Contact with pressure-treated wood (eg, treated with wood preservatives containing chromium-copper-arsenate [CCA] or other arsenic preservatives)",
"     </li>",
"     <li>",
"      Contaminated well water from industrial sources",
"     </li>",
"     <li>",
"      Ingestion of chicken that has been given feed supplements with arsenic (used to control intestinal parasites) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Arsenicals have been used in medications in the past to treat syphilis (arsphenamine) and skin conditions (Fowler's solution) and presently to treat trypanosomiasis (melarsoprol) and acute promyelocytic leukemia (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/47/16119?source=see_link\">",
"       arsenic trioxide",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/12,13\">",
"       12,13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14059280\">",
"    <span class=\"h2\">",
"     Drinking water",
"    </span>",
"    &nbsp;&mdash;&nbsp;In more recent years, attention to chronic exposures of arsenic found in drinking water has grown [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. In some locations, this contamination presents an enormous health hazard, as in the case of the ongoing epidemic of arsenic poisoning in West Bengal, India, and Bangladesh. High levels of arsenic leaching from natural underground sources have contaminated newly drilled wells, leading to more than one million people drinking arsenic-contaminated water (above 50",
"    <span class=\"nowrap\">",
"     mcg/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/15,17-20\">",
"     15,17-20",
"    </a>",
"    ]. Thousands of people living there have been found to have arsenic-related skin lesions, liver problems, decreased motor function, and neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/21\">",
"     21",
"    </a>",
"    ]. Although less common, there have also been case reports of arsenic poisoning from contaminated well water in the US [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The greater focus of the United States and other countries has been on the potential long-term adverse health outcomes from chronic exposures to much lower doses of arsenic in drinking water (below a level that causes clinical manifestations) that could lead to future increased risk of cancer (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Cancer'",
"    </a>",
"    below). To reduce the risk of cancer and other chronic effects, the US Environmental Protection Agency (EPA) lowered the arsenic standard for drinking water from 50 parts per billion (ppb) to 10 ppb, and the US Food and Drug Administration (FDA) has set 10 ppb for bottled water [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/16,23\">",
"     16,23",
"    </a>",
"    ]. In the US, drinking water generally contains an average of 2",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    of arsenic, although 12 percent of water supplies from surface water sources in the North Central region of the country and 12 percent of supplies from ground water sources in the Western region have levels exceeding 20",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14059287\">",
"    <span class=\"h2\">",
"     Dietary ingestion",
"    </span>",
"    &nbsp;&mdash;&nbsp;People also eat small amounts of inorganic arsenic in their diet. US dietary intake of inorganic arsenic has been estimated to range from 1 to 20",
"    <span class=\"nowrap\">",
"     mcg/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/3\">",
"     3",
"    </a>",
"    ]. There have also been concerns about elevated arsenic levels detected in some samples of apple and grape juice [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/24\">",
"     24",
"    </a>",
"    ]. In one study of 88 samples from the US, 10 percent of samples were found to have total arsenic levels greater than 10 ppb with the highest level being 24.7 ppb [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/25\">",
"     25",
"    </a>",
"    ]. The total arsenic was further speciated and found to be the more toxic inorganic form of arsenic. The FDA also performed testing from 2005 to 2011 in 160 apple juice samples from several countries, noting mild elevation of the toxic arsenic species in some samples, but the FDA has not yet set a reference range for juices [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/26\">",
"     26",
"    </a>",
"    ]. Specific source of the arsenic contamination is unclear, but concerns have been raised about arsenic residues from arsenic-containing pesticides, particularly from imported juices (banned in the US, but still used in other countries), or contaminated water used in the preparation process. In addition, arsenic contamination has been found in rice products [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. In one study, a toddler milk formula containing organic brown rice syrup as a sweetener had total arsenic concentrations of up to six times the EPA safe drinking water limit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pressure-treated wood",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wood has been preserved by pressure-treatment with pesticides including chromate copper arsenate (CCA), ammoniacal copper arsenate (ACA), and ammoniacal copper zinc arsenate (ACZA) in order to protect it from insect infestation, decay, and marine environments. In 2003, United States manufacturers began a voluntary phase-out of arsenic containing wood preservatives for wood employed in some residential uses such as play structures, picnic tables, decks, and fencing [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/3\">",
"     3",
"    </a>",
"    ]. However, wood structures still exist that have CCA-treated elements.",
"   </p>",
"   <p>",
"    Episodes of arsenic poisoning have been described in workers sawing the wood who were exposed to arsenic through inhalation or skin contact and in people burning arsenical-treated wood who were exposed to the arsenic-contaminated smoke [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The US Environmental Protection Agency has produced a Consumer Safety Information Sheet that advises on the safe handling of inorganic arsenical pressure-treated wood,",
"    <a class=\"external\" href=\"file://www.epa.gov/oppad001/reregistration/cca\">",
"     www.epa.gov/oppad001/reregistration/cca",
"    </a>",
"    , and it is also engaged in a process of risk assessment for wood preservatives containing arsenic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     BIOLOGICAL BASIS OF DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tasteless and odorless, arsenic compounds are well absorbed after ingestion or inhalation. For most trivalent and pentavalent arsenical compounds dissolved in water, gastrointestinal absorption exceeds 90 percent, whereas poorly soluble compounds such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/47/16119?source=see_link\">",
"     arsenic trioxide",
"    </a>",
"    are less well absorbed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. Skin absorption is minimal acutely, but could result in low level absorption from chronic application of arsenic containing products. Arsenic can cross the placenta and accumulate in the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Arsenic is readily taken up by red blood cells and then quickly distributed to other tissues. Peak serum levels are reached about 30 to 60 minutes after a single oral dose. Kidney excretion occurs in three phases with half times estimated at: Phase-I, two to three hours (90 percent may be cleared); Phase-II, three hours to seven days; Phase-III, eight days or more [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,29\">",
"     1,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Primary target organs for toxicity are the gastrointestinal tract, skin, bone marrow, kidneys, and peripheral nervous system. There is some controversy as to how readily arsenic crosses the blood-brain barrier [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,29\">",
"     1,29",
"    </a>",
"    ]. Chronic ingestion of small amounts of inorganic arsenic results in the highest concentration in hair, nails, skin, and tissues rich in cysteine-containing proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,30\">",
"     1,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Trivalent arsenic (+3), the most toxic form, avidly binds to sulfhydryl groups (proteins, glutathione, cysteine) and interferes with numerous enzyme systems, such as those involving cellular respiration (inhibiting pyruvate dehydrogenase [PDH]), gluconeogenesis and glucose uptake, and glutathione metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. Pentavalent arsenic (+5) and arsine gas are converted to trivalent arsenic in vivo, but they may also have some direct effect on uncoupling oxidative phosphorylation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of trivalent arsenic is metabolized via methylation to form monomethylarsonic acid (MMA) followed by dimethylarsinic acid (DMA) and excreted through the urine [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL TOXICITY AND PRESENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Acute poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute arsenic poisoning can occur after ingestions or, in workers, from acute inhalation exposure to high levels of arsenic dusts or fumes. Symptoms following acute, large exposures to inorganic arsenic may develop within minutes or hours. Acute toxicity typically starts in the gastrointestinal system and includes nausea, vomiting, abdominal pain, and severe watery diarrhea. There may be a garlic odor of the breath and stool in severely poisoned patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/6\">",
"     6",
"    </a>",
"    ]. These symptoms are soon followed by dehydration, hypotension, and QTc prolongation. In severe cases, patients may experience cardiac arrhythmias, shock, acute respiratory distress syndrome, and sometimes death [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,3,6,32\">",
"     1,3,6,32",
"    </a>",
"    ]. In some cases, acute encephalopathy can develop and progress over several days, with delirium, coma, and seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/33\">",
"     33",
"    </a>",
"    ]. There have also been reports of more persistent central nervous system symptoms such as headache, confusion, and memory problems [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. Renal injury can lead to proteinuria, hematuria, acute tubular necrosis, and anuria [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/6,34\">",
"     6,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The severity of the toxicity and symptom presentation depends upon the form and dose of the arsenic compounds. Acute oral exposure to inorganic arsenic at doses of 600 mcg per kg body weight per day or higher has resulted in death [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/32,34\">",
"     32,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If severely poisoned individuals survive the initial illness, they usually develop hepatitis and pancytopenia within a week, and then may experience a painful sensorimotor peripheral neuropathy one to three weeks after the exposure. This has been described as beginning with distal paresthesias, followed rapidly by an ascending sensory loss and weakness, which can sometimes mimic Guillain-Barr&eacute; syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,29,35-38\">",
"     1,29,35-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The blood changes are usually reversible once exposure ceases. Partial recovery from peripheral neuropathy can occur in some cases, especially in the more mild cases of poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/36,39\">",
"     36,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other symptoms that can develop after severe acute poisoning include dermatologic lesions (patchy alopecia, diffuse pruritic macular rash, herpetic-like ulcers in the mouth), respiratory symptoms (dry, hacking cough),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Mees lines (horizontal 1- to 2-mm white lines on the nails, also called transverse leukonychia), which occur from a disturbance in the nail matrix keratinization [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,37,40,41\">",
"     1,37,40,41",
"    </a>",
"    ]. It usually takes at least 30 days for the Mees lines to become visible.",
"   </p>",
"   <p>",
"    Less severely acutely poisoned patients may experience persistent gastroenteritis and mild hypotension necessitating intravenous fluids, along with a metallic taste and irritated mucous membranes that can mimic pharyngitis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chronic toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic effects can occur as the sequelae of acute poisoning (as discussed above) or as the result of chronic longer-term exposure to lower levels of arsenic. Chronic exposure to arsenical compounds have occurred at work, usually through inhalation of arsenic-containing vapors or dusts, or through non-work environmental exposures, such as drinking arsenic-contaminated water. The clinical effects of chronic toxicity can have an insidious onset and thus be more difficult to diagnose. In chronic poisoning, the skin manifestations and peripheral neurologic complaints are usually more prominent than the gastrointestinal symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Different types of arsenic-related skin lesions have been described in the West Bengal and Bangladesh chronic poisonings [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/14,18,19,42\">",
"     14,18,19,42",
"    </a>",
"    ]. Hyperpigmentation or hypopigmentation can be an early manifestation (",
"    <a class=\"graphic graphic_picture graphicRef57673 \" href=\"UTD.htm?6/24/6528\">",
"     picture 1",
"    </a>",
"    ). Hyperkeratoses and scaling, particularly diffusely on the palms and soles, also are quite characteristic (",
"    <a class=\"graphic graphic_picture graphicRef78647 \" href=\"UTD.htm?32/44/33486\">",
"     picture 2",
"    </a>",
"    ). Eczematous lesions have also been described. Skin manifestations, particular maculopapular eruptions, have been described following an acute curry-poisoning incident, and included maculopapular eruptions (sometimes in intertriginous areas), nail changes (Mee&rsquo;s or Beau&rsquo;s Lines), and periungual pigmentation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Skin carcinomas and Bowen's disease (squamous cell carcinoma in situ) (",
"    <a class=\"graphic graphic_picture graphicRef57673 \" href=\"UTD.htm?6/24/6528\">",
"     picture 1",
"    </a>",
"    ) are associated with latent effects of arsenic poisoning (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Cancer'",
"    </a>",
"    below). A cohort study from Bangladesh found a dose-response relationship between exposure to arsenic in drinking water and the risk of premalignant lesions; compared with exposure to well water with a concentration of arsenic below 8.1",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    the adjusted odds ratio for premalignant skin lesions was 5.4 in people exposed to water with a concentration between 175.1 and 864",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Peripheral vascular disease with associated gangrene, called \"Blackfoot\" disease, has been described in relationship to chronic arsenic poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/45-47\">",
"     45-47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Neurologic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A symmetrical sensorimotor polyneuropathy is one of the most prominent symptoms of arsenic poisoning and can develop one to three weeks after acute poisoning or insidiously from chronic exposures.",
"   </p>",
"   <p>",
"    Sensory symptoms tend to present first and to predominate, starting with numbness and tingling particularly in the soles of the feet and then later in the hands as well [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/29,35,38\">",
"     29,35,38",
"    </a>",
"    ]. These may be the only symptoms in milder forms of arsenic polyneuropathy.",
"   </p>",
"   <p>",
"    In more severe forms, the pain is more intense, particularly with even light touch, so that affected persons are unable to walk because of intense burning pain in the soles [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/38\">",
"     38",
"    </a>",
"    ]. Cramping in the calves is another common symptom. An early sign on physical examination is diminished vibratory sense.",
"   </p>",
"   <p>",
"    Progressive symptoms may then develop in a",
"    <span class=\"nowrap\">",
"     stocking/glove",
"    </span>",
"    distribution with decreased pain, decreased sensation of touch and temperature, and symmetrical weakness, along with decreased deep tendon reflexes. Electrophysiological findings of arsenic neuropathy typically suggest a distal motor and sensory axonopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neurologic findings may also occur with chronic exposure. A study of 43 smelter workers exposed to inorganic arsenic dust for 13 to 45 years found moderate clinical symptoms and nerve conduction velocities that were significantly lower in two peripheral nerves as compared with matching referents [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/48\">",
"     48",
"    </a>",
"    ]. There was a significant negative correlation between cumulative absorption of arsenic and nerve conduction velocities.",
"   </p>",
"   <p>",
"    In one of the more recent descriptive case series studies examining the health consequences of drinking arsenic-contaminated water in India, a sample of 21 of 40 individuals with skin lesions and elevated arsenic in biological samples were diagnosed with clinical neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/18\">",
"     18",
"    </a>",
"    ]. Most of the cases presented with distal paresthesias and distal hypesthesias in stocking and glove distribution, followed by limb pains and diminished or absent deep tendon reflexes in those most affected.",
"   </p>",
"   <p>",
"    In chronic arsenic exposure, peripheral nerve manifestations may also be subclinical. A blinded study of copper smelting factory workers exposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/47/16119?source=see_link\">",
"     arsenic trioxide",
"    </a>",
"    found that the incidence of both subclinical (reduced conduction velocity and amplitude measurements on nerve conduction studies without signs or symptoms of clinical neuropathy) and clinical neuropathy was greater in arsenic-exposed workers than in controls [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although peripheral neuropathy has been the predominant neurologic manifestation of chronic arsenic poisoning, there have also been case reports of encephalopathy, described as cognitive impairment, disorientation, hallucinations, agitations, and memory problems [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. It is not clear from these case reports, however, how much of the symptoms can be attributed to arsenic and how much to other potential work exposures or psychiatric problems [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are many epidemiological studies and case reports showing an association between arsenic exposure and cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/3,14,42,54-57\">",
"     3,14,42,54-57",
"    </a>",
"    ]. This association has been the basis for regulatory actions (see",
"    <a class=\"local\" href=\"#H27\">",
"     'Prevention'",
"    </a>",
"    below). Arsenic exposure is associated with cancers of the skin, nose, lung, liver, kidney, bladder, and prostate.",
"   </p>",
"   <p>",
"    Ingestion of inorganic arsenic increases the risk of developing skin cancers (",
"    <a class=\"graphic graphic_picture graphicRef57673 \" href=\"UTD.htm?6/24/6528\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/58\">",
"     58",
"    </a>",
"    ]. Lesions commonly described are multiple squamous cell carcinomas, arising from the arsenic hyperkeratotic warts, as well as basal cell carcinomas arising from cells not associated with hyperkeratinization.",
"   </p>",
"   <p>",
"    There has also been considerable epidemiologic evidence to support the association between exposure to inorganic arsenic and bladder cancer. A cohort study from Taiwan found that, compared with people drinking water with an arsenic concentration of &le;10",
"    <span class=\"nowrap\">",
"     mcg/L,",
"    </span>",
"    the adjusted relative risks of bladder cancer in people exposed to well water containing arsenic in concentrations of 10.1 to 50, 50.1 to 100, and &gt;100",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    were 1.9, 8.2, and 15.3, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26586?source=see_link&amp;anchor=H13#H13\">",
"     \"Epidemiology and etiology of urothelial (transitional cell) carcinoma of the bladder\", section on 'Drinking water'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similarly, a report from Chile showed a dose-response relationship between the risk of lung cancer and exposure to arsenic in drinking water; the adjusted relative risk was 8.9 for drinking water with arsenic concentrations of 200 to 400",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/60\">",
"     60",
"    </a>",
"    ]. Both this study and another from Taiwan found evidence of synergy between arsenic and smoking on the risk of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Others have shown a decline in mortality rates from lung cancer following the elimination of arsenic from drinking water [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/62\">",
"     62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12298?source=see_link&amp;anchor=H15#H15\">",
"     \"Cigarette smoking and other risk factors for lung cancer\", section on 'Occupational and environmental carcinogens'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A region of Chile that experienced a sudden rise and then fall of arsenic levels in drinking water developed an increase in lung and bladder cancer mortality rate ratios about ten years after the start of the high arsenic exposures [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Arsenic exposure is believed to increase the risk of hepatic angiosarcomas, but it does not appear to be associated with hepatocellular carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Cardiovascular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arsenic toxicity appears to be associated with hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/64-66\">",
"     64-66",
"    </a>",
"    ] and QTc prolongation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study in Bangladesh found a dose-effect relationship between levels of arsenic in drinking water and the prevalence of hypertension; for a 50",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    concentration of arsenic in water, the risk of hypertension was doubled when compared with unexposed individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/64\">",
"     64",
"    </a>",
"    ]. This relationship is similar to that seen with exposure to lead, which is also associated with the development of hypertension. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/39/12922?source=see_link\">",
"     \"Adult lead poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute arsenic poisoning can also result in QTc prolongation with subsequent torsades do Pointes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/67\">",
"     67",
"    </a>",
"    ]. In addition, some leukemia patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/47/16119?source=see_link\">",
"     arsenic trioxide",
"    </a>",
"    have been found to develop QTc prolongation and ventricular arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/68,69\">",
"     68,69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some studies have described the effect of arsenic on the vascular endothelial cells and proposed an association between arsenic exposure and the risk of cardiovascular outcomes such as coronary heart disease and stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/70\">",
"     70",
"    </a>",
"    ]; however, other epidemiologic studies have not found such an association [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Liver",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arsenic exposure has been associated with hepatic angiosarcoma (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Cancer'",
"    </a>",
"    above). A study in Mexico found evidence of increased bilirubin and alkaline phosphatase concentrations in people exposed to arsenic in drinking water [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/72\">",
"     72",
"    </a>",
"    ]. A study of 248 people in India with evidence of chronic arsenic toxicity found that hepatomegaly was present in 77 percent; among a subset who underwent liver biopsy, noncirrhotic portal fibrosis was the predominant lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Endocrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some studies have demonstrated an association between arsenic exposure and the development of type II diabetes mellitus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. Some incidence and prevalence studies have found a dose-response relationship between exposure to arsenic in drinking water and the risk of diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/74,76\">",
"     74,76",
"    </a>",
"    ] whereas a large population-based cross-sectional study did not demonstrate an association between low levels of As levels and prevalence of diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Respiratory",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study from West Bengal found higher rates of respiratory symptoms and reduced lung function in men, but not women, with arsenic exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/78\">",
"     78",
"    </a>",
"    ]. The &ldquo;HEALS&rdquo; (Health Effects of Arsenic Longitudinal Study) prospective, longitudinal cohort of 11,746 Bengali adults with chronic arsenic exposure in the drinking water found a dose-response relationship between arsenic exposure and respiratory symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H266025104\">",
"    <span class=\"h3\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other studies from the &ldquo;HEALS&rdquo; cohort found that chronic arsenic exposure through drinking water (&gt;150",
"    <span class=\"nowrap\">",
"     mcg/L)",
"    </span>",
"    was associated with increased all-cause mortality (HR 1.68, 95% CI 1.26-2.23) and increased cardiovascular mortality (HR 1.92, 95% 1.07-3.43) over seven year follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/20,80\">",
"     20,80",
"    </a>",
"    ]. Another important finding was that decreasing arsenic exposure after chronic exposure did not reduce an individual&rsquo;s risk of mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/20\">",
"     20",
"    </a>",
"    ]. This implies that, in addition to removing exposure, other strategies are needed to prevent mortality from chronic exposure to arsenic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H266025123\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h4\">",
"     Reproductive and developmental",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since inorganic arsenic has been found to cross the placenta, there is a potential for adverse reproductive and developmental outcomes. Some studies have found evidence suggesting increased infant mortality, spontaneous abortions, stillbirths, and preterm births associated with arsenic exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. A 2001 review found that the evidence was not conclusive, since the various studies suffered from limitations such as lack of information about lifestyle and other exposures [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, a subsequent study of 29,134 pregnancies in Bangladesh addressed some of these concerns with better information on individual exposures and other risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/83\">",
"     83",
"    </a>",
"    ]. This study found that pregnant women drinking water from sources with arsenic concentrations above 50",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    experienced significant increases in fetal loss (RR 1.14) and infant death (RR 1.17).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h4\">",
"     Nursing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data suggest that arsenic levels in breast milk are low even in women exposed to high levels of environmental arsenic [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. This has potentially important implications for protecting infants from arsenic toxicity in regions where there are high concentrations of arsenic in the drinking water.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h4\">",
"     Childhood exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children, in general, are more susceptible to toxicants, such as arsenic, for a variety of reasons including: more opportunities for exposure from increased hand-to-mouth behavior and breathing closer to the ground, differences in metabolism, and greater sensitivity of the developing nervous system to toxic insults [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/86-88\">",
"     86-88",
"    </a>",
"    ]. Children are less able than adults to internally detoxify inorganic arsenic through methylation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children can become poisoned with arsenic through accidental ingestion, as in the case of two siblings who drank outdated arsenic-containing pesticide stored in a water bottle [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/34\">",
"     34",
"    </a>",
"    ]. Children can also develop arsenic poisoning from playing on soil contaminated with arsenic from nearby mining or smelting or in hazardous waste sites. Another potential source of exposure is through contact with \"pressure treated wood\" through playing on it, chewing it, or being in the vicinity when it is burned. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Pressure-treated wood'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of an individual with potential arsenic toxicity involves taking a",
"    <span class=\"nowrap\">",
"     medical/environmental",
"    </span>",
"    history. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14553?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of occupational and environmental health\", section on 'Occupational and environmental history'",
"    </a>",
"    .) The history should identify potential sources of exposures and symptoms consistent with arsenic poisoning.",
"   </p>",
"   <p>",
"    The physical examination should include examination for skin changes, including areas of hyper and hypo pigmentation and hyperkeratotic lesions, Mee&rsquo;s lines in the nails, and peripheral neuropathy.",
"   </p>",
"   <p>",
"    Potential",
"    <span class=\"nowrap\">",
"     environmental/occupational",
"    </span>",
"    exposures should be documented and measured. Soil, air, and water can be sampled, if indicated, and arsenic levels determined through reliable laboratories or government agencies. Biological monitoring evidence can also be obtained to confirm excessive arsenic exposure (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Acute exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the case of an acute ingestion, abdominal radiographs may demonstrate gastrointestinal radiopaque material soon after ingestion, although the absence of opaque material does not rule out exposure. An ECG should be obtained to assess the QTc interval as well as cardiac monitoring for tachyarrhythmias. In general, measurement of arsenic levels in urine is preferable to blood, since blood arsenic is cleared rapidly. In the emergent situation, a spot urine arsenic can be obtained prior to beginning chelation therapy. The urine creatinine in the spot sample should also be obtained to correct for urine concentration. During treatment, 24-hour urine arsenic monitoring is usually performed to follow the levels of arsenic excretion over time.",
"   </p>",
"   <p>",
"    In acutely symptomatic patients, urine arsenic levels are usually in the thousands of micrograms per liter. Because urine arsenic excretion can be intermittent, a definitive diagnosis usually is supported by finding a concentration greater than or equal to 50",
"    <span class=\"nowrap\">",
"     mcg/L,",
"    </span>",
"    or 100 mcg of arsenic (As) per gram creatinine in the absence of recent fish or shellfish intake [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If there has been fish, shellfish, seaweed, or sushi intake within the last 48-72 hours, the nontoxic \"fish arsenic\" may lead to increased urine levels of total arsenic. Because a diet history is frequently uncertain, it is best to obtain speciation of elevated urine arsenic levels in order to avoid mislabeling a person with arsenic poisoning and to obtain an accurate assessment of inorganic (toxic) arsenic levels and toxic metabolites [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/89\">",
"     89",
"    </a>",
"    ]. For speciation, the laboratory will report the levels of inorganic arsenic, metabolites monomethylarsonic acid (MMA), and dimethylarsonic acid (DMA), as well as the total arsenic. At the time of ordering a total urine arsenic test, we request that speciation be performed if total levels are elevated, as some laboratories do not automatically speciate the urine when levels are elevated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Chronic exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;In evaluating a patient for chronic arsenic exposure, either a 24-hour urine arsenic or spot urine arsenic and creatinine can be obtained after advising the patient to eat no fish, seaweed, or shellfish for 48 to 72 hours. The 24-hour urine determination is more accurate but less convenient. Regular surveillance for arsenic exposure in workers (for instance, after shifts) is done with measurements of spot urine arsenic and creatinine. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=see_link\">",
"     \"Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A single meal of fish can increase total urine arsenic to more than 1000",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/31\">",
"     31",
"    </a>",
"    ]. It is therefore important to request that the patient refrain from ingesting any fish, shellfish, or seaweed prior to ordering a urine specimen for arsenic. If the total arsenic is elevated, but there are little to no inorganic species detected, one can usually assume that the urine arsenic has derived from the non-toxic arsenic species.",
"   </p>",
"   <p>",
"    In persons who do not have occupational exposures to inorganic arsenic and who have not recently eaten seafood, the total urine arsenic is generally less than 10 mcg per gram creatinine [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/31\">",
"     31",
"    </a>",
"    ]. There have been varying results from studies reporting the relationship between work-related air exposures and urinary arsenic measurements, but based upon more recent studies from copper smelters, 30 to 35 mcg",
"    <span class=\"nowrap\">",
"     As/g",
"    </span>",
"    creatinine would be expected from exposure to air levels of arsenic averaging 10",
"    <span class=\"nowrap\">",
"     mcg/m3",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since inorganic arsenic (to a much greater extent than organic arsenic) is taken up and bound in hair and fingernails, hair and nails could be good indicators for recent past exposures for the amount of inorganic arsenic absorbed during the growth period (hair grows at 0.4 mm per day, while nails grow at a rate of 0.1 mm per day). However, in a setting in which air exposure is a consideration, as in an industrial environment, it is very difficult to remove exogenous arsenic from hair, and therefore to get a reliable reading [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/31\">",
"     31",
"    </a>",
"    ]. Also contributing to the variability of results from hair and nail testing is lack of standardization for analyses. Commercial laboratory hair analyses for multiple elements including arsenic are highly inaccurate [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/90,91\">",
"     90,91",
"    </a>",
"    ]. Determination of arsenic in hair and nails has been most useful in epidemiological studies performed to evaluate environmental exposures of populations to inorganic arsenic. For individual patients with other signs or symptoms of arsenic poisoning thought due to past exposures, careful collection of appropriate hair samples (ideally from areas of slow growth such as pubic hair) or nails can be sent and analyzed for arsenic.",
"   </p>",
"   <p>",
"    Laboratory testing to assess chronic toxicity, including laboratory parameters that could become abnormal days to weeks after an acute overexposure, should include a complete blood count, renal and liver function tests, ECG (looking for persistent QTc prolongation), and a urinalysis. If there are signs or symptoms of peripheral neuropathy, nerve",
"    <span class=\"nowrap\">",
"     conduction/EMG",
"    </span>",
"    testing should be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in treatment is the elimination of further exposure. In cases of acute exposure, care should be taken to avoid contamination of medical personnel during the decontamination process.",
"   </p>",
"   <p>",
"    The management of exposure to arsine gas is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/20/8521?source=see_link&amp;anchor=H25#H25\">",
"     \"Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons\", section on 'Toxic asphyxiants'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Acute poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial therapy of severe arsenic poisoning relies on the provision of basic and advanced life support. Patients may be acutely ill and require aggressive critical care to preserve organ function. Extracorporeal membrane oxygenation (ECMO), hemodialysis, and exchange transfusion may be helpful, although there are few data supporting their use [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/34\">",
"     34",
"    </a>",
"    ]. Subsequent therapy usually involves chelation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. Consultation with a regional poison center",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    clinical toxicologist is recommended to assist with the management of the severely poisoned patient. For pediatric poisonings in the US, it is also possible to contact one of the regional Pediatric Environmental Health Specialty Units (",
"    <a class=\"external\" href=\"file://www.aoec.org/PEHSU/index.html\">",
"     www.aoec.org/PEHSU/index.html",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Careful attention must be paid to fluid and electrolyte balance.",
"   </p>",
"   <p>",
"    The approach to the patient with acute arsenic poisoning includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decontamination &mdash; Skin decontamination is particularly important in cases of poisoning from arsenical pesticides. Remove contaminated clothing, and wash the pesticide from the skin and hair taking care to avoid contaminating providers [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/92\">",
"       92",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Gastrointestinal decontamination can be performed in cases of recent ingestion (typically within one hour). Do not administer cathartics since arsenic typically causes diarrhea. Use nasogastric suction, and administer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"       activated charcoal",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,92\">",
"       1,92",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fluids &mdash; Administer intravenous fluids to maintain adequate urine flow.",
"     </li>",
"     <li>",
"      Monitoring &mdash; Patients should have continuous cardiac monitoring. Additionally, fluid and electrolyte balance should be monitored.",
"     </li>",
"     <li>",
"      Chelation &mdash; Chelation therapy is usually indicated in patients with symptomatic arsenic poisoning. In a severely ill patient with known, or highly suspected, acute arsenic poisoning, chelation may need to be started before laboratory confirmation of arsenic levels is available [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"       Activated charcoal",
"      </a>",
"      &mdash; The role of activated charcoal, other than in patients who have had recent oral ingestion, is uncertain. In the absence of reliable data, some sources recommend its use [",
"      <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H201734145\">",
"    <span class=\"h3\">",
"     Chelation for acute poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two chelating agents are available in the US:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/42/9893?source=see_link\">",
"     dimercaprol",
"    </a>",
"    (British Anti-Lewisite, or BAL) and meso-2,3-dimercaptosuccinic acid (DMSA, succimer). A third drug, unithiol (sodium 2,3-dimercapto-1-propane sulfonate abbreviated DMPS), is marketed by a German pharmaceutical company under the trade name \"Dimaval\" and may have the most favorable profile for the treatment of acute poisoning by inorganic arsenic. It can be given intravenously, but has not been FDA approved for that use in the US [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/93\">",
"     93",
"    </a>",
"    ]. In the US, BAL remains the initial chelating drug for severe, acute arsenic toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. The precise dosing for BAL for severe inorganic arsenic exposure poisoning has not been specifically established. Most of the regimens for arsenic treatment, particularly with BAL, rely on studies that are more than 20 years old, but are still recommended by respected toxicological experts [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1,94\">",
"     1,94",
"    </a>",
"    ]. A regimen for administering BAL is 3 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of deep intramuscular BAL administered every four to six hours [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/94\">",
"     94",
"    </a>",
"    ]. The endpoint for chelation is a 24 hour urinary arsenic concentration of &lt;50",
"    <span class=\"nowrap\">",
"     mcg/L.",
"    </span>",
"   </p>",
"   <p>",
"    Since",
"    BAL is administered intramuscularly, it can be used in patients with reduced consciousness or decreased gastrointestinal motility. BAL is associated with significant side effects (",
"    <a class=\"graphic graphic_table graphicRef69443 \" href=\"UTD.htm?11/12/11468\">",
"     table 1",
"    </a>",
"    ) and has a narrow therapeutic:toxic ratio [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. BAL is formulated in peanut oil, and patients must be carefully questioned about presence of known peanut allergy. It should also be used with caution in patients with G-6-PD deficiency. Although BAL helps to speed excretion of arsenic and may help to inhibit some of the toxic effects, it is not clear that administration will prevent the development of the peripheral neuropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5643077\">",
"    <span class=\"h2\">",
"     Chronic or subacute poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data to support the use of chelation in subacute or chronic arsenic poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. In general, we only start chelation therapy for subacute or chronic poisoning in the setting of ongoing or recent arsenic exposure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5643085\">",
"    <span class=\"h3\">",
"     Chelation for chronic poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;For treating subacute or chronic severe toxicity, DMSA (an oral hydrophilic analogue of BAL) is the chelator of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. The dosing of DMSA is based on testing in children being treated for lead poisoning. The recommended dose from the manufacturer is 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose three times per day for five days, followed by 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose twice per day for two weeks. Although we have found this dosing to be acceptable in treating some adults for lead poisoning, the dose can become quite high, especially in heavier adults. Given the lack of adult treatment data with DMSA, we have also used an adult dosing level of 500 mg twice per day for 2 weeks as a sensible maximum limit for treating adults with mild symptomatic lead poisoning, and similar dosing may be appropriate for treating arsenic poisoning until there are additional clinical data available for adults.",
"   </p>",
"   <p>",
"    Adverse effects of chelating agents are listed in a table (",
"    <a class=\"graphic graphic_table graphicRef69443 \" href=\"UTD.htm?11/12/11468\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    DMPS is a water-soluble analogue of BAL that can be administered by oral, IV, or IM routes and may also be of benefit in treating chronic arsenic toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/95\">",
"     95",
"    </a>",
"    ]; it is not approved in the US for this use, but has been used in other countries [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/93\">",
"     93",
"    </a>",
"    ]. When given IM, it is administered at 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose as a 5 percent solution; a typical regimen would be dosing every 6 to 8 hours on the first day, every 8 to 12 hours on the second day, and every 12 to 24 hours thereafter [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/1\">",
"     1",
"    </a>",
"    ]. Intravenous dosing would be 3 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every 4 hours by slow infusion over 20 minutes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;To obtain emergent consultation with a medical toxicologist, call the US Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     General issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Efforts should be taken to reduce exposures to inorganic arsenic, to the extent feasible, from both naturally occurring and man-made sources. In the United States, the Occupational Safety and Health Administration (OSHA) regulates inorganic arsenic exposure in air in the workplace through a \"permissible exposure limit\" or PEL of 10",
"    <span class=\"nowrap\">",
"     mcg/m3",
"    </span>",
"    as a time-weighted average over an eight-hour work day [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/96\">",
"     96",
"    </a>",
"    ]. The National Institute of Occupational Safety and Health (NIOSH) is more conservative and advises minimizing exposures to a recommended exposure limit (REL) of 2",
"    <span class=\"nowrap\">",
"     mcg/m3",
"    </span>",
"    (15 minute exposure) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The World Health Organization (WHO), in its 1993 guidelines for drinking water quality, reported that based on health criteria the guideline value for arsenic in drinking water should ideally be less than 10",
"    <span class=\"nowrap\">",
"     mcg/L,",
"    </span>",
"    but given measurement limitations the WHO recommended a provisional guideline value of 10",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2002, the US Environmental Protection Agency (EPA) lowered the maximum contaminant level for the amount of arsenic allowed in drinking water from 50 ppb to 10 ppb (10",
"    <span class=\"nowrap\">",
"     mcg/L)",
"    </span>",
"    based upon review of carcinogenic risks [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To reduce the exposure to potential arsenic-contaminated rice products, the 2012 American Academy of Pediatrics guidelines advised giving children more foods made from wheat and oats [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/100\">",
"     100",
"    </a>",
"    ]. The US Pediatric Environmental Health Specialty Units advised limiting consumption of foods higher in arsenic content, rinsing rice, limiting rice milk in children younger than 54 months of age, and reducing intake of foods containing high amounts of brown rice syrup [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/101\">",
"     101",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33098?source=see_link&amp;anchor=H49#H49\">",
"     \"Overview of acquired peripheral neuropathies in children\", section on 'Arsenic'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most of the arsenical pesticides (including the common sodium arsenate ant killer, \"Terro\") were banned for use in the United States in 1991, but they may still be found in use in other countries. Copper chromium arsenate (CCA), used as a wood preservative, was not included in that ban. The use of CCA in pressure-treated wood for residential uses in the United States was supposed to voluntarily cease by December 31, 2003. However, existing structures remain as potential sources of concern. Care should be taken never to burn pressure-treated wood in fireplaces or campfires [",
"    <a class=\"abstract\" href=\"UTD.htm?8/33/8730/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Practitioners involved in the care of patients with arsenic poisoning, or patients who have questions about arsenic exposures, may find it helpful to consult with",
"    <span class=\"nowrap\">",
"     occupational/environmental",
"    </span>",
"    medicine clinicians who can assist in the diagnosis of arsenic poisoning, in the arrangement for",
"    <span class=\"nowrap\">",
"     environmental/work",
"    </span>",
"    site evaluations and interventions, and in evaluations for worker compensation.",
"    <span class=\"nowrap\">",
"     Occupational/environmental",
"    </span>",
"    medicine clinicians can also help with the decision for chelation therapy and administration of appropriate therapy.",
"   </p>",
"   <p>",
"    Clinicians specializing in Occupational and Environmental Medicine can be located by contacting the Association of Occupational and Environmental Clinics (AOEC), a group of occupational medicine clinics (frequently academically affiliated) with board-certified occupational medicine physicians (phone: 202-347-4976; website:",
"    <a class=\"external\" href=\"file://www.aoec.org/\">",
"     www.aoec.org",
"    </a>",
"    ), or the American College of Occupational and Environmental Medicine Physicians (",
"    <a class=\"external\" href=\"file://www.acoem.org/\">",
"     www.acoem.org",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary target organs for arsenic toxicity are the gastrointestinal tract, heart, skin, bone marrow, kidneys, and peripheral nervous system. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Biological basis of disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute toxicity typically starts in the gastrointestinal system and includes nausea, vomiting, abdominal pain, and diarrhea. These symptoms are soon followed by dehydration, hypotension, and QTc prolongation. In severe cases, patients may experience cardiac arrhythmias, shock, acute respiratory distress syndrome, and sometimes death. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Acute poisoning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In chronic poisoning, the peripheral neurologic complaints and skin manifestations are usually more prominent than the gastrointestinal symptoms. Chronic arsenic exposure is associated with increased all-cause mortality. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Chronic toxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Arsenic is rapidly cleared from the blood, so measurement of urinary arsenic either on a 24-hour urine collection or in a spot urine (along with a creatinine to correct for the concentration of the spot urine) is generally preferable. A concentration greater than or equal to 50",
"      <span class=\"nowrap\">",
"       mcg/L",
"      </span>",
"      or 100 mcg of arsenic per gram creatinine in the absence of recent fish, seaweed or shellfish intake strongly suggests arsenic poisoning. For more accurate assessment, both total and inorganic arsenic species should be measured in the urine. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of acute poisoning involves decontamination of the skin and gastrointestinal tract as appropriate for the exposure, administration of fluids, cardiac monitoring, and usually chelation with BAL. DMPS is another option for treatment in countries where it is available. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Acute poisoning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some patients with chronic toxicity and ongoing arsenic exposure may also benefit from chelation with DMSA. (See",
"      <a class=\"local\" href=\"#H5643077\">",
"       'Chronic or subacute poisoning'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Mundy SW, Ford MD. Arsenic. In: Goldfrank's Toxicological Emergencies, Nelson LS, Lewin NA, Howland MA, et al (Eds), Mcgraw-Hill, New York 2010.",
"    </li>",
"    <li>",
"     Yip L, Dart RC. Arsenic. In: Clinical Environmental Health and Toxic Exposures, Sullivan JB, Krieger GR (Eds), Lippincott Williams &amp; Wilkins, 2001. p.858.",
"    </li>",
"    <li>",
"     Agency for Toxic Substances and Disease Registry. Toxicological Profile for Arsenic. U.S. Department of Health &amp; Human Services, Public Health Service 2007. Available at: www.atsdr.cdc.gov/toxprofiles/tp.asp?id=22&amp;tid=3 (Accessed on October 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/4\">",
"      Rose M, Lewis J, Langford N, et al. Arsenic in seaweed--forms, concentration and dietary exposure. Food Chem Toxicol 2007; 45:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/5\">",
"      Almela C, Clemente MJ, V&eacute;lez D, Montoro R. Total arsenic, inorganic arsenic, lead and cadmium contents in edible seaweed sold in Spain. Food Chem Toxicol 2006; 44:1901.",
"     </a>",
"    </li>",
"    <li>",
"     Reigart JR, Roberts JR. Arsenical Pesticides. In: Recognition and Management of Pesticide Poisonings. 5th ed. U.S. Environmental Protection Agency, Washington 1999. p.126. Available at: www.epa.gov/oppfead1/safety/healthcare/handbook/handbook.htm (Accessed on October 12, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/7\">",
"      Eisler R. Arsenic hazards to humans, plants, and animals from gold mining. Rev Environ Contam Toxicol 2004; 180:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/8\">",
"      Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA 2004; 292:2868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/9\">",
"      Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA 2008; 300:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/10\">",
"      Gerhardt RE, Crecelius EA, Hudson JB. Moonshine-related arsenic poisoning. Arch Intern Med 1980; 140:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/11\">",
"      Lasky T, Sun W, Kadry A, Hoffman MK. Mean total arsenic concentrations in chicken 1989-2000 and estimated exposures for consumers of chicken. Environ Health Perspect 2004; 112:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/12\">",
"      Miller WH Jr, Schipper HM, Lee JS, et al. Mechanisms of action of arsenic trioxide. Cancer Res 2002; 62:3893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/13\">",
"      Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998; 339:1341.",
"     </a>",
"    </li>",
"    <li>",
"     National Research Council. Arsenic in Drinking Water, 2001 Update. National Academy Press; Washington, DC 2001.",
"    </li>",
"    <li>",
"     World Health Organization. Arsenic in drinking water: WHO Information Fact Sheet No 210. World Health Organization; 2001.",
"    </li>",
"    <li>",
"     US Environmental Protection Agency. Arsenic in Drinking Water. Available at: file://water.epa.gov/lawsregs/rulesregs/sdwa/arsenic/index.cfm (Accessed on January 10, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/17\">",
"      Smith AH, Lingas EO, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ 2000; 78:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/18\">",
"      Chakraborti D, Mukherjee SC, Pati S, et al. Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger? Environ Health Perspect 2003; 111:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/19\">",
"      Chowdhury UK, Biswas BK, Chowdhury TR, et al. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect 2000; 108:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/20\">",
"      Argos M, Kalra T, Rathouz PJ, et al. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 2010; 376:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/21\">",
"      Parvez F, Wasserman GA, Factor-Litvak P, et al. Arsenic exposure and motor function among children in Bangladesh. Environ Health Perspect 2011; 119:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/22\">",
"      Franzblau A, Lilis R. Acute arsenic intoxication from environmental arsenic exposure. Arch Environ Health 1989; 44:385.",
"     </a>",
"    </li>",
"    <li>",
"     US Food and Drug Administration. Questions &amp; Answers: Apple Juice and Arsenic. December 16, 2011. Available at: file://www.fda.gov/Food/ResourcesForYou/Consumers/ucm271595.htm (Accessed on January 10, 2012).",
"    </li>",
"    <li>",
"     ConsumerReports.org. Consumer Reports tests juices for arsenic and lead. November 30, 2011. Available at: file://news.consumerreports.org/safety/2011/11/consumer-reports-tests-juices-for-arsenic-and-lead.html (Accessed on January 10, 2012).",
"    </li>",
"    <li>",
"     Consumer Reports. Results of our apple juice and grape juice tests. Available at: file://news.consumerreports.org/Consumer%20Reports%20Arsenic%20Test%20Results%20January%202012.pdf (Accessed on January 10, 2012).",
"    </li>",
"    <li>",
"     US Food and Drug Administration. Arsenic in Apple Juice Analytical Results, 2005-2011 Toxic Elements Food and Foodware Program. Available at: file://www.fda.gov/Food/FoodSafety/FoodContaminantsAdulteration/Metals/ucm273328.htm (Accessed on January 10, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/27\">",
"      Jackson BP, Taylor VF, Karagas MR, et al. Arsenic, organic foods, and brown rice syrup. Environ Health Perspect 2012; 120:623.",
"     </a>",
"    </li>",
"    <li>",
"     Consumer Reports. Arsenic in your food. Available at: file://www.consumerreports.org/cro/magazine/2012/11/arsenic-in-your-food/index.htm (Accessed on January 02, 2013).",
"    </li>",
"    <li>",
"     Windebank AJ. Arsenic. In: Experimental and Clinical Neurotoxicology, Spencer PS, Schaumburg HH (Eds), Oxford University Press, New York 2000. p.203.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/30\">",
"      Aposhian H. Biochemical toxicology of arsenic. Rev Biochem Toxicol 1989; 10:265.",
"     </a>",
"    </li>",
"    <li>",
"     Lauwerys RR, Hoet P. Industrial Chemical Exposure - Guidelines for Biological Monitoring, Lewis Publishers, Boca Raton 2000.",
"    </li>",
"    <li>",
"     U.S. Environmental Protection Agency. Technology Transfer Network Air Toxics. Available at: www.epa.gov/ttn/atw/hlthef/arsenic.html (Accessed on October 12, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/33\">",
"      Danan M, Dally S, Conso F. Arsenic-induced encephalopathy. Neurology 1984; 34:1524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/34\">",
"      Lai MW, Boyer EW, Kleinman ME, et al. Acute arsenic poisoning in two siblings. Pediatrics 2005; 116:249.",
"     </a>",
"    </li>",
"    <li>",
"     Feldman RG. Arsenic. In: Occupational and Environmental Neurotoxicology, Feldman RG (Ed), Lippincott-Raven, Philadelphia 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/36\">",
"      HEYMAN A, PFEIFFER JB Jr, WILLETT RW, TAYLOR HM. Peripheral neuropathy caused by arsenical intoxication; a study of 41 cases with observations on the effects of BAL (2, 3, dimercapto-propanol). N Engl J Med 1956; 254:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/37\">",
"      Reynolds ES. An Account of the Epidemic Outbreak of Arsenical Poisoning occurring in Beer Drinkers in the North of England and the Midland Counties in 1900. Med Chir Trans 1901; 84:409.",
"     </a>",
"    </li>",
"    <li>",
"     Chhuttani P, Chopra J. Arsenic Poisoning. In: Handbook of Clinical Neurology: Intoxication of the Nervous System, part I, Vinken P, Bruyn G (Eds), North Holland, Amsterdam 1979. Vol 36, p.199.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/39\">",
"      Chhuttani PN, Chawla LS, Sharma TD. Arsenical neuropathy. Neurology 1967; 17:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/40\">",
"      Mees R. The nails with arsenical polyneuritis. JAMA 1919; 72:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/41\">",
"      Aldrich C. Leuconychia striata arsenicalis transversus. Am J Med Sci 1904; 127:702.",
"     </a>",
"    </li>",
"    <li>",
"     National Research Council. Arsenic in Drinking Water. National Academy Press; Wasthington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/43\">",
"      Uede K, Furukawa F. Skin manifestations in acute arsenic poisoning from the Wakayama curry-poisoning incident. Br J Dermatol 2003; 149:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/44\">",
"      Ahsan H, Chen Y, Parvez F, et al. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am J Epidemiol 2006; 163:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/45\">",
"      Yu HS, Lee CH, Chen GS. Peripheral vascular diseases resulting from chronic arsenical poisoning. J Dermatol 2002; 29:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/46\">",
"      Tseng WP. Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 1977; 19:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/47\">",
"      Lin TH, Huang YL. Chemical speciation of arsenic in urine of patients with blackfoot disease. Biol Trace Elem Res 1995; 48:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/48\">",
"      Lagerkvist BJ, Zetterlund B. Assessment of exposure to arsenic among smelter workers: a five-year follow-up. Am J Ind Med 1994; 25:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/49\">",
"      Feldman RG, Niles CA, Kelly-Hayes M, et al. Peripheral neuropathy in arsenic smelter workers. Neurology 1979; 29:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/50\">",
"      Morton WE, Caron GA. Encephalopathy: an uncommon manifestation of workplace arsenic poisoning? Am J Ind Med 1989; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/51\">",
"      Freeman JW, Couch JR. Prolonged encephalopathy with arsenic poisoning. Neurology 1978; 28:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/52\">",
"      Beckett WS, Moore JL, Keogh JP, Bleecker ML. Acute encephalopathy due to occupational exposure to arsenic. Br J Ind Med 1986; 43:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/53\">",
"      Rodr&iacute;guez VM, Jim&eacute;nez-Capdeville ME, Giordano M. The effects of arsenic exposure on the nervous system. Toxicol Lett 2003; 145:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/54\">",
"      Cuzick J, Sasieni P, Evans S. Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol 1992; 136:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/55\">",
"      Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995; 55:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/56\">",
"      Marshall G, Ferreccio C, Yuan Y, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 2007; 99:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/57\">",
"      Huang CY, Chu JS, Pu YS, et al. Effect of urinary total arsenic level and estimated glomerular filtration rate on the risk of renal cell carcinoma in a low arsenic exposure area. J Urol 2011; 185:2040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/58\">",
"      J&auml;rup L. Hazards of heavy metal contamination. Br Med Bull 2003; 68:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/59\">",
"      Chiou HY, Chiou ST, Hsu YH, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 2001; 153:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/60\">",
"      Ferreccio C, Gonz&aacute;lez C, Milosavjlevic V, et al. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 2000; 11:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/61\">",
"      Chen CL, Hsu LI, Chiou HY, et al. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA 2004; 292:2984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/62\">",
"      Chiu HF, Ho SC, Yang CY. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan. Lung Cancer 2004; 46:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/63\">",
"      Guo HR. The lack of a specific association between arsenic in drinking water and hepatocellular carcinoma. J Hepatol 2003; 39:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/64\">",
"      Rahman M. Arsenic and hypertension in Bangladesh. Bull World Health Organ 2002; 80:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/65\">",
"      Chen CJ, Hsueh YM, Lai MS, et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995; 25:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/66\">",
"      Rahman M, Tondel M, Ahmad SA, et al. Hypertension and arsenic exposure in Bangladesh. Hypertension 1999; 33:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/67\">",
"      Beckman KJ, Bauman JL, Pimental PA, et al. Arsenic-induced torsade de pointes. Crit Care Med 1991; 19:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/68\">",
"      Ohnishi K, Yoshida H, Shigeno K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med 2000; 133:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/69\">",
"      Barbey JT, Pezzullo JC, Soignet SL. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol 2003; 21:3609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/70\">",
"      Balakumar P, Kaur J. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc Toxicol 2009; 9:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/71\">",
"      Navas-Acien A, Sharrett AR, Silbergeld EK, et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005; 162:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/72\">",
"      Hern&aacute;ndez-Zavala A, Del Razo LM, Aguilar C, et al. Alteration in bilirubin excretion in individuals chronically exposed to arsenic in Mexico. Toxicol Lett 1998; 99:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/73\">",
"      Santra A, Das Gupta J, De BK, et al. Hepatic manifestations in chronic arsenic toxicity. Indian J Gastroenterol 1999; 18:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/74\">",
"      Tseng CH, Tai TY, Chong CK, et al. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 2000; 108:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/75\">",
"      Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008; 300:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/76\">",
"      Rahman M, Tondel M, Ahmad SA, Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol 1998; 148:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/77\">",
"      Chen Y, Ahsan H, Slavkovich V, et al. No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ Health Perspect 2010; 118:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/78\">",
"      von Ehrenstein OS, Mazumder DN, Yuan Y, et al. Decrements in lung function related to arsenic in drinking water in West Bengal, India. Am J Epidemiol 2005; 162:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/79\">",
"      Parvez F, Chen Y, Brandt-Rauf PW, et al. A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: findings from the Health Effects of Arsenic Longitudinal Study (HEALS). Thorax 2010; 65:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/80\">",
"      Chen Y, Graziano JH, Parvez F, et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 2011; 342:d2431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/81\">",
"      Ahmad SA, Sayed MH, Barua S, et al. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect 2001; 109:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/82\">",
"      Hopenhayn-Rich C, Browning SR, Hertz-Picciotto I, et al. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect 2000; 108:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/83\">",
"      Rahman A, Vahter M, Ekstr&ouml;m EC, et al. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am J Epidemiol 2007; 165:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/84\">",
"      Concha G, Vogler G, Nermell B, Vahter M. Low-level arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in the drinking water. Int Arch Occup Environ Health 1998; 71:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/85\">",
"      Sternowsky HJ, Moser B, Szadkowsky D. Arsenic in breast milk during the first 3 months of lactation. Int J Hyg Environ Health 2002; 205:405.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics Committee on Environmental Health. Pediatric Environmental Health, Etzel RA (Ed), American Academy of Pediatrics, 2003. p.721.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/87\">",
"      Quang LS, Woolf AD. Addressing specific populations: children's unique vulnerabilities to environmental exposures. Environ Epidem &amp; Toxicol 2000; 2:79.",
"     </a>",
"    </li>",
"    <li>",
"     US EPA, Toxicity and Exposure. Assessment for Children's Health. Inorganic Arsenic, TEACH Chemical Summary, 2007. file://www.epa.gov/teach/chem_summ/ (Accessed on January 31, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/89\">",
"      Kales SN, Huyck KL, Goldman RH. Elevated urine arsenic: un-speciated results lead to unnecessary concern and further evaluations. J Anal Toxicol 2006; 30:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/90\">",
"      Steindel SJ, Howanitz PJ. The uncertainty of hair analysis for trace metals. JAMA 2001; 285:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/91\">",
"      Seidel S, Kreutzer R, Smith D, et al. Assessment of commercial laboratories performing hair mineral analysis. JAMA 2001; 285:67.",
"     </a>",
"    </li>",
"    <li>",
"     Reigart JR, Roberts JR. Arsenical Pesticides. In: Recognition and Management of Pesticide Poisonings, 5th ed, U.S. Environmental Protection Agency, Washington 1999. p.126. Available at: www.epa.gov/oppfead1/safety/healthcare/handbook/handbook.htm (Accessed on October 12, 2011).",
"    </li>",
"    <li>",
"     Kosnett MJ. Arsenic. In: Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient, Brent J, Wallace K, Burkhart KK, et al.  (Eds), Mosby, Philadelphia 2004. p.799.",
"    </li>",
"    <li>",
"     Howland, MA. Dimercaprol (British Anti-Lewisite or BAL). In: Goldfrank's Toxicological Emergencies, Nelson, LS, Lewin, NA, Howland, MA, et al (Eds), McGraw-Hill, New York 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/95\">",
"      Guha Mazumder DN, De BK, Santra A, et al. Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water. J Toxicol Clin Toxicol 2001; 39:665.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Labor. Occupational Safety and Health Administration. Available at: www.osha.gov/SLTC/arsenic/index.html (Accessed on October 12, 2011).",
"    </li>",
"    <li>",
"     National Institute of Occupational Safety and Health. NIOSH Pocket Guide to Chemical Hazards. Available at: www.cdc.gov/niosh/npg/npgd0038.html (Accessed on October 12, 2011).",
"    </li>",
"    <li>",
"     World Health Organization. Arsenic in Drinking Water. Available at: www.who.int/water_sanitation_health/dwq/arsenic/en (Accessed on October 12, 2011).",
"    </li>",
"    <li>",
"     National Research Council (NRC). Arsenic in Drinking Water, 2001 Update. National Academy Press, Washington, DC 2001. Available at: www.epa.gov/safewater/arsenic/index.html (Accessed on October 12, 2011).",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Arsenic in Food Products. Available at: file://www.aap.org/en-us/about-the-aap/aap-press-room/pages/Arsenic-in-Food-Products.aspx?nfstatus=401&amp;nftoken=00000000-0000-0000-0000-000000000000&amp;nfstatusdescription=ERROR%3a+No+local+token (Accessed on January 02, 2013).",
"    </li>",
"    <li>",
"     Pediatric Environmental Health Specialty Units. Information on Arsenic in Food. Available at: file://aoec.org/PEHSU/documents/arsenic_in_food_geller_oct2012.pdf (Accessed on January 02, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/33/8730/abstract/102\">",
"      Peters HA, Croft WA, Woolson EA, et al. Seasonal arsenic exposure from burning chromium-copper-arsenate-treated wood. JAMA 1984; 251:2393.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2778 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-6CC31590FA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8730=[""].join("\n");
var outline_f8_33_8730=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1229512021\">",
"      SOURCES OF EXPOSURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14059280\">",
"      Drinking water",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14059287\">",
"      Dietary ingestion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pressure-treated wood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      BIOLOGICAL BASIS OF DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL TOXICITY AND PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Acute poisoning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chronic toxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Skin lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Neurologic manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Liver",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Endocrine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Respiratory",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H266025104\">",
"      - Mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H266025123\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Reproductive and developmental",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Nursing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Childhood exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Acute exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Chronic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Acute poisoning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H201734145\">",
"      - Chelation for acute poisoning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5643077\">",
"      Chronic or subacute poisoning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5643085\">",
"      - Chelation for chronic poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      General issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Referral",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/2778\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2778|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/24/6528\" title=\"picture 1\">",
"      Arsenical skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/44/33486\" title=\"picture 2\">",
"      Arsenical hyperkeratosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/2778|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/12/11468\" title=\"table 1\">",
"      Arsenic chelating agents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/39/12922?source=related_link\">",
"      Adult lead poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/20/8521?source=related_link\">",
"      Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12298?source=related_link\">",
"      Cigarette smoking and other risk factors for lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26586?source=related_link\">",
"      Epidemiology and etiology of urothelial (transitional cell) carcinoma of the bladder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33098?source=related_link\">",
"      Overview of acquired peripheral neuropathies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14553?source=related_link\">",
"      Overview of occupational and environmental health",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=related_link\">",
"      Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_33_8731="Sleep restriction rules";
var content_f8_33_8731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69303&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sleep restriction rules",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Determine the patient's average sleep time from a sleep diary.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Use this average sleep time as the new time allowed in bed each night.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Set a consistent wake time based upon the type of insomnia and patient need.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Have patient avoid daytime naps.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. If sleep efficiency increases above 90 percent (85 percent for patients over 65 years of age), then increase time in bed by 15 to 30 minutes.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. If sleep efficiency decreases below 85 percent (80 percent for patients over 65 years of age), then decrease time in bed by 15 to 30 minutes.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Spielman, AJ, Yang, et al. Insomnia: Sleep restriction therapy. In: Insomnia Diagnosis and Treatment, Sateia, MJ, Buysse, DJ (Eds), Informa UK Ltd, London 2010. p.277.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8731=[""].join("\n");
var outline_f8_33_8731=null;
var title_f8_33_8732="CF microorganisms";
var content_f8_33_8732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F55018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F55018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Microorganisms isolated from respiratory secretions of patients with cystic fibrosis, all ages",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Organism",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent with positive respiratory cultures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Staphylococcal aureus",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        67",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Methicillin resistant S. aureus",
"       </td>",
"       <td class=\"sublist_other\">",
"        26",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist1_start\">",
"        P. aeruginosa",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        51",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Multiple drug resistant",
"       </td>",
"       <td class=\"sublist_other\">",
"        10",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        H. influenzae",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Stenotrophomonas maltophilia",
"       </td>",
"       <td>",
"        14",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist1_start\">",
"        Burkholderia cepacia complex",
"       </td>",
"       <td rowspan=\"4\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        B. cenocepacia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        B. multivorans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Others",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Achromobacter (Alcaligenes) xylosoxidans",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist1_start\">",
"        Non-tuberculous mycobacteria",
"       </td>",
"       <td rowspan=\"4\">",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        M. avium complex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        M. abscessus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Others",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Aspergillus species",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: the Cystic Fibrosis Foundation Registry, 2010.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8732=[""].join("\n");
var outline_f8_33_8732=null;
var title_f8_33_8733="American Society of Anesthesiologists physical status scale";
var content_f8_33_8733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    American Society of Anesthesiologists physical status scale",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        ASA class",
"       </td>",
"       <td class=\"subtitle1\">",
"        Physical status",
"       </td>",
"       <td class=\"subtitle1\">",
"        Functional status",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples",
"       </td>",
"       <td class=\"subtitle1\">",
"        Risk status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        Healthy, no disease outside surgical process",
"       </td>",
"       <td>",
"        <p>",
"         Can walk up one flight of stairs or two level city blocks without distress",
"        </p>",
"        <p>",
"         Little or no anxiety",
"        </p>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <p>",
"         Little or no risk",
"        </p>",
"        <p>",
"         <strong>",
"          Green flag for treatment",
"         </strong>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        Mild to moderate systemic disease, medically well controlled, with no functional limitation",
"       </td>",
"       <td>",
"        <p>",
"         Can walk up one flight of stairs or two level city blocks but will have to stop after completion of the exercise because of distress",
"        </p>",
"        <p>",
"         ASA I with extreme anxiety and fear, a respiratory condition, pregnancy or active allergies",
"        </p>",
"       </td>",
"       <td>",
"        Well controlled disease states including diabetes, hypertension, obesity, epilepsy, asthma or thyroid conditions",
"       </td>",
"       <td>",
"        <p>",
"         Minimal risk",
"        </p>",
"        <p>",
"         <strong>",
"          Yellow flag for treatment",
"         </strong>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        Severe systemic disease that results in functional limitation",
"       </td>",
"       <td>",
"        Can walk up one flight of stairs or two level city blocks but will have to stop enroute because of distress",
"       </td>",
"       <td>",
"        History of angina pectoris, MI, CVA; HF &gt;six months ago, COPD, diabetes with vascular complications, poorly controlled HTN, morbid obesity",
"       </td>",
"       <td>",
"        <strong>",
"         Yellow flag for treatment",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        Severe incapacitating disease process that is a constant threat to life",
"       </td>",
"       <td>",
"        Unable to walk up one flight of stairs or two level city blocks. Distress is present even at rest.",
"       </td>",
"       <td>",
"        <p>",
"         History of unstable angina, MI or CVA within last&nbsp;six months; severe HF, severe COPD; uncontrolled diabetes, HTN, epilepsy or thyroid condition",
"        </p>",
"        <p>",
"         Advanced pulmonary, renal or hepatic dysfunction",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         The risk may be too great for elective surgical procedure",
"        </p>",
"        <p>",
"         Medical consultation needed for emergency treatment",
"        </p>",
"        <p>",
"         <strong>",
"          Red flag for treatment",
"         </strong>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        Moribund patient not expected to survive 24 hours without an operation",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Ruptured abdominal aneurysm, pulmonary embolus, head injury with increased intracranial pressure",
"       </td>",
"       <td>",
"        <p>",
"         Elective treatment is contraindicated; however, emergency surgery may be necessary",
"        </p>",
"        <p>",
"         <strong>",
"          Red flag for treatment",
"         </strong>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        A declared brain-dead patient being maintained for harvesting of organs",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E",
"       </td>",
"       <td>",
"        Suffix to indicate emergency surgery for any class",
"       </td>",
"       <td>",
"        Any patient in whom an emergency operation is required",
"       </td>",
"       <td>",
"        Otherwise healthy young woman requiring D&amp;C for persistent vaginal bleeding",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MI: myocardial infarction; CVA: cerebrovascular accident; HF: heart failure; HTN: hypertension; D&amp;C: dilation and curettage.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Cohen MM, Duncan PG, Tate RB. Does anesthesia contribute to operative mortality? JAMA 1988; 260:2859 and Malamed SF. Medical Emergencies in the Dental Office, Sixth Edition, Mosby Elsevier, St Louis 2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8733=[""].join("\n");
var outline_f8_33_8733=null;
var title_f8_33_8734="Contents: Primary care ophthalmology";
var content_f8_33_8734=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care ophthalmology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care ophthalmology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/52/6986\">",
"           Age-related macular degeneration: Clinical presentation, etiology, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/29/26074\">",
"           Age-related macular degeneration: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/54/9063\">",
"           Angle-closure glaucoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/16/26888\">",
"           Approach to the adult with acute persistent visual loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/38/19048\">",
"           Blepharitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/19/2362\">",
"           Cataract in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/11/36023\">",
"           Classification and clinical features of diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/28/29128\">",
"           Complications of contact lenses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/17/20760\">",
"           Conjunctivitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/50/34600\">",
"           Corneal abrasions and corneal foreign bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/11/25784\">",
"           Dry eyes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/63/4088\">",
"           Eyelid lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/12/33992\">",
"           Herpes simplex keratitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/29/42457\">",
"           Laser refractive surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/59/15289\">",
"           Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/2/34855\">",
"           Open-angle glaucoma: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/48/18183\">",
"           Overview of contact lenses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/2/15396\">",
"           Photokeratitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/38/32362\">",
"           Prevention and treatment of diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/57/41879\">",
"           Pterygium",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/41/36504\">",
"           Retinal detachment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/13/4311\">",
"           Retinal vein occlusion: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/53/38743\">",
"           Retinal vein occlusion: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/27/19896\">",
"           Retinitis pigmentosa: Clinical presentation and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/53/17239\">",
"           Retinitis pigmentosa: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/16/23817\">",
"           Uveitis: Etiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/10/10407\">",
"           Uveitis: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/17/2329\">",
"           Visual impairment in adults: Refractive disorders and presbyopia",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-C970BB8C3D-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f8_33_8734=[""].join("\n");
var outline_f8_33_8734=null;
var title_f8_33_8735="Metaphyseal transverse bands congenital syphilis";
var content_f8_33_8735=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital syphilis: Transverse metaphyseal bands and diaphyseal destruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 186px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transverse bands of increased density across the metaphyses (small arrows) associated with patchy areas of bone destruction in the diaphyses. There is solid periosteal new bone formation (large arrow), which is best seen about the distal humerus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Eisenberg RL. An Atlas of Differential Diagnosis, 4th ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_33_8735=[""].join("\n");
var outline_f8_33_8735=null;
         